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Abstract
Prevalence rates of type 2 diabetes and impaired fasting glyceamia (IFG) in Sri Lanka are high and an 
increasing number of people are succumbing to disease. Identifying people at risk of developing 
complications is a healthcare priority of the county to prevent morbidity and mortality. Type 2 
diabetes is familiarly aggregated and maternal influence for disease transmission has been observed in 
European countries but not in South India. The severity of periodontitis is reported to be high when 
diabetes control decreases but data relating to periodontitis as a complication of diabetes is not present 
in this population. Periodontal associated genotype (PAG), presence of allele 2 of both {ILIA (+4845) 
& IL1B (+3954)}) is positively associated with periodontal disease in some populations but ruled out 
in other populations. Heightened levels of TNF-a level have been observed in both patients with type 
2 diabetes and periodontitis.
This study aimed to determine familial aggregation of type 2 diabetes and parental influence of disease 
transmission in the Sri Lankan population. The project also aimed to investigate periodontal status in 
diabetic patients and the effect of glycaemic control on periodontal status. The final aim of the project 
was to investigate the role of cytokine polymorphisms PAG and TNFA (-308) in association with 
periodontitis in people with type 2 diabetes.
Family history data for one thousand patients was collected and analyzed. Subjects with established 
diabetes were recruited to the periodontal study (n=285) with an age and sex matched control 
population (n=72). All subjects underwent both periodontal and general health examination. Their 
periodontal parameters and metabolic parameters were measured including blood pressure, TG and 
LDL values. Patients were genotyped by PCR/RFLP method.
The results of the study indicated that 59.4% of the diabetic subjects had at least one affected first 
degree relative in the family. It was also observed that 15.6% of mothers transfer the disease compared 
to (12.5%) of fathers (p<0.001). When both parents had diabetes the early age of onset of diabetes is 
observed among offspring compared to offspring of maternal, paternal and no parental history of 
diabetes respectively (p<0.05). 16.67% (12/72) of the control patients were identified as IFG and 
66.67% (8/12) of this group were diagnosed with periodontitis. Systolic BP, diastolic blood pressure 
and LDL values were significantly lower in patients than controls (P<0.05). Triglyceride levels were 
significantly higher in patients with diabetes than controls (p=0.001). A higher number of diabetic 
subjects were affected with chronic periodontitis (33.3%) compared to the non diabetic population 
(21.7%) (p=0.077). People with diabetes had significantly higher mean recession, percent bleeding on 
probing (BOP), maximum Probing depth (PD), PD > 4mm, PD >5mm and maximum loss of 
attachment (LOA) scores than the non diabetic population (p<0.01). Glycaemic control had no 
significant effect on periodontal status (p>0.05). Subjects with periodontitis were significantly older 
than those with gingivitis or periodontally healthy (p<0.01). Only FBG values were significantly 
higher in subjects with chronic periodontitis compared to periodontally healthy subjects (p<0.01). 
Population frequency analysis of allele 1 vs. allele 2 were 0.9 & 0.1 for IL1B (+3954), 0.74 and 0.26 
for ILIA (+4845) and 0.91 and 0.09 for TNFA (-308) respectively. The TNFA (-308) polymorphism 
deviates from the frequencies observed in North British Caucasians but similar to that observed in 
Taiwan and Japan. PAG had no significant effect on periodontal status in diabetes and controls 
(p>0.05). The percentage of PAG (12.5%) is low compared to Caucasians but higher compared to 
Chinese population. TNFA (-308) allele distribution had no significant effect on periodontal status. 
TNFA (-308) genotypes were significantly correlated with HDL.
The results of the present study indicate that type 2 diabetes is familiarly aggregated in the Sri Lankan 
diabetic population and maternal excess is observed in the transmission pattern. There is a trend 
towards periodontital status to be higher in the diabetic population. Severity of periodontitis is higher 
in people with diabetes than those without and there is an indication that periodontitis may induce 
hyperglycaemia. PAG distribution shows population variation and the TNFA (-308) polymorphism 
may be associated with diabetes.
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1.1. Diabetes mellitus: a brief overview
Diabetes Mellitus is a common metabolic disorder of multiple aetiology characterised by 
hyperglycaemia. According to recent estimated measures this disease has afflicted 246 
million people throughout the world in the year 2007 and the projected disease prevalence 
in year 2025 is 380 million representing 7.1% of the world adult population (UN resolution 
61/225 2007). This spreading epidemic causes a major public health problem and has a 
huge economic impact. The effects of diabetes mellitus are long term. Prolonged 
hyperglycaemia causes failure and damage to various organs in the body (Alberti &
Zimmet 1998). It is associated with reduced life expectancy, significant morbidity due to 
specific diabetes related microvascular complications, increased risk of macrovascular 
complications (ischaemic heart disease, stroke and peripheral vascular disease), and 
diminished quality o f life.
The disease is known to prevail from antiquity. The first written record of the disease dates 
back to ancient Egypt in 1550 B.C. George Moritz Ebers discovered the papyrus named 
after him in 1862 in a Thebes cave, which describes the polyuric state of diabetes. Aretaeus 
of Cappadocia assigned the epithet diabetes to the disease in second century AD referring 
to the excessive passage of urine. The existence of two forms of diabetes, one clearly 
affecting thin people who did not survive and the other affecting older fatter people was 
first reported in Sanskrit Literature by two Indian Physicians, Susruta and Charuka. 
Accurate clinical features, gangrene and collapse of sexual function and the sweet taste of 
the urine of the diabetic patients came to light in the 10th century. Thomas Willis 
rediscovered the presence of sweet taste of urine in the 17th century. Mellitus, a Latin term 
meaning as sweet as honey was used to distinguish the disease from other polyuric states 
and some important thoughts for the involvement of pancreas with the disease were put 
forward in 18th century. Claude Bernard (1813-1878) discovered the association of the 
central nervous system in the balance of blood glucose concentration and storage of glucose 
in the liver in the form of glycogen during the progression of understanding of the disease 
in the 19th century (Conti 2001). Coma associated with diabetes, retinosis in glycosuria 
patients, the glucose lowering property of the pancreas, and the discovery of islet cells in 
the pancreas by Paul Langerhans were some other important discoveries during the latter 
19th century (Egeler et al. 1994). The most important breakthrough was made in 1921 with
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the discovery of insulin by the Toronto team (Macleod, Banting, Best and Collip) (Jarrett 
1991).
The principal feature of diabetes is hyperglycaemia, which may result due to disturbances 
in carbohydrate, fat and protein metabolism. The endocrine and metabolic systems of the 
body collectively play a major role in glucose homeostasis. Glucose is consumed by the 
peripheral tissues to produce energy. In abundance it is stored as glycogen in the liver and 
excess is converted to lipid via lipogenesis. When the metabolic fuels are insufficient, the 
liver converts stored glycogen to glucose to overcome the deficit and if this is not 
sufficient, it will produce glucose via gluconeogenesis. All these metabolic pathways are 
regulated by specific enzymes that are coded by different genes but the tissue uptake and 
utilisation of glucose is controlled by the hormone insulin secreted by pancreatic beta cells 
(Bergman 2007).
Insulin is a major anabolic hormone. It regulates glycogenolysis, gluconeogenesis, 
lipogenesis and glycolysis. In the absence of, or with defects in insulin secretion, mutated 
insulin or with an insulin resistance state, the normal tissue uptake o f glucose diminishes 
and plasma level of glucose rises. This signals to the metabolic system a glucose reducing 
state, converting the entire anabolic system to a catabolic state. The ultimate result is the 
production of glucose in the liver via gluconeogenesis further increasing blood glucose 
levels. If one of the enzymes is defective in one of the metabolic pathways of carbohydrate 
metabolism, it may lead to disturbances of glucose homeostasis. Enzymes are products of 
genes. Therefore, different genotypes can result in a common phenotype of glucose 
homeostasis. Thus, the disease is heterogeneous and complex in etiology. Certain clear 
monogenic forms of diabetes have shown defects in different genes, peroxisome 
proliferator activated receptor gamma (PPARy) (Altshuler et al, 2000), Hepatocyte nuclear 
factor l a  (HNFla) and 4a (HNF4a) (Hegele et al, 1999), Insulin receptor (Huxtable et al, 
2000), Calpain 10 gene (Tsuchiya 2006), Transcriptional factor 7 (TCF7L2) (Grant et al. 
2006) and mitochondrial genome (Poulton et al, 2002) appear to influence type 2 diabetes.
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1.2 Classification and diagnosis of diabetes
The present classification system was based on the clinical stages and aetiological types of 
diabetes mellitus (Report of WHO, 2006). Based on the clinical stages, the early stages are 
classified firstly as impaired glucose regulation in which two distinct states have been 
identified, impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG). These 
stages are encountered during the progression of the disease and an individual subject may 
move from one stage to another in either direction, either towards normoglycaemia or 
towards diabetes mellitus. A fasting venous plasma glucose concentration <1 lOmg/dl has 
been considered as normoglycaemia. Individuals with impaired glucose regulation (either 
IGT or IFG) are at greater risk of developing micro and macrovascular complications \ 
(Table 1.1).
Diabetes is considered to be present when sequential fasting plasma glucose levels are 
>126mg/dl (7 mmol/1) or 2-hour post glucose loading plasma levels are > 200mg/dl 
(11.1 mmol/1). Individuals with impaired fasting glucose (IFG) demonstrate fasting plasma 
levels of 110-126mg/dl (6.1 - 6.9 mmol/1), while those with impaired glucose tolerance 
(IGT) display 2-hour post glucose loading plasma levels between 140mg/dl and 200mg/dl. 
(Alberti & Zimmet 1998 & report of WHO 2006). Diagnosis of diabetes by impaired 
fasting glucose or an oral glucose tolerance test requires that the patient be fasting.
Recently, consensus was generated regarding screening and diagnosis of diabetes with 
particular reference to the use of hemoglobin A le (HbAlc). HbAlc is a form of 
hemoglobin used primarily to identify the average plasma glucose concentration over 
prolonged periods of time. It is formed in a non-enzymatic pathway by hemoglobin's 
normal exposure to high plasma levels of glucose. There are several advantages of using 
HblAc for screening and diagnosis over currently established diagnostic methods as 
patients do not need to be fasting, HbAlc values more accurately reflect the longer term 
glycaemia than plasma glucose, and laboratory methods are standardized and reliable. 
Errors, if any, can be minimized by confirming the diagnosis with a plasma glucose specific 
test. At present HbAlc >6.1% confirmed by plasma or oral glucose tolerance test can be 
used to confirm the diagnosis of diabetes (Saudek et al. 2008).
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Table 1.1 WHO diagnostic criteria for diabetes diagnosis
Glucose concentration (mmol I'1 (mgdl'1)}
whole blood Plasma
Diabetes Venous Capillary Venous
Fasting or >6.1(>110) >6.1 (>110) >7.0 (>126)
2hours post glucose load or both >10.0 (>180) >11.1 (>200) >11.1 (>200)
Impaired Glucose Tolerance (IGT)
Fasting if measured <6.1 (110) <6.1(<110) <7.0 (<126)
And 2hours glucose load >6.7 (>120) and >7.8 (>140) and >7.8 (>140) and
<10.0 (<180) <11.1(<200) <11.1 (200)
Impaired fasting glycaemia (IFG)
Fasting >5.6 (>100) and >5.6 (>100) and >.1(>110) and
<6.1 (<110) <6.1 (<100) <7.0 (< 126)
2 hours if measured* <6.7 (<120) <7.8 (<140) <7.8 (<140)
*Venous plasma glucose- 2 hours after ingestion of 75g oral glucose load.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 
(1997 & Report of WHO/IDF consultation 2006).
1.2.1 Type 1 diabetes
In type 1 diabetes, major contributory factors to the predisposition of the disease are genetic 
and environmental factors which are poorly understood. Autoimmune antibodies destroy 
the p cells in the pancreas resulting in an absolute deficiency of insulin (Jarrett 1991). The 
presence of anti-glutamic acid decarboxylase (anti-GAD) islet cell or insulin antibodies that 
cause p-cell destruction have been observed in some patients with type 1 diabetes. GAD is 
an intracellular enzyme required for the synthesis of neurotransmitter gamma-amino butyric 
acid (GABA). GAD65 is primarily expressed in pancreatic p cells (Lemmark 1996). In 
some patients there is no evidence for an autoimmune process, and their diabetes falls into 
the category of idiopathic type 1 diabetes mellitus. The rate of destruction of p cells is rapid 
in children but slower in adults. Adult onset of type 1 diabetes is also referred to as latent 
autoimmune diabetes in adults (LADA) (Pozzilli & Di Mario 2001).
There are seven symptoms listed by the American Diabetes Association (ADA) in 
association with type 1 diabetes. These are thirst, polyuria, weight loss, increased fatigue 
and tiredness with minor symptoms like muscular cramps, irritability and blurred vision 
due to osmotic changes in the lens. (Nathaniel et al. 2007). In addition, skin infections, 
penile or vulval pruritis due to Candidiasis is common. Nausea, vomiting and drowsiness 
usually denote impending ketoacidosis and possible coma. Microvascular complications are 
extremely rare. The duration of symptoms is short, usually only 2-3 weeks or less (Alberti 
& Zimmet 1998).
Clinical stages of the disease are diagnosed according to the WHO criteria mentioned 
above (Table 1.1). Apart from the clinical features, the presence of islet cell auto­
antibodies, antibodies to insulin and antibodies to (GAD65) confirm type 1 diabetes 
(Yliharsila et al. 1999).
Patients with type 1 diabetes require insulin for survival or to prevent ketoacidosis, coma 
and death (Alberti & Zimmet 1998). After commencing insulin treatment many patients 
enjoy excellent glycaemic control with only small doses of insulin (sometimes referred to 
as the honeymoon period). This improvement corresponds to temporary improvements in (3 
cell function caused by lowering of high glucose levels, which directly impair (3 cell 
function and insulin release. However, continued autoimmune destruction o f the remaining 
P cells may reach a point that cannot be compensated for by insulin. As hyperglycaemia 
itself may damage remaining p cells, intensive blood glucose control is required 
immediately after diagnosis. Islet cell transplantation offers the potential to improve 
glycaemic control (Shapiro et al. 2006).
1.2.2 Type 2 diabetes mellitus
The disease is characterised by insulin resistance and impaired insulin secretion (Valsania 
& Micossi 1994) and both are present at the time of clinical manifestation. The question of 
which defect occurs first was debated for a long period. Recent studies provide evidence 
that a phase of hyperinsulinaemia is preceded by the development of type 2 diabetes, thus 
insulin resistance is the possible initiator for the etiology. During this stage, hepatic glucose 
output is normal (Gorden 1997). Insulin resistance primarily affects the peripheral 
utilisation of glucose mainly by the muscle (Granner & O’Brien 1992). Increased glucose
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levels in the blood signal to the pancreatic p cells an insulin reduced state, which leads to 
further secretion of insulin. Finally, the p cells reach an ‘exhausted’ state where they are no 
longer capable of producing insulin. Thus, impaired insulin secretion results, ultimately 
leading to glucose imbalance. The disease usually remains undiagnosed for several years. 
Hyperglycaemia may be present but it alone is not severe enough to provoke the symptoms. 
By the time of diagnosis, hyperglycaemia has often caused significant damage to the organs 
and these patients are at a risk of developing micro- and macrovascular complications 
(Alberti & Zimmet 1998).
The classical symptoms of type 2 diabetes are those of hyperglycaemia, thirst, polyuria and 
fatigue. Weight loss and ketoacidosis are not frequent (Jerrett 1991). Ketoacidosis may be 
associated with the stress of another illness such as infection (Nathaniel et al. 2007).
Patients are initially treated with a normocaloric diet excluding refined carbohydrates; if 
this control is still inadequate a sulphonylurea drug is usually added (Mooradian 1996). 
These drugs act by stimulating insulin release from pancreatic p cells in response to a 
glucose load and promote insulin uptake in body tissues. Short acting sulphonylurea drugs 
are tolbutamide, tolazamide and acetohexamide which are maximally effective for up to 24 
hours, while long active agents such as chloropropamide and glipizide are effective for up 
to 36 hours (Physicians’ Desk Reference 1998). Repaglinide is an ultra-short-acting agent 
with rapid onset and is usually taken immediately prior to each meal and has a decreased 
risk of hypoglycaemia (Melander 1996). Obesity promotes insulin resistance, and insulin 
sensitivity can be improved by weight reduction and increased physical activity. Obese 
patients are initially treated with a weight-reducing diet (also sugar free), with metformin 
often used as second line drug treatment (Jerrett 1991). This is thought to act by stimulating 
glucose uptake by skeletal muscle and decreasing hepatic glucose output. It also causes 
anorexia and reduces glucose absorption thereby reducing weight. In decreased insulin 
production, injectable insulin is available in multiple forms from bovine, porcine and 
human made by recombinant DNA technology (Mealey 1998).
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1.2.3 Other forms of diabetes
Maturity onset of diabetes of the young (MODYf
This is a less common early onset form of diabetes, and the disease has a clear autosomal 
dominant inheritance pattern. However, a variation in different genes to this form has been 
observed in different families (Froguel & Velho 1999). Therefore MODY is a genetically 
heterogeneous monogenic form of type 2 diabetes, characterised by early onset, usually 
before 25 years of age (Fajans 1989). Approximately 5% o f the patients with type 2 
diabetes have this form.
Gestational hyperglycaemia and diabetes.
Gestational diabetes is carbohydrate intolerance resulting in hyperglycaemia of variable 
severity with onset or first recognition during pregnancy (Moore 2005). Pregnant women 
who meet the WHO standards for diabetes diagnosis following an oral glucose tolerance 
test after an overnight fast fall into this category.
Diabetes Insipidus
This results from a deficiency in the pituitary hormone vasopressin or resistance for this 
honnone by the kidney. The decreased production of an action of vasopressin results in 
excessive urine production and polyuria but does not have any effect on blood glucose 
levels (Position paper 2000).
1.3 Genetics of complex diseases
Many complex diseases such as type 2 diabetes, obesity and periodontitis are regarded as 
resulting from the interaction between genes, proteins and the environment. Therefore, 
improved understanding of genetic and environmental contributions to complex diseases 
may ultimately shift the focus of medicine from the disease itself to the genetic 
characteristics of individuals, and to their experiences, habits and environmental conditions. 
A focus on the genetic, developmental and environmental components of diseases and their 
unique combinations in a given individual could potentially facilitate more effective 
methods of prevention. Once the genetic basis for susceptibility to a complex disease is 
established, the healthcare profession could target and monitor potential sufferers, help 
them to avoid the environmental factors that can provoke disease and encourage early self- 
detection of signs and symptoms.
The basis of genetic variation
Variations in DNA have arisen during evolution as a consequence of mutations, and new 
mutations arise in single individuals in somatic cells or in the germline. If a germline 
mutation does not impair an individual’s ability to have offspring who can transmit the 
mutation, it can become established in the population, and such mutations are frequently 
called polymorphisms (Greek polymorphos, which means multiform) (Chakravarti 1999, 
Strachan & Read 1999). In genetics, the term “polymorphism” is used to indicate that a 
particular position in the DNA has more than one form in the population (Strachan & Read 
1999). The term “allele” is used to refer to a particular form occurring at a given position, 
and the position is called a “locus.” A genotype is a description of the two alleles at a 
particular locus. A distinction has been made between “variations” and “polymorphisms” in 
that a locus is only called polymorphic if the most common variant occurs in < 99% of the 
population and consequently all other variants occur with a total frequency of > 1%. The 
term “mutation” refers to a rare variant that is the primary cause of a clinical phenotype or 
disease, whereas the term “polymorphism” is used to denote a variant present in the 
population in a relatively high frequency. Polymorphism itself is not sufficient to cause a 
disease, although it may contribute to susceptibility to a disease or variation in functional 
properties of a protein (Romero et al. 2002).
There are different types of variations in DNA. The simplest is a single nucleotide 
polymorphism (SNP). This is a variation in the identity of a single nucleotide at a particular 
site in the genome (Chakravarti 1999, Weiss & Terwilliger 2000, Fallin et al. 2001, Tabor 
et al. 2002). SNPs are classified according to their position in or around genes into coding 
and noncoding polymorphisms (Chakravarti 1999). Noncoding polymorphisms may occur 
in the promoter region of the gene, within introns, 5'- and 3'- untranslated regions (regions 
of the gene that are present in the mRNA but do not code for protein), and intergenic 
regions (Strachan &Read 1999). Noncoding polymorphisms do not alter the base pair 
sequence in the part of the DNA that codes for the protein but may alter the rate of 
transcription, the processing, or the stability of the mRNA. They may change the amount o f 
protein generated by translation. Coding SNPs are classified into synonymous and 
nonsynonymous (Chakravarti 1999, Weiss & Terwilliger 2000, Fallin et al. 2001, Tabor et 
al. 2002). Synonymous polymorphisms change the codon into another that codes for the 
same amino acid. Therefore, there is no change in the structure of the protein.
Nonsynonymous SNPs change the codon to one specifying for a different amino acid and 
therefore may change protein structure. In addition there are more complex type of DNA 
variations, microsatellite repeats and minisatellite repeats which consist of repeated units of 
nucleotides of variable lengths (Strachan & Read 1999).
1.3.1 DNA markers for genetic mapping
To identify polymorphisms in the genome by genetic mapping DNA markers are required. 
Minisatellites and microsatellites DNA markers are used to identify polymorphisms in the 
genome. They are highly polymorphic and microsatellites are preferred as a marker since 
they are evenly spaced across the genome and PCR has made mapping using microsatellites 
relatively quick and easy. Mapping genes with SNPs has also become easy using high 
throughput methodologies such as DNA microarrays. There could be 3 genotypes for a 
single SNP among individuals in a given population. A SNP which generates a restriction 
fragment length polymorphism (RFLP) can be easily typed by PCR. A sequence including 
the variable restriction site is amplified; the PCR product is incubated with the appropriate 
restriction enzyme and then run on a gel to analyse the digestion products.
1.3.2 Mapping genes in complex diseases
There are several main approaches that have been used in the search for the genes involved 
in complex diseases
Candidate gene approach
In the candidate gene approach, genes with a known or proposed function with potential to 
influence the disease phenotype are investigated for a direct role in the disease. Here, a 
candidate gene encodes a protein of known function which, if  mutated, could account in 
part for the pathogenesis of the disorder. The success of this approach depends on knowing 
enough about the possible molecular pathogenesis of the disorder to make an educated 
guess as to candidates. These approaches can be applied without any prior knowledge of 
the biological basis of the disease using genome-wide studies, combined with the candidate 
gene approach and comparative analyses using animal models of disease. The most 
successful application of the candidate gene approach to mapping complex diseases in 
humans has been with the HLA region. Genes in the HLA region have been implicated in 
the aetiology of over 200 diseases (Svejgaard 1996, Thorsby 1997). These include:
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complex autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple 
sclerosis; cancers such as Hodgkin's disease; infectious diseases such as malaria, 
tuberculosis and AIDS; and other diseases such as narcolepsy.
Parametric linkage analysis
Parametric linkage analysis depends on following the inheritance of genetic markers in 
extended pedigrees to look for cosegregation of marker alleles in affected individuals, 
under a defined model of inheritance. The logic is that if a gene somewhere in the genome 
is responsible for the disease, affected family members are expected to have inherited the 
same disease-predisposing allele at the locus, and markers that lie physically near this 
disease gene will be transmitted with the disease allele (Risch 2000). This requires a precise 
genetic model, detailing the mode o f transmission, gene frequencies, penetrance, 
dominance, and genetic heterogeneity. This is successful in mapping genes for Mendelian 
diseases. In the context of complex diseases this method is successful in a subset of cases 
where alleles are segregating in a Mendelian fashion. (BRCA1 and BRCA 2 genes)
Non-parametric analysis
This method does not require a specific genetic model. These methods ignore unaffected 
people and look for alleles or chromosomal segments that are shared by affected 
individuals. Shared segment methods can be used in whole populations, within nuclear 
families and within known extended families.
Population association studies
Association studies are usually carried out in populations and based on the assumption that 
affected individuals carry a particular marker allele more frequently than unaffected 
members of the control group (tests for co occurrence of marker and disease) (Khoury et al. 
1993, Cardon & Bell 2001). Association may also be due to linkage disequilibrium which 
can occur because an ancestral mutation responsible for the disease in a population 
occurred on a chromosome carrying the associated allele at a closely linked site. Linkage 
disequilibrium is a population association between a marker and a disease allele (Khoury et 
al. 1993). The most commonly applied strategies for association studies are case control 
study designs (Cardon & Bell 2001). The advantage of this approach is that cases are 
readily available, can be efficiently genotyped and compared with control populations.
However, the results of case control studies are often inconsistent and this can be attributed 
to number of factors including clinical heterogeneity (associations are observed with certain 
subsets of the disease), genetic heterogeneity (it should be expected to find ethnic 
differences in association studies) and study design ( small sample size, poor quality control 
of genotyping data and inappropriate selection of controls which are not ethnically matched 
will lead to spurious associations).
Family based association studies
A study design unique to genetic epidemiology is the “family-based association” design 
(Risch & Merikangas 1996, Collins-Schramm et al. 2002, Cardon & Bell 2001). Genetic 
association methods developed have focused on the need to account for population 
stratification. Family-based association studies use relatives of cases as controls, such as 
unaffected siblings or the non-transmitted alleles from parents.
Affected sibpair analysis (ASP)
This is usually based on affected sib pairs (ASP). Identity by state (IBS) alleles look the 
same and may have the same DNA sequence but are not derived from a known common 
ancestor. Identity by descent alleles (IBD) are demonstrably copies o f the same ancestral 
(usually parental) allele. A pair of siblings are expected to share 0, 1 or 2 parental 
haplotypes with percentage frequency of 25%, 50% and 25%. If the diseased siblings carry 
a mutant allele at a particular locus and if the disease is dominant they will share at least 
one parental haplotype and if the disease is recessive they will share both haplotypes 
(Strachan & Read 1999).
Patients and parents (Trio Model)
A commonly used family based association study is heterozygous parents and affected 
cases using transmission disequilibrium test statistics (TDT) (Dahlman et al. 2002). The 
test examines the transmission of potential disease alleles from a parent who is 
heterozygous for the marker to an affected offspring. It is a test of association only in the 
presence of linkage, and because family members act as controls, spurious associations due 
to population differences do not arise. The original test uses a single affected offspring and 
both parents. A number of modifications to the original TDT have been proposed that allow
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parents and an unaffected sibling to be analysed, making maximum use of incomplete 
nuclear family data.
1.4 Genetic basis of diabetes
Twin studies in type 2 diabetes have repeatedly shown that the concordance rate (the 
parameter that is usually measured in twins which describes the percentage proportion of 
identical twins to suffer from the same disease) in monozygotic twins is higher than that of 
the dizygotic twins, which ranges from 34% to 58% in monozygotic twins and 10% to 16% 
in dizygotic twins (Newman et al.1987, Kaprio et al.1992). According to the fundamental 
twin theory, monozygotic twins are genetically identical (Neale & Cardon 1990), and 
therefore if the compared disease rate in monozygotic twins is significantly higher than in 
dizygotic twins, this indicates that genetic factors are important in the disease etiology. If 
the rates are approximately equal this would infer that environmental factors predominate. 
Twin studies in Finland and Denmark, which were based on National Twin Registries 
(Hawkes, 1997) support the theory of additive genetic factors and shared and unshared 
environment factors, which may be the cause of type 2 diabetes (Kaprio et al. 1992).
Further evidence supporting a genetic basis for type 2 diabetes is provided by the fact that 
prevalence of diabetes varies in different ethnic backgrounds. It is believed that the unique 
genetic composition of each population may interact differently with environment factors 
for the development of the disease. The highest prevalence (48%) of type 2 diabetes of any 
population in the world is observed in the Pima Indians of Arizona (King & Rewers 1993, 
Pratley 1998). A high prevalence of 30.2% was observed among Nauruans (Diabetes Atlas 
2003) and 30% of aborigines in Australia when compared to 4% in the general population 
(Australian Institute of Health and Welfare 2003)
The prevalence of diabetes in the USA is 6.3% (National Diabetes Statistics fact Sheet 
NIDDK 2003) and 5.1% in the British population (Joint Health Survey Unit 2008). In the 
USA 8.7% of the people over 20 have diabetes, which is approximately 18 million people 
and an estimated 5.2 million people in the USA have undiagnosed type 2 diabetes (National 
Diabetes Statistics fact Sheet NIDDK 2003). The prevalence of type 2 diabetes is 11.4% of 
all non Hispanic Black and 8.2% for Hispanic Latino Americans over 20 years of age in the 
US (National Diabetes Statistics fact Sheet NIDDK 2003). 3% of women and 4% of men
were reported to have type 2 diabetes in Canada (Statistics Canada, National Population 
Health Survey, Health Canada, 1996/97) A low prevalence of 2% is seen in Iceland and 
2.7% in China (Diabetes Atlas 2003). Recent findings suggest that the prevalence of type 2 
diabetes in Sri Lanka is 14.2% in women and 13.5% in men (Wijewardena et al. 2005). 
Impaired glucose tolerance has risen from 5.07% in 1992 to 14.2% in 2005 in the adults 
between 35-65 years (Fernando 1992, Wijewardena et al. 2005). A similar cross sectional 
study conducted in Sri Lankans > 20 years of age revealed that the age-sex standardized 
prevalence of diabetes is 10.3% males and 10.9% for females. This study also highlighted 
that 36% of the people with diabetes were previously undiagnosed. The prevalence of pre­
diabetes (IFG, IGT and IFG+IGT) was 11.5%. This study forecasts the prevalence of 
diabetes, pre-diabetes and overall dysglycaemia for the year 2030 would be 13.9%, 13.1% 
and 26.2% respectively ( Katulanda et al. 2008).
The prevalence of diabetes can increase as members of populations move from one 
geographical area to another. For example, the prevalence of diabetes has been observed to 
increase in Japanese as they moved from Hiroshima to Hawaii, and then from Hawaii to 
Seattle (Gorden 1997). As another example, the prevalence of diabetes in South Asian 
immigrants to UK was reported to be 20-30% in the age 40-70 years age group in 1991 
(Jarrett 1991), whereas the prevalence of type 2 diabetes in the same ethnic groups in 
Singapore was 7.5% for Chinese and 14.7% for Malaysians at the same point in time (King 
& Rewers 1993).
A study in people of African descent, who reside in geographically diverse environments, 
provided an opportunity to examine the effects of environment and genetic factors which 
contribute to the predisposition of the disease (Osei et al. 1993). The populations examined 
were glucose tolerant first degree relatives of African American and Nigerian type 2 
diabetic patients living in US and healthy control subjects living in their native countries. It 
was clearly observed that geographical differences exist in insulin secretion (the mean 
fasting serum insulin levels were significantly greater in African American relatives than 
controls 16.0 ± 3.0 vs 6.3 ± 1.4 mU/L) and possibly also in metabolism in African 
immigrants living in the industrialized world compared to native Africans (Osei et al.
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1993). These data provide evidence for variation in the interactions between genetics and 
different environmental conditions.
1.4.1 Impact of lifestyle on diabetes prevalence
Life style clearly has a profound effect on the prevalence of diabetes. For example, 
prevalence increases as people move from a rural environment to an urban environment. 
This has been attributed to the changes o f traditional lifestyle from rural to westernized 
lifestyle in urban areas, such as increased food intake and reduced physical activity. 
Evidence supporting this was found in rural and urban Polynesians of Western Samoa, in 
which populations the prevalence of diabetes was 3.6% and 10.0% respectively (Permutt 
1990). In rural communities in Mexico the prevalence of type 2 diabetes in 1990 was 0.9 - 
3.0% in contrast to urban Mexican populations in which the estimate was 6.7 - 8.7% 
(Permutt 1990). The prevalence of type 2 diabetes in rural communities in Sri Lanka was 
only 2.5% in 1990 (Illangasekera et al. 1994), but this had risen to 8.5% by 2000 
(Illungasekera et al. 2004) and 8.7% in 2006 (Katulanda et al. 2008). The prevalence rates 
in Sri Lankan urban communities have risen froml3.9 % in 2005 (Wijewardena et al. 2005) 
to 16.4% in 2006 (Katulanda et al. 2008). The absence of type 2 diabetes mellitus in the 
traditional indigenous communities from Durango, Mexico, Tepehuano, Huichol and 
Mexicanero tribe members who do not have racial admixture and a minimal Western 
influence on lifestyle suggests that this disease is rare in traditional indigenous 
communities. It is assumed that this group of people in Mexico may be associated with less 
exposure to environmental risk factors or genetic susceptibility (Guerrero-Romero et al.
1997). According to King and Rewers prevalence of diabetes among certain ethnic groups 
in rural and urban areas is presented in figure 1.1. (King & Rewers 1993).
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Figure 1.1. Prevalence o f type 2 diabetes within the same or similar ethnic groups living 
under different geographical regions and environments
Figure 1.1 highlights the large range o f  type 2 diabetes prevalence even within the same or 
similar ethnic groups when living under different geographical and environmental 
conditions (King & Rewers 1993 adapted from Diabetes Atlas 2003).
1.4.2 Thrifty genotype and thrifty phenotype hypotheses
James Neel, in 1962, first suggested the concept o f  the thrifty genotype (Neel 1962). Based 
on his observations in Pima Indians, he assumed that so-called “thrifty genes” which 
increase susceptibility to diabetes, m ight have provided some form o f  evolutionary 
advantage for survival during the periods o f  starvation which regularly confronted our 
ancestors. Such a genotype would permit for storage o f  energy in the form o f  lipid during 
times o f plenty to be utilised for survival in times o f  starvation. However, although this 
would provide an evolutionary advantage to our hunter-gatherer ancestors, in m odern day 
times o f  plenty, and in a more sedentary society, this genotype instead increases 
susceptibility to diabetes (Turner et al. 1993). As a very rapidly occurring and recent 
example o f this, during the last 100 years Nauruans in the South Pacific have developed 
extreme obesity, insulin resistance and type 2 diabetes as a result o f  rapid introduction o f 
W estern lifestyles (Turner et al. 1993). The mechanism o f action o f  thrifty genotype in 
different ethnic groups has been suggested. They may operate via selective tissue insulin 
resistance.
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In addition to the thrifty genotype hypothesis, the thrifty phenotype hypothesis has also 
been proposed. This suggests that during gestation and the early postnatal period of life an 
individual becomes programmed for nutritional thrift in order to adapt to and survive in an 
environment of limited resources and poor nutrition (Barker et al. 2002, Wells 2007). This 
hypothesis raises questions regarding the extent to which the associations between 
nutrition, birth weight and adult health outcomes such as type 2 diabetes can be explained 
by common genetic factors or whether they result from foetal programming by the early 
environment (Hales et al. 1991, Philips 2004). Once established, this acquired metabolic 
phenotype is maintained throughout the lifetime of the individual and does not change. 
Thus, type 2 diabetes and related symptoms arise if  the metabolic program is set to “thrift” 
during early life and does not “match” the Westernised environment that an individual may 
encounter later in life. An example in support of this hypothesis is a study conducted in the 
Netherlands (“Dutch Hunger Winter Study”) that found a significantly higher incidence of 
obesity in a cohort of young adults whose mothers had been exposed to famine during their 
first two trimesters in 1944-1945 (Ravelli et al. 1976). The intrauterine environment 
appears to be a strong determinant of the body fat mass of an individual later in life (Wells 
et al. 2007). These findings led to the conclusion that the future functioning of hypothalmic 
centers regulating food intake is influenced by the amount of calorie intake at crucial times 
during development supporting early foetal programming (Wells et al. 2007).
1.5. Thrifty epigenotype hypothesis
A recently established thrifty epigenotype hypothesis states that the metabolic thrift, which 
is the capacity for efficient acquisition, storage and utilization of energy, is a complex trait. 
It further states that the environmentally responsive gene network of this trait is subjected 
to genetic canalization. According to this mechanism polygenic traits such as type 2 
diabetes are insensitive to allelic variations which are buffered and protected against these 
changes (Stoger 2008). Furthermore, this model predicts most of the polymorphisms 
identified in candidate genes play a minor role in aetiology in type 2 diabetes and obesity. 
Moreover, the hypothesis states that disease susceptibility is mainly due to epigenetic 
variations which are heritable variations that occur in the DNA structure (Methylation of 
CpG islands and modification of histone proteins) without that information being encoded 
in the nucleotide sequence of the gene (Bernstein et al. 2007).
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1.5.1 Genetic information about diabetes based on family studies
The positive family history observed in patients with type 2 diabetes also provides evidence 
of shared environmental and genetic factors among relatives. Familial aggregation of type 
2 diabetes is observed in Japan (Ryoko et al. 1994), India (Ramachandran et al. 1988, 
Viswanathan et al. 1985), Tunisia (Arfa et al. 2007) and the USA (Valdez et al. 2007). It 
has been indicated that people with a family history of diabetes have a two to six times risk 
of developing type 2 diabetes than those without (Harrison et al. 2003). Moreover, some 
European populations have shown excess of mothers' influence in the disease transmission 
(Arfa et al. 2007, Ramachandran et al. 1988, Alcolado & Alcolado 1991, Scott et al. 1992, 
Thomas et al. 1994, Ryoko et al. 1994, Gonzalez-Ortiz et al. 1997) but not in other 
populations (Viswanathan et al. 1996, Osei 1999). Possible ethnic and racial differences 
have been suggested to explain the absence of excess maternal influence in some 
communities (Viswanathan et al. 1996). These aspects are discussed in further detail in 
chapter 2.
1.6 Type 2 diabetes mellitus and mechanisms of tissue damage
Type 2 diabetes is associated with a wide range of complications that increase morbidity 
and mortality in affected individuals. These complications result from abnormal regulation 
of glucose metabolism. Long term, systemic complications of diabetes may include 
microvascular disease, which may lead to devastating complications of diabetic 
retinopathy, potentially leading to loss of vision, and diabetic nephropathy leading to 
progressive renal dysfunction. In the macrovasculature, accelerated and aggressive 
atherosclerosis portends the development of premature cardiovascular and cerebrovascular 
events. Peripheral neuropathy and vascular disease leads to loss of limbs. In addition, there 
is increasing evidence that diabetes increases the susceptibility to progressive periodontal 
disease (Kannel et al. 1979, Terry 2000).
1.6.1 Hyperglycaemia induces tissue damage in diabetes
There are many mechanisms by which hyperglycaemia may induce diabetes complications. 
Many of these mechanisms are linked by the overproduction of superoxide by the 
mitochondrial electron transport chain. In cells exposed to hyperglycaemia, there is 
increased production of reactive oxygen species (ROS). In diabetes, cells have elevated 
intra-cellular glucose levels and thus more glucose is oxidised in the TCA cycle which
pushes more NADH and FADH2 into the electron transport chain. As a result, the potential 
across the mitochondrial membrane increases until a critical threshold is reached. At this 
point, electron transfer inside the mitochondrial complex III is blocked, causing electrons to 
back up to coenzyme Q which donates electrons one at a time to molecular oxygen, thereby 
generating superoxide. The mitochondrial isoform of the enzyme superoxide dismutase 
(MnSOD) degrades this free radical to hydrogen peroxide (H2 O2) which is then converted 
to H2O and O2 by other enzymes. Hyperglycaemia-induced mitochondrial superoxide 
production activates damaging pathways inside a cell by activating initially poly (ADP- 
ribose) polymerase (PARP) due to strand breaks in nuclear DNA and this inhibits 
glyceraldehyde 3 phosphate dehydrogenase (GAPDH) activity of glycolysis. As a result, 
glycolytic intermediates accumulate inside a cell (Brownlee 2005).
In the hyperglycaemic state, glucose accumulates in the cell. Cells utilize intracellular 
glucose by the polyol pathway via the enzyme aldose reductase (Lee & Chung 1999).
Under homeostatic, normoglycaemic conditions, this enzyme has a low affinity for glucose 
and processes little substrate. However, in hyperglycaemia the production of sorbitol 
increases, which is later oxidised to fructose. In this process, the enzyme consumes the 
cofactor NADPH which is a critical cofactor required in the regeneration of the antioxidant, 
glutathione. Thus, due to a lack of glutathione (which is a critical in removing reactive 
oxygen intermediates from cells), oxidative stress develops inside cells (Brownlee 2005). 
In support of this, in certain populations, recognized polymorphisms in the aldose reductase 
gene have been associated with increased prevalence of diabetes complications (Heesom et 
al. 1997).
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Figure 1.2 Influx o f glucose through polyol pathway
Figure 1.2 shows under hyperglycaemic conditions increases glucose flux through polyol 
pathway resulting in reduced levels of glutathione and increased oxidative stress.
(Brownlee 2001).
1.6.2 The role of AGEs (advanced glycation end products) in tissue damage
A second mechanism by which glucose is utilized in cells is through production o f 
advanced glycation end products (AGEs). AGEs appear to damage cells by three 
mechanisms. Firstly, inside endothelial cells they tend to modify intracellular proteins, 
most importantly the proteins involved in the regulation o f  gene transcription (Giardino et 
al. 1994). Secondly, these AGE precursors can diffuse out from the cells and modify 
extracellular m atrix molecules nearby (M cLellan et al. 1994). This changes the signaling 
between the m atrix and the cell and causes cellular dysfunction. Thirdly, AGE precursors 
diffuse out and modify circulating proteins in the blood. Interaction o f  these m odified 
products with AGE receptors (RAGE) induces multiple effects in the target cells (Vlassara 
et al. 2002) (Figure 1.3).
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Figure 1.3 Effect o f AGE precursors on nuclear factors and transcription factors, 
extracellular matrix and macrophages that causes pathological consequences (Brownlee 
2001).
Interaction o f  AGEs with RAGE leads to various effects including a reduction o f 
enzymatic activity, damage to nucleic acids, impaired degradation o f  proteins (mainly 
collagen), and an increase in collagen cross-linking, resulting in the thickening o f  the 
basement membrane. This leads to abnormal barrier function and integrity, which impairs 
oxygen diffusion, waste elimination, leukocyte migration and the diffusion o f  immune 
factors such as immunoglobulins and complement proteins. As a result o f  induction o f 
cytotoxic pathways inside cells, ROS are generated leading to altered cellular function and 
activation o f  proinflammatory pathways inside the cell (Lalla et al. 2001), usually via 
nuclear factor-kB (NF-kB), an oxidative stress marker (Schmidt et al. 1994). These 
alterations in cellular phenotype result in an environment in which proinflam matory events 
favour the development and sustained progression o f  vascular lesions. Some studies 
indicate that susceptibility to diabetic complications may be influenced by genetic factors 
because environmental influences do not appear to explain all the variation in presentation 
o f  vascular disorders. Sequence variants within the RAGE gene may influence developm ent 
o f  complications by altering the AG E-RAGE interaction.
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1.6.3 PKC activation and the hexosamine pathway
A third mechanism by which cellular activities can be altered in hyperglycaemic cells is 
through activation of the PKC pathway. When glyceraldehyde 3 phosphate dehydrogenase 
(GAPDH) is inhibited by PARP, the level of dihydroxy acetone phosphate (DHAP) level 
inside the cell increases. This leads to increased levels of diacyl glycerol (DAG) which 
activates the protein kinase C pathway inside the cell which has implications on vascular 
changes such as blood flow abnormalities (vasoconstriction increases), vascular and 
capillary occlusions and proinflammatory gene expression via activating NF-kB (Koya & 
King 1998).
A further mechanism by which hyperglycaemia mediates tissue damage is via the 
hexosamine pathway, in which fructose-6-phosphate (an intermediate of glycolysis) is 
converted to glucosamine-6-phosphate by glutamine fructose-6-phosphate amidotransferase 
(GFAT). Glucosamine-6-phosphate is then converted to UDP-N-acetylglucosamine which 
interacts with serine and threonine residues of transcription factors. Modification of the 
transcriptional factor Sp-I in this way results in increased expression of transforming 
growth factor (TGF-pl) and Plasminogen activator inhibitor-1 (PAI-1) resulting in damage 
to diabetic vessel walls.
1.7 Type 2 diabetes as an inflammatory disease
Pickup and Crook first proposed the concept that type 2 diabetes may be an inflammatory 
condition characterized by elevated concentrations of acute phase inflammatory reactants in 
the plasma such as sialic acid and proinflammatory cytokines such as TNF-a and IL-6 
(Pickup & Crook 1998). A major source of these mediators in type 2 diabetes may be the 
adipocytes, and they are also produced by AGE-stimulated leucocytes ( Hotamisligil et al. 
1995, Vlassara & Palace 2002).
Hyperglycaemia results in inflammation and cellular oxidative stress by activation o f NF- 
kB inducing proinflammatory pathways. Hyperglycaemia is now considered as a pro- 
inflammatory state. In support of this, ex vivo experiments on human monocytes have 
demonstrated increased levels of IL-6 and TNF-a production when cells are exposed to 
increasing concentrations of glucose (Morohoshi et al. 1995, Morohoshi et al. 1996).
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Adipokines secreted by adipose tissue also contribute to inflammation. There is a wide 
range of molecules synthesized by adipose tissues (referred to collectively as adipokines). 
Some of these molecules serve as key mediators of energy management and metabolic 
homeostasis. However, in obesity, enlarging adipocytes begin to produce chemotactic 
signals (increased chemokine secretion) leading to macrophage recruitment and activation. 
Adipocytes constitutively release TNF-a in obese animals and humans (adipose and 
muscles) and a significant correlation between BMI and plasma TNF-a concentrations has 
been observed (Tsigos et al. 1999).
IL-6 and TNF-a both play a direct role in inflammation and immunity and are both 
produced by adipocytes. Other adipokines such as leptin, adiponectin, resistin and visfatin 
have interesting immunobiological properties (Preshaw et al. 2007). Leptin levels are 
upregulated and adiponectin levels are down regulated in type 2 diabetes (Dullaart et al. 
2008). Both leptin and adiponectin are implicated in inflammation acting as pro- 
inflammatory and anti-inflammatory mediators, respectively (Preshaw et al. 2007). Leptin 
is also believed to contribute to diabetes pathogenesis by inhibition of insulin secretion and 
action (Girard 1997)
In addition to its pro-inflammatory role, TNF-a also contributes to insulin resistance. The 
action of insulin is mediated via its receptor, which belongs to the receptor tyrosine kinase 
family. Among a large number of intracellular substrates used by these receptors, six 
belong to the family of insulin receptor substrate (IRS) proteins (IRS-1 -  6). Insulin 
stimulated IRS protein activation is a crucial event in mediating insulin action. However, 
this step in insulin receptor signaling is defective in most cases of systemic insulin 
resistance both in experimental models and humans. The effect of TNF-a on insulin 
resistance is related to inhibition of serine phosphorylation of IRS-1 and IRS-2 by TNF-a. 
(Grossi & Genco 1998, Valverde et al. 1998).
Wound healing is delayed in diabetes, and this is also linked to pro-inflammatory events. 
Wound healing occurs in phases (inflammatory, proliferative, maturation) in which PMNs 
play a key role in the inflammatory phase to remove foreign materials and cell debris, 
followed by protein synthesis for tissue repair. Inadequate insulin impairs protein synthesis,
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specifically collagen formation in the maturation phase. Increased collagenase in diabetes 
also contributes to delayed wound repair. Glycosylation of existing collagen (i.e. formation 
of AGEs) at the wound margins results in reduced solubility and delayed remodelling and 
increased collagenase activity readily degrades newly synthesized (less completely cross- 
linked) collagen at the wound site, further delaying the healing process (Lien et al. 1984).
AGEs also contribute to inflammation and micro-chemotaxis experiments have 
demonstrated that movement of macrophages is arrested when AGEs are immobilized on 
the surface. AGEs, via interaction with macrophage RAGE may result in migration of 
macrophages toward an inflammatory focus, resulting in chronic macrophage activation. 
(McMullen et al. 1981, Lien et al. 1984).
1.8 Periodontal disease
Periodontitis is an inflammatory disease of the periodontium characterised by destruction of 
periodontal attachment tissues that can ultimately lead to exfoliation of teeth. The two 
most common periodontal diseases are gingivitis and chronic periodontitis.
In health, the gingiva is a band of specialized keratinized tissue mucosa closely adapted to 
the tooth. The junctional epithelium is the tissue that joins the soft tissues of the gingiva to 
the tooth and acts as a ‘seal’ between the oral environment and the underlying supporting 
tissues. The periodontal ligament, which consists of collagenous fiber bundles, is the 
connective tissue structure that attaches the roots of the teeth to the alveolar bone (figure 
1.4). The gingival sulcus is normally 0.5-2.5mm in depth.
There is continuity of the oral epithelium, the sulcular epithelium and junctional epithelium. 
The connective tissue is comprised of well ordered densely packed collagen fiber bundles, 
and even in clinically healthy tissues, inflammatory cells such as neutrophils are usually 
present (though in low numbers) adjacent to the junctional epithelium (Preshaw 2004).
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Figure 1.4. A longitudinal section through dento-gingival part of a healthy tooth and its 
periodontium (Gillet et al, 1990 )
Gingivitis is inflammation of the gingiva, and is the first stage of inflammatory changes in 
the gingival tissues. Gingivitis results from accumulation of dental plaque, a biofilm of 
many hundreds of bacterial species that produces a variety of waste products and 
proinflammatory antigens that penetrate the junctional epithelium and invoke an 
inflammatory response in the tissues. As a result of this, there is increased infiltration of the 
tissues by defense cells, breakdown of collagen fiber bundles, increased vascular 
permeability and vasodilatation, and the clinical signs of gingivitis thus become apparent. 
The clinical signs and symptoms include erythema, oedema, and bleeding on brushing and 
probing. Bleeding may be induced when the tissue at the depth of the gingival sulcus is 
gently manipulated by probing. It is a sign of inflammation which occurs as a result of 
ulcerated pocket epithelia. (Fermin 2002). Bleeding on probing is considered as a poor 
predictor of periodontitis. However, absence of bleeding on probing is a strong predictor of 
periodontal health (Lang et al. 1990) and has become a standard diagnostic test for 
identifying sites at risk for disease progression (Lang & Tonetti 1996). Treatment at this 
stage (removal of plaque and improved oral hygiene) will resolve the inflammation.
Periodontitis is extension of the gingival inflammation to involve the periodontal ligament 
and the alveolar bone (Scully 2004). As the junctional epithelium breaks down in response 
to the inflammatory challenge, it migrates apically along the root surface following 
destruction of the underlying connective tissue attachment. The pathologically deepened 
sulcus now constitutes a periodontal pocket. Periodontal pocket formation is one of the
GS
oral sulcular epithelium 
(OSE)
oral epithelium (OF)
junctional epithelium 
(epithelial attachment)
CEJ —
norma! connective 
tissueRD
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most important clinical signs of periodontitis. A true pocket results from the apical 
migration of the junctional epithelium following loss of connective tissue attachment to the 
root surface. As the pocket deepens, the subgingival plaque biofilm proliferates down the 
root surface, providing a continued challenge, and propagating the inflammatory response. 
Inflammation extends apically and laterally, leading to increased collagen breakdown, 
further recruitment of inflammatory cells, and osteoclastic resorption of alveolar bone. 
Breakdown of the attachment apparatus results in tooth mobility. Clinical features include 
oedema, erythema, bleeding upon probing, and loss of clinical attachment and alveolar 
bone loss. Additional features include gingival recession and enlargement, root furcation 
exposure, increased tooth mobility, drifting and eventually exfoliation o f teeth. The 
condition is usually painless but may be associated with bleeding, halitosis, and tooth 
mobility. The condition is diagnosed by clinical and radiographic examination. Severity 
can be characterized by measuring the depth of the pocket to determine the amount of 
clinical attachment loss (Wiebe & Putnins 2000). Radiographs are used to assess resorption 
of the alveolar bone (Figures 1.5 & 1.6).
Chronic periodontitis can be considered localized (<30% of sites involved) or generalized 
(>30% of sites involved). Severity is determined by the amount of clinical attachment loss 
(CAL) (Slight =T-2mm, moderate = 3-4mm, severe >= 5mm) (Wiebe & Putnins 2000). 
Although both gingivitis and periodontitis are inflammatory conditions, they are usually 
regarded as different disease entities. That is to say, while gingivitis is the precursor to 
periodontitis, not all gingivitis progresses to periodontitis (Lehner 2003). Gingivitis is a 
relatively simpler local inflammatory response to the accumulation of the plaque biofilm, 
and is so common as to be almost considered normal. However, periodontitis is much more 
complex, and the multifactorial model for the aetiology of periodontitis incorporates the 
role of personal, environmental and systemic factors along with the presence of the plaque 
biofilm and subsequent inflammatory responses to explain varying susceptibility to 
periodontitis (Clarke & Hirsch 1995, Haffajee & Socransky 1994). Most important risk 
factors for plaque associated gingivitis and periodontitis are ineffective oral hygiene, 
cigarette smoking and age (Pihlstrom et al. 2005). In addition, epidemiological studies, a 
number of case reports, cross sectional studies and a few longitudinal studies have shown 
that diabetes is a major risk factor for periodontitis (Mealy & Moitz 2003, Southerland et al.
2006).
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(A) Healthy periodontium (B ) radiographic status o f healthy
periodontium
Figure 1.5 (A) healthy periodontium and (B) radiographic photograph of a healthy 
periodontium
(A) Clinical status o f Periodontitis (B) Radiographic photograph illustrating
status o f periodontitis
Figure 1.6 (A) clinical status of a patient with chronic periodontitis and (B) 
radiographic photograph illustrating alveolar bone loss in the same patient with 
periodontitis
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1.9 Evidence for association between type 2 diabetes and periodontitis
Table 1.2. summarizes a number of studies conducted to identify associations between type 
2 diabetes and periodontitis over the last two decades. Most of the earlier studies were 
conducted in the USA in Pima Indians, a population with a uniquely high prevalence of 
diabetes (Knowler et al. 1978). In one of these studies, 3219 subjects from this community 
were examined, and attachment loss and radiographic alveolar bone loss quantified. This 
study identified that subjects with diabetes had a higher prevalence of periodontitis than 
those without, irrespective of their age (Shlossman et al. 1990). Further studies conducted 
by Emrich et al. on a subset o f dentate individuals in this population (n=1342) showed that 
diabetes mellitus increased the risk for periodontal disease by 2.8x when periodontal 
disease was defined by clinical attachment loss and 3.4x when defined by radiographic 
bone loss. This increased risk for periodontitis could not be explained on the basis of age, 
sex, oral hygiene or other oral measures (Emrich et al. 1991). In another study conducted 
in the same population, a significant association between diabetes mellitus and periodontitis 
was identified, and diabetes increased the risk for periodontal disease 2-fold independent of 
the confounding effect of age and local factors such as dental plaque and calculus. This 
study reported age and gender adjusted incidence estimates of periodontitis in subjects with 
type 2 diabetes to be 2.6x compared to those without type 2 diabetes (Nelson et al. 1990).
In addition to these studies conducted in the Pima Indians of Arizona, studies in Yugoslavia 
(Bacic et al. 1988), Minnesota, Brazil (Novaes et al. 1996), Sweden (Sandberg et al. 2000), 
Mauritius (Morton et al. 1995), Hispanic Americans (Novak et al.2008), Australia (Cutler et 
al. 1999), France (Mattout et al. 2006), South Africa ( Peck et al. 2006), China (Lu and 
Young 2004 & Hao et al.2007) Japan (Marugame et al.2003) and Jordan (Khader et al. 
2008) collectively provide evidence that type 2 diabetes is associated with increased 
prevalence, severity and incidence of periodontitis.
Similar to type 2 diabetes, positive associations between type 1 diabetes and periodontitis 
have also been reported by some studies while others have reported no significant 
associations (Kjellman et al. 1970, Goteiner et al. 1986, Harrison & Brown 1987). Many of 
these studies were performed in young type 1 subjects in whom periodontitis may have not 
yet developed (Little et al. 1997). A definite relationship between type 1 diabetes and
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periodontitis has been shown in studies of adult populations (Firali 1997). Furthermore, a 
recent review by Mealy and co-workers after analysing over 200 publications in relation to 
these two conditions concluded that diabetes (both type 1 and type 2) increases the risk for, 
and severity of, periodontal disease (Mealy et al. 2006).
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1.10 Periodontal disease, insulin resistance and dyslipidemia
To date molecules that are known to induce insulin resistance in humans are TNF-a, and 
free fatty acids (Boden et al. 1994). IL-6 is also reported to cause insulin resistance 
(Lagathu et al. 2003, Rotter et al. 2003) by selectively suppressing insulin action in 
hepatocytes (Klover et al. 2003, Senn et al. 2002). In people with diabetes, upon 
periodontal infection, tissue resident macrophages and Kupffer cells express increased 
amounts of IL-6 leading to stimulation of hepatocytes. This results in increased 
synthesis and secretion o f acute phase proteins such as C reactive proteins (Gabay & 
Kushner 1999).
Activated Kupffer cells also express higher amounts of tumour necrosis factor alpha 
(TNF-a) resulting in increased insulin resistance in the liver. Patients with severe 
periodontitis exhibit increased IL-6 and C reactive protein levels, as compared with 
systemically and orally healthy controls (Loos et al. 2000). Additionally these 
inflammatory markers as well as TNF-a a levels decline with successful periodontal 
treatment (D’Aiuto et al. 2004, Iwamoto 2001, Iwamoto 2003). All these data support 
the fact that severe periodontal disease causes insulin resistance (Nishimura et al. 2001). 
The most probable target organ influenced by periodontal infection is hepatocytes in the 
liver as it is well known that CRP is produced by hepatocytes (Gabay & Kushner
1999). Circulating TNF-a may also cause insulin resistance in muscle cells (Ciaraldi
1998) and adipocytes (Szalkowski 1995).
Chronic inflammation and infection may also influence lipid metabolism (Khovidhunkit
2000). Infections by gram negative bacteria has been suggested to cause abnormal lipid 
profiles including increased concentrations of both very low density lipoproteins (LDL) 
and LDL cholesterol in rats (Lanza-Jacoby et al.1992) It has been suggested that the 
changes in the plasma lipoprotein composition might be attributed to altered hepatic 
synthesis, peripheral metabolism or hepatic uptake of lipoproteins and their remnants, 
indicating that hepatic function may play a key role in abnormal, infection induced lipid 
profiles (Lanza-Jacoby et al. 1992). Endotoxin itself also causes hypertriglyceridemia in 
an animal model (Gouni et al. 1993).
An association between periodontal disease and abnormal levels of triglycerides, LDL, 
cholesterol and total cholesterol in subjects with severe periodontitis has been reported 
( Katz et al. 2002). In addition a recent report indicated that intensive periodontal
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treatment resulted in decreased total LDL cholesterol levels as well as a C - reactive 
protein value suggesting that periodontal infection and/or inflammation up-regulates the 
LDL-cholesterol level (D’Aiuto et al. 2005).
1.11 Two-way relationship between diabetes and periodontal disease
Diabetes is a major risk factor for periodontitis, and there is strong evidence to suggest 
that the incidence and severity of periodontitis is influenced by the presence or absence 
o f diabetes (Bacic et al. 1988), the level of diabetes control (Tervenon & oliver 1993, 
Tervonen & Karjalainen, 1997), and diabetes duration (Hugoson et al. 1989). The data 
regarding the effect of diabetes mellitus on the oral cavity suggest that oral tissues are 
adversely affected similarly to other body systems, by uncontrolled diabetes mellitus 
(Bartolucci & Parks 1981, Seppala et al. 1997). In addition, animal studies in diabetic 
rats provide evidence that periodontal disease has a negative impact on metabolic 
control in diabetes (Andersen et al. 2006). Periodontal disease has been described as the 
sixth complication of diabetes mellitus (Loe 1993), and a variety of mechanisms link 
the two diseases, as described below.
PMN leucocytes are the primary defensive cells in the periodontium. Although some 
defects of PMN function are o f genetic origin (Bisanda et al. 1982), patients with 
diabetes demonstrate impaired PMN chemotaxis, adherence and phagocyte function due 
to interaction of AGE with cell surface receptor RAGE. It has been observed that 
diabetic patients with severe periodontitis have depressed PMN chemotaxis compared 
to those with mild periodontitis or non-diabetic subjects with severe or mild 
periodontitis (Manouchehr-Pour et al. 1981). Furthermore, apoptosis of PMNs is 
delayed in diabetes, leading to prolonged retention o f PMNs in the periodontal tissues, 
which likely results in increased tissue destruction as a result of extra-cellular release of 
destructive enzymes (Preshaw et al. 1999). An abnormal monocyte inflammatory 
response to lipopolysaccharides (LPS) challenge has also been shown to result in an 
exaggerated secretion of inflammatory mediators such as IL-1 p in patients with diabetes 
(Offenbacher 1993, Salvi et al. 1997). Complicating matters further increased AGE 
deposition increases collagen cross linking in people with diabetes, leading to reduced 
flexibility o f vessel walls and narrowing of the lumen. This impairs leukocyte migration 
into the tissues. An altered inflammatory response is probably the key link in the so- 
called bidirectional relationship between periodontitis and diabetes. The assumption 
underlying this concept is that changes in immunologically active molecules as a result
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of diabetes disturb the finely balanced cytokine network within the periodontium, 
leading to increased tissue damage. Increased levels of inflammatory markers such as 
CRP and proinflammatory cytokines have been observed in systemic circulation in both 
periodontal and type 2 diabetes (Engebretson et al. 2007, Salzberg et al. 2006). In 
diabetes, binding o f macrophage RAGE to AGE leads to an hyperinflammatory 
phenotype resulting in the upregulation of cytokine expression. With increased secretion 
o f IL-6 and TNF-a there is an induction of oxidative stress (Schmidt et al. 1994). 
Macrophages that are already activated and primed by binding to AGE via RAGE 
demonstrate a magnified inflammatory response when challenged with LPS from 
periodontal organisms leading to greater destruction of periodontal connective tissue 
and increased periodontitis severity (Grossi & Genco 1998).
In addition to an effect of diabetes in periodontitis, it is likely that periodontitis has a 
negative impact on glycaemic control. It is already well recognised that acute infections 
cause increased insulin resistance. In periodontitis, inflammation results in local 
production of TNF-a and other inflammatory mediators, which could induce insulin 
resistance and poorer diabetes control. There is increasing evidence from controlled 
studies to indicate that severe oral infection of any type, including periodontitis may 
increase insulin resistance (Grossi and Genco 1998).
In support of this concept, significantly higher cytokine levels have been found in the 
gingival crevicular fluid (GCF) of diabetics compared with non-diabetics, and in those 
who suffer from periodontitis (Oliver & Tervonen 1993). Furthermore some studies 
have demonstrated a significant correlation of GCF IL-ip levels with level of 
glycaemic control. Patients with HbAlc >8% had significantly higher levels o f GCF IL- 
lp  levels than those with HbAlc < 8% (Engebretson et al. 2004). Since people with 
diabetes already have impaired immune defense mechanisms, they are more susceptible 
to infection and those infections are more severe when compared to people with normal 
glucose tolerance (Mealey 1999). There is evidence for decreased insulin-mediated 
glucose uptake by skeletal muscles if bacterial infections are present (position paper 
1996). Infection-induced insulin resistance further complicates and increases 
hyperglycaemia, enhancing AGE formation, which in turn intensifies cytokine levels 
(via activation of macrophages via RAGE), contributing to a ‘vicious circle’ that is 
difficult to break and increases susceptibility to diabetic complications (Donahue 2001). 
A proposed bidirectional model whereby chronic periodontitis could magnify elevated
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cytokines response associated with diabetes and its contribution to the overall burden of
system ic inflam m ation is presented in figure 1.7.
Periodontal d isease Diabetes
AGE ProteinPeriodontal pathogen
Insulin resistance Hyperglycaemia
Macrophage AGE 
receptorEndotoxin, toxins, cell 
Membrane products
Synthesis & Secretion  
Of IL-1p & TNF-aProinflammatory
C ascade
Hydrolase, MMP, 
C ollagenase secretion
Secretion 
Of IL-ip & TNF-a
Degradative cascad e
Connective tissue  
destruction 
and bone resorption Connective tissue  
destruction
Figure 1.7 Proposed two way relationship betw een type 2 diabetes and
periodontitis (Grossi & Genco 1998)
In patients with diabetes, hyperglycaemia induces formation o f AGEs. Interaction ofAGEs with 
blood monocytes/macrophages causes the secretion o f IL-If,  IL-6 and TNF-a. As a 
consequence a tissue degradative cascade is initiated. Host defense responses to periodontal 
infection proinflammatory cytokines are produced which will further intensify tissue breakdown.
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1.12 Cytokines and periodontitis
Cytokines are signaling proteins that have an extensive role in cellular communication. 
They are effective in very low concentrations, produced transiently, act locally and are 
often self regulatory. They act on their target cells by binding to specific receptors and 
initiate intracellular second messengers resulting in phenotypic changes in the cell via 
altered gene regulation (Birkedal-Hansen 1993). Individual cytokines do not act in 
isolation; they act as a flexible complex network bringing together elements of both 
adaptive and innate immunity in the defense against infection and disease (Banyer et al. 
2000).
Cytokines play a key role in the immune response in periodontal disease (Gemmell et 
al. 2000, Landi et al. 1997 & Okada & Murakami 1998). In response to 
periodontopathic bacteria, a variety of cell types in the periodontium including 
macrophages and B cells have been shown to secrete cytokines importantly IL -lp and 
TNF-a (Seymour et al. 2001). These proinflammatory cytokines have a key role in the 
initiation, regulation and perpetuation o f the innate response in the periodontium 
(Alexander et a l.l994, Birkdel-Hansen 1993, Darveau 2000 & Gemmell et al. 2000). 
This results in vascular changes and the migration of effector cells into the 
periodontium with appropriate immune response aimed at containing and eradicating 
periodontal pathogens. However, inappropriate cytokine responses can lead to 
inflammation and concomitant tissue damage which is mainly due to host inability to 
regulate the immune response. Other key inflammatory mediators include 
prostaglandins (e.g. prostaglandin E2 , PGE2) and matrix metalloproteinases (MMPs) 
which can induce bone and connective tissue degradation (Komman et al. 2000). The 
nature of the host inflammatory response is governed by genetic factors as well as 
environmental and local risk factors for the disease (Seymour and Taylor 2004). It is 
now recognized that the host immune-inflammatory response is the critical determinant 
in defining disease susceptibility and inter-individual variations observed in 
susceptibility to periodontal disease (Komman 1997).
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1.12.1 Genetic polymorphism in IL-1 and TNF cytokine genes
Duff and coworkers have revealed that many cytokine genes harbour genetic 
polymorphisms. This genetic polymorphism may directly influence complex common 
diseases via a direct effect on gene function (Duff 2006). Inter-individual genomic 
variations are mainly encoded by SNPs.
SNPs in ILIA  and IL1B and TNFA
SNPs exists at ILIA (-889) position and ILIA (+4845) and in IL1B gene IL1B (-31), 
IL1B (-511) and IL1B (+3954) positions (Bailly et al 1993). Inter individual variation in 
cytokine production by peripheral blood mononuclear cells has been observed (Enders 
et al. 1988, Molvig et al. 1988, Enders et al. 1989, Jacob et al. 1990, Danis et al. 1995). 
In particular the three genotypes of IL1B at (+3954) are associated with different levels 
of IL-1 p production (Pociot et al. 1992). Elevated Gingival Crevicular Fluid (GCF) 
concentrations of IL-1 (3 have been observed in the shallow sites of patients carrying risk 
allele (allele 2) (Engebretson et al. 1999). Monocytes from individuals homozygous for 
the IL1B (+3953) allele 2 produce four-fold more IL-lp and heterozygous cells produce 
approximately two fold more IL-lp than cells from individuals homozygous for allele 1 
(Pociot et al. 1992).
IL l-a  protein is reported to be present at very low level in healthy GCF. In addition to 
ILIA (+4845), (Gubler et al. 1989) another polymorphism was detected at (-889) in the 
promoter region. Polymorphism analysis of ILIA (-889) variant with IL l-a  levels in 
GCF implicated that in the diseased population there was at least a four fold increase in 
the mean level of IL-1 a  protein in patients who carried one or two copies o f the allele 2 
of the ILIA (-889) gene variant when compared with those who were homozygous for 
allele l(Shirodaria et al. 2000).
Several polymorphisms within the TNFA gene have been characterised (Wilson et 
al.1992 & Alfonso & Richiardi 1994) and have been studied in association with 
periodontitis and type 2 diabetes. Wilson et al identified the genetic G/A polymorphism 
at the 308 nucleotide upstream of the transcriptional start site. This polymorphism 
affects the consensus sequence for a binding site of the transcriptional factor AP-2 
(Abraham & Kroeger 1999). The rare allele of TNFA (-308) promoter polymorphism has 
been connected with a higher transcriptional activity (transcriptional factors
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preferentially binds to rare allele) (Wilson et al. 1997) and leads to a two or four fold 
increase in transcriptional activity when stimulated with lipopolysaccharides ( LPS) 
(Braun et al. 1996, Kroeger et al. 2000). It has also been observed that LPS stimulated 
TNF-a secretion from blood cells (neutrophils) is higher in individuals carrying 
homologous or heterologous allele 2 than subjects carrying homologous TNFA allele 1 
( Galbraith et al. 1998). Therefore in response to a given bacterial challenge these 
individuals may produce more tissue destructive TNF-a levels than those who carry 
wild type allele 1 (Folwaczny et al. 2004). Consistent with this, individuals who are 
homozygous for -308 A (allele 2) have higher circulating TNF-a than homozygotes for 
the -308 G (allele I) (Bouma et al. 1996).
1.12.2 Inteivindividual variations in cytokine response in periodontal disease
A heritable component to both susceptibility and progression or severity of periodontal 
disease has been reported (Hodge & Michalowicz 2001, Baker & Roopenian 2002, 
Schenkein 2002). A continuum of variation in the development and progression of 
periodontitis has been observed in different individuals. Inter-individual variation in 
periodontal microflora and the immune inflammatory response to the presence of 
subgingival plaque (Offenbacher 1996), cytokine synthesis and secretion to standard 
stimuli (Molvig et al. 1988, Enders et al. 1989) and cytokine polymorphisms have been 
observed.
The concept of population dichotomy of high and normal responders with respect to IL1 
secretion has been reported (Endres et al. 1989). To a standard stimulus, high 
responders will produce elevated quantities o f inflammatory mediators and destructive 
cytokines. As a result, for a given bacterial challenge, this group of individuals is more 
susceptible to periodontitis than normal responders who produce minimal levels of 
inflammatory mediators (Position paper 1996).
1.12.3 Association of cytokine gene polymorphism and periodontal disease
Several recent reports provide evidence that cytokine gene polymorphism may influence 
the severity of chronic periodontitis (Komman et al. 1997, Galbraith et al. 1998, Gore et 
al. 1998). A study by Gore and coworkers also reported that allele 2 of the IL1B 
(+3954) genotype was significantly increased among patients with chronic periodontitis 
(Gore et al. 1998). An investigation of IL-1 genotype and periodontal disease in a 
diabetic population has revealed an association of IL1B (-511) genotype with
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periodontal disease in African American patients. The same study reports a borderline 
significant association between IL1B (+3954) and periodontal disease in Caribbean 
periodontal patients (Guzman et al. 2003). No significant difference was found between 
early onset periodontitis and either IL1B (+3954) polymorphism or ILIA (-889) 
polymorphism in European White Caucasian population (Hodge et al. 2001).
Gore et al found no significant association of ILIA (-889) polymorphism with chronic 
periodontitis (Gore et al. 1998). In order to address the question of how cytokine (IL-1) 
polymorphism may affect the cytokine profile with patients with chronic periodontitis, 
Havemose-Poulsen et al investigated genotypes of ILIA (-889), ILIA (+4845), IL1B (- 
511) and IL1B (+3954). It has been found that allele 2 of IL1B (+3954) is associated 
with lower levels of IL l-a , IL-6, IL-10 and TNF-a levels (Havemose-Poulsen et al.
2007). Recently conducted meta- analysis of this polymorphism has indicated a 
moderate positive association between the ILIA (-889) variant and chronic periodontitis 
in Caucasians (Nikolopoulos et al. 2008).
1.12.4 The role of periodontal associated genotype (PAG) and pathogenesis of 
periodontal disease
Komman et al. observed a significant association of aggressive periodontitis in non 
smokers, when considered together with the presence of at least one copy o f the rare 
allele of bothZLM (-889) and IL1B (+3954) polymorphism (Komman et al. 1997). This 
genotype was named as the periodontal associated genotype (PAG). The currently used 
two SNP positions in PAG definition are IL1B (+3954) and ILIA (+4845). Papapanou 
and coworkers also discovered the association of PAG with severity of periodontal 
disease as measured by attachment loss (Papapanou et al. 2001). However, research so 
far conducted in PAG in association with susceptibility to periodontitis has generated 
conflicting results. A Meta analysis performed considering 13 studies published on 
composite genotype concluded that the rare allele of ILIA (-889) and rare allele o f IL1B 
(+3954) positive genotype has significant association with chronic periodontitis. This 
analysis has revealed that the positive genotype is more frequent among periodontitis 
cases compared with controls, even though the estimates were marginally insignificant. 
However, Caucasians carrying the positive genotype (ILIA (-899) and IL1B (+3954) 
loci) had a statistically significant elevated risk of developing chronic periodontitis 
compared with the separate effect of each SNP. It also documents an elevated risk for 
IL1B (+3954) allele 2 carriers particularly in Asian patients (Nikolopoulos et al. 2008)
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based on the observation of a study conducted in India to access the SNPs at ILIA  
(+4845) and IL1B (+3954). This study found associations of the IL-1 genotype as a risk 
factor for severe chronic periodontitis (Agrawel et al. 2006). Moreover, the IL-ip 
levels in shallow periodontal pockets have been reported to be higher in PAG positive 
patients compared to PAG negative patients (Engebretson et al. 1999). Another 
longitudinal study has observed that PAG is associated with the extent o f tooth loss 
(McGuire et al.1999) but some other studies were unable to repeat the results 
(Cattabriga et al. 2001 & Ehmke et al. 1999).
1.12.5 Smoking and IL-1 genotype in association with periodonttis
Smoking is considered as an increased risk factor for periodontitis (Tomar & Asma 
2000). Smokers demonstrate more severe periodontitis and are resistant to periodontal 
therapy (Kinane & Chestnutt 2000). It is also known that smoking elevates serum 
LDL/TRG levels (Vincelj et al. 1997). Therefore smoking could obscure the 
polymorphism related increase in risk. In a study of patients with aggressive 
periodontitis, Parkhill and co-workers suggest that an IL1B (+3954) genotype in 
combination with smoking and a combined IL1B (+3954) and IL1RA genotype are risk 
factors for aggressive periodontitis and support a role for genetic and environmental 
factors in susceptibility to aggressive periodontitis (Parkhill et al. 2000). Komman in his 
study found that severity o f disease was correlated in non-smokers with chronic 
periodontitis and suggested that non-smoking PAG positive subjects had an 
approximately 7 times greater chance of having severe periodontitis than those who 
were PAG-negative (Kornman et al. 1997). Contradicting these results Meisel and 
coworkers reported smokers bearing PAG positive genotype {ILIA (-889) and IL1B 
(+3954)) have an increase risk of periodontitis in a study conducted in Germany 
(Meisel et al. 2004). It has also been demonstrated that heavy smoking and positive 
genotype act as synergistic risk factors for earlier tooth loss (Meisel et al. 2002). 
However a study conducted by Laine et al. found PAG was not significantly associated 
in either smokers with chronic periodontits or non smokers with chronic periodontitis 
(Laine et al. 2001).
The role of smoking in the pathogenesis of periodontal disease is uncertain, One 
possible mechanisms may include altered subgingival microflora (Zambon et al. 1996), 
vasoconstriction of gingival micro circulation (Clarke et al. 1981) and decreased 
immune cell function and impaired inflammatory response (Johnson et al. 1990). In
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vitro studies have addressed the potential alteration of cytokine production in smoke 
exposed macrophages. There are variable reports of suppressed or unaltered IL-lp 
secretion from macrophages in smokers (Soliman & Twigg 1992, Sauty et al. 1994). It 
has been suggested that smoking may not actually affect the synthesis of IL -lp but may 
suppress its release from cells (Soliman & Twigg 1992). Furthermore, Berzweig and 
colleagues observed that nicotine significantly down regulates IL-1 p secretion by 
gingival mononuclear cells (Bemzweig et al. 1998). It has been suggested that allele 1 
of the IL1B (+3954) SNP may have a synergistic immunosuppressive effect with 
smoking, thereby increasing susceptibility to aggressive periodontitis.
1.12.6 TNF- a  and Periodontitis
TNF-a has a strong potential to increase bone resorption and is involved in the 
degradation of connective tissue. Therefore, it was assumed that individuals susceptible 
to periodontitis might be related to genetically determined differences in the TNF-a 
production and polymorphisms (Shapira et al. 2001, Craandijk 2002). Although the 
biological significance of these findings are not yet fully established it was proposed 
that this genotype could be a prognostic marker in periodontitis.
A Meta analysis of cytokine SNPs in association with periodontitis has revealed that 15 
studies thus far have examined the TNFA (-308) polymorphism, the majority carried out 
in Caucasian populations (Nikolopoulos et al. 2008). The role of TNFA (-308) SNP was 
not found to be associated with disease severity in a study of 134 patients with chronic 
periodontitis (Komman et al. 1997). Furthermore, Galbraith et al. studied 32 patients 
with chronic periodontitis but found no significant association with three separate SNPs 
(including the -308 SNP) in the promoter region o f the TNFA gene (Galbraith et al. 
1998). No significant disease associations were found in a study of four TNFA promoter 
SNPs in 90 chronic periodontitis patients (Craandijik et al. 2002) and TNFA 
microsatellite polymorphisms and aggressive periodontitis in a study of 91 patients 
(Kinane et al. 1999). There was no significant association between TNFA genotype and 
aggressive periodontitis in a Japanese population (Endo et al. 2001). A lack of 
association between TNFA (-308) promoter polymorphism and periodontal disease has 
been demonstrated in Germany (Folwaczny et al. 2004) and a Czech population 
(Fassmann, 2003). In summary all data indicates the lack of association between the 
TNFA alleles and susceptibility to chronic periodontitis. In contrast Komman and di 
Giovine reported a higher TNFA (-308) allele 2 frequency in Caucasian patients with
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chronic periodontitis than in healthy individuals. This difference was correlated with the 
severity of the disease. (Komman et al. 1997, Komman & di Giovine 1998). Similarly 
Galbraith et al. demonstrated that the TNFA allele 2 is a risk factor for the severity of 
adult chronic periodontitis (Galbraith et al. 1999) as its presence is detected in the most 
severe cases of the disease (Galbraith et al. 1998). More recently Lin et al demonstrated 
an increased frequency for the TNFA allele 2 in Chinese patients with chronic 
periodontitis (Lin et al. 2003).
1.12.7 Composite polymorphism of IL1B (+3954) and TNFA (-308)
Lin et al. have studied the correlation of these two polymorphisms and the genetic 
susceptibility to moderate or advance adult periodontitis. They revealed a relationship of 
IL1B (+3954) and TNFA (-308) positive genotype to disease status while adjusting for 
other potential confounders. The frequency of IL1B (+3954) (28.23%) and TNFA (-308) 
(29.03%) allele 2 positive genotype in patients with moderate-to-advanced aggressive 
periodontitis showed a statistically significant increase compared to the control group 
frequency of 13.95% IL1B (+3954) and 11.05% TNFA (-308) respectively (Lin et al. 
2003). This study concluded that IL1B (+3954) and TNFA (-308) allele 2 positive 
genotype may increase the odds of having moderate-to-advanced aggressive 
periodontitis (Lin et al. 2003).
1.13 Summary
Type 2 diabetes and periodontal disease both are common complex diseases in which 
genetic factors and environment factors contribute to disease pathogenesis. High 
prevalence of periodontal disease has been observed in patients with type 2 diabetes and 
severity of the disease increases as the diabetes control decreases. Conversely, 
periodontal disease may have a negative impact on glycaemic control in people with 
diabetes. Both diseases are inflammatory conditions, and a multiplicity o f excessive and 
dysregulated inflammatory processes are likely to link the pathogenesis o f the two 
diseases. In Sri Lanka, type 2 diabetes prevalence rates are moderately high and the 
genetic basis for the disease has not been previously investigated. Furthermore, 
prevalence estimates do not exist for periodontitis in the diabetic population and further, 
the association of cytokine gene polymorphisms in relation to type 2 diabetes or 
periodontitis were not assessed in this population.
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1.14 Aims and objectives of the study
This study was initiated with broad aims of establishing a database of patients with type 
2 diabetes to study genetic epidemiology and provide background to the genetic basis of 
the disease and to study the relationship between diabetes and newly recognised 
diabetes related complication periodontitis. Constructing a DNA repository is one of the 
secondary objectives in order to conduct population association genetic research in 
related to diabetes.
There are several lines of evidence to indicate that type 2 diabetes is familiarly 
aggregated and there may be parental influence for the transmission pattern of the 
disease where mothers seems to play a predominant role. Therefore the initial studies 
investigated the family history o f diabetes in patients with diabetes to see whether the 
disease is familiarly aggregated in the Sri Lankan population. This component of the 
study also investigated whether possible influence for the transmission pattern does 
exist from the maternal side in Sri Lankan population. It also evaluated whether the 
parental diabetes could influence the onset of diabetes in the offspring.
Generally tissues o f people with diabetes are affected due to long term exposure to 
hyperglycaemia. As a consequence the immune system of these people is compromised 
and they are prone to more infections than those who have not developed diabetes. 
Periodontitis, a chronic complex disease is more common in patients with diabetes than 
normal healthy controls. Although the exact molecular mechanisms that link the two 
diseases are not known yet it is believed that periodontitis worsens the underlying 
metabolic imbalance in diabetes, and poorly controlled diabetes aggravates the severity 
of periodontitis. In this study it was hypothesized that periodontal disease is more 
prevalent in the type 2 diabetic population than the control population in Sri Lanka. In 
addition the severity of periodontal disease was expected to be higher in patients with 
diabetes than those without as measured by probing pocket depth. This study also 
aimed to investigate the effect of level of glycaemic control (as measured by 
glycosylated hemoglobin) with disease severity (as measured by probing pocket depth).
Komman 1997 found that the presence of recessive alleles of both ILIA -889, 
IL1B+3954 (PAG,) is associated with periodontal disease and may be a risk factor in 
never smokers. It was suggested that SNPs within the IL-1 cluster increase the genetic 
risk of periodontal pathogenesis and population variation of PAG percentage and
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association with periodontitis was observed. Therefore, one of the hypotheses to be 
tested is that PAG status may be a risk factor in the Sri Lankan population too.
Secretory TNF-a levels are high in patients with type 2 diabetes. Also it induces insulin 
resistance via interacting with the insulin receptor substrate. Inducing insulin resistance 
will lead to abnormal lipid metabolism. Therefore it was hypothesized that TNF-(308) 
promoter sequence SNP aggravates pathogenesis o f diabetes by impairing the metabolic 
conditions of the affected individual. It was assumed that TNF-(308) genotypes may be 
influencing changes in blood chemical parameters, exposing them to more diabetes 
complications and therefore people with periodontitis with polymorphic allele may have 
more severe periodontal destruction than those without.
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Chapter 2
Genetic epidemiology of type 2 diabetes in Sri Lanka
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2.1 Introduction
The precise causative factors for type 2 diabetes remain obscure. Twin studies, family 
studies, population studies, some genetic admixture studies and certain monogenic 
forms of the disease provide evidence that genetic and environmental factors together 
contribute to the predisposition of the disease. If a single gene was the mode of 
inheritance, then we would expect a Mendelian pattern of inheritance of type 2 diabetes 
with complete penetrance. But, for diabetes, except for certain maturity onset diabetes 
in the young there is no clear Mendelian pattern o f inheritance observed. Type 2 
diabetes is therefore considered a multigenic disorder with a threshold in which 
individual genetic factors contribute additively with a major locus and relatively minor 
influencing loci. Environmental factors together with the genetic factors are thought to 
contribute additively and the disease develops when the susceptibility threshold is 
exceeded. Hence, type 2 diabetes develops through a progression of stages and 
manifests late in life rather than at birth (Granner & O’Brien 1992).
2.1.1 Evidence for familial aggregation of type 2 diabetes
In addition to the evidence for a general genetic susceptibility to type 2 diabetes as 
described in Chapter 1, increased risk of diabetes with increasing familial aggregation 
was first proposed by Steinberg (Steinberg 1959). In Japan, a reported positive family 
history increases risk for diabetes. In 1982, the reported familial aggregation was 43- 
49% for type 2 diabetes (Ryoko et al. 1994). In another study in India, the probability 
o f diabetes developing in a person with only one diabetic parent was estimated at 36%, 
while the estimate increased to 54% if there was one diabetic parent and the other parent 
had a relative with diabetes (Ramachandran et al. 1988). The cumulative risk of 
developing diabetes by the age of 70 years increases from 41.3% - 64.2% by this 
additional influence of familial aggregation (Viswanathan et al. 1985). If both parents 
have diabetes there is an increased prevalence of type 2 diabetes in their offspring. The 
highest prevalence rate for diabetes among offspring of conjugal parents is reported in 
India (50%) and a further 12% had impaired glucose tolerance. Thus, 62% of offspring 
had abnormal glucose tolerance (Ramachandran et al. 1988). A recent study conducted 
in Tunisia reported that familial aggregation of diabetes was prominent among first 
degree relatives (70%) of the diabetic probands (Arfa et al. 2007).
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2.1.2 Evidence of Maternal Influence on diabetes susceptibility
Recent studies on the parental history of type 2 .diabetes provide evidence of maternal 
influence in the transmission pattern (Arfa et al. 2007, Ramachandran et al. 1988, 
Alcolado & Alcolado 1991, Scott et al. 1992, Thomas et al. 1994, Ryoko et al. 1994, 
Gonzalez-Ortiz et al. 1997). A sex-specific parental effect was observed on insulin and 
HDL concentrations (Grrop et al. 1996) and a sex-specific environmental and genetic 
effect transmitted differently between sexes was suggested by Mitchell and co workers 
in the USA (Mitchell et al. 1993). Evidence for a possible maternal influence on 
predisposition to gestational diabetes has been observed and this finding confirms that 
vulnerability to gestational diabetes is increased by exposure to an abnormal 
environment during intrauterine development (Martin et al. 1985).These results indicate 
that maternal influence may play a major role in the environmental and genetic 
predisposition to type 2 diabetes. Gonzalez-Ortiz and colleagues have studied the 
maternal effect of insulin sensitivity and metabolic profile in healthy young Mexicans 
and found that family history of maternal side increases both systolic blood pressure and 
serum uric acid levels in the probands without modification in their insulin sensitivity. 
Probands of this study had a tendency for higher triglyceride concentrations than 
controls (Gonzalez-Ortiz et al. 1999).
Mitchell tested the hypothesis of excess maternal influence for transmission of diabetes 
(Mitchell et al. 1995). His findings suggested that there is no evidence for parental 
differences in the transmission, if  both parents and their offspring were actually tested 
for diabetes. He concluded that this apparent excess could be attributed to reporting 
bias. Absence of excess maternal transmission was observed by a family study in South 
India (Viswanathan et al. 1996) and the study of Kwame Osei (Osei 1999). Possible 
ethnic and racial differences have been suggested to explain the absence o f excess 
maternal influence in some communities (Viswanathan et al. 1996).
If  a maternal influence exists on susceptibility to type 2 diabetes, then it must be 
questioned whether there is a plausible biologic rationale to explain this. For example, 
13 essential oxidative phosphorylation (OXPHOS) proteins are synthesised within the 
mitochondria from the maternally inherited mitochondrial DNA (mtDNA). Specific 
mtDNA deletions can cause maternally-inherited diabetes often associated with 
deafness (Scott et al. 1992). Subtle genetic variation of the mtDNA might contribute to 
the risk o f developing the disorder by interacting with other genetic and environmental
48
factors. A study conducted in the UK with 897 cases and 1010 population matched 
controls showed that European mtDNA haplogroups are unlikely to play major role in 
the risk of developing the disorder (Chinnery et al. 2007). A recently conducted study in 
Sri Lanka has revealed the low prevalence of the mt3243A>G mutation, which is 
related to deafness in association with diabetes, was 0.9% in young adult onset patients 
with diabetes (Katulanda et al. 2008).
According to novel epigenetic hypothesis, heritable modifications in the DNA structure 
can be induced by environmental factors (Jablonka & Lamb 2005). Epigenetic 
variations seem to determine specific genes transcriptional potential ranges from high 
expression to complete inactivity (Bird 2002). Evidence for epigenetic variations is 
observed from animal studies (Cropley et al. 2006). When obese yellow pregnant mice 
were fed with extra vitamins they give birth to standard brown, lean and healthy babies 
as a result of interaction of vitamins with the foetus which turns off the yellow allele. 
The addition of methyl groups to the DNA backbone is used on some genes to 
distinguish between the gene copy inherited from the father and that inherited from the 
mother. In this situation, known as ‘imprinting’ the marks both distinguish the gene 
copies and tell the cell which copy to use to make proteins. In contrast to Mendel’s laws 
of inheritance imprinted genes depend on which parent it was inherited from. For some 
imprinted genes, the cell only uses the copy of the mother to make proteins and for 
others only that from the father. Imprinted genes are expressed only from one allele in a 
strict parent of origin manner (Surani 1998).
Nutrients, toxins, behaviour or environmental exposures of any sort can silence or 
activate a gene without altering its genetic code in any way by adding methylation 
markers on DNA structure (Bernstein et al. 2007). Thus anything that influences 
methylation patterns during development can change the animal or person lifetime. 
Epidemiological data from Sweden provide evidence of transgenerational effects from 
the paternal line. A grandfather who was well nourished before puberty may transmit a 
four times higher than normal risk of type 2 diabetes to his grandchildren. This study 
also showed that paternal grandfather’s food supply during mid childhood was linked to 
the mortality risk ratio of grandsons, but not grand daughters. The study suggested that 
in humans a one off environmental event could influence phenotype for more than one 
generation in a sex specific way ( Kaati et al. 2002, Pembrey et al. 2006). However, 
the molecular basis of this transgenerational effect is not yet fully understood.
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2.1.3 Family History and early onset of type 2 diabetes
A stronger family history of diabetes associated with an earlier age at diagnosis of 
diabetes was observed in India (Vishwanathan et al. 1995). Similar findings were 
observed in Japan that younger onset of type 2 diabetes has a strong hereditary 
background. In patients with younger age of onset a high prevalence of diabetes was 
observed among parents (Hagura et al. 1994).
In summary, mutations in mitochondrial genome and haplotypes may have a direct 
influence and association with maternally inherited diabetes. There is considerable 
evidence to suggest that maternal nutrition imbalance and metabolic disturbances during 
critical times of development may have a persistent effect on health of the offspring and 
may even be transmitted to the next generation. Genetic imprinting and effect of 
epigenetic markers provide evidence that transmission of polygenic traits such as 
diabetes occurs in a sex specific manner. Recent evidence suggests that the paternal diet 
and behaviour may also affect health of offspring. Epigenetics may contribute 
profoundly to the observed familial aggregation of the disease in different populations. 
Thus it can be assumed that intrauterine environment and early foetal programming 
based on epigenetic markers and genetic imprinting onto maternal DNA may have a 
direct collective influence to transmit disease predominantly in a maternal excess way. 
Earlier onset of diabetes among offspring of conjugal diabetes parents may be as a result 
o f stronger effect of bilineal inheritance of both environment and genetic factors.
2.1.4 Chapter aims and objectives 
This part of the study was designed to
1. construct a database with family histories of patients with type 2 diabetes with a 
view o f drawing samples for genetic research in relation to type 2 diabetes.
2. investigate the familial aggregation of type 2 diabetes in Sri Lanka and to determine 
the effect of parental history in relation to development of type 2 diabetes.
3. investigate whether the existence of an excess parental transmission pattern in 
patients with type 2 diabetes is present in Sri Lanka
4. create a DNA bank for patients with type 2 diabetes for the Sri Lankan population
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2.2 Methods
2.2.1 Patient identification and data collection for family history database
Prim ary-care (general) practitioners in defined suburbs in the greater Colom bo area o f  
Sri Jayaw ardenapura, M aharagam a, Dehiw ela, M ount Lavinia, Rathm alana, M oratuwa, 
N ugegoda, Pannipitiya and Piliyandala were invited to participate in the study by 
referring all new ly diagnosed diabetic patients to a specialist diabetic clinic. The clinic 
was held on three days o f  the week. All the patients who attended the clinic had clinical 
data recorded in standardised form s and stored in a com puterized database. These data 
included their name, address, diabetic status, date o f  birth, and age o f  onset and clinical 
data on glycaem ic control and com plications (W eerasuriya et al. 1998).
Figure 2.1 M ap that indicates the local area from  where patients were recruited
One thousand index patients from  the above database were given a questionnaire to 
com plete relating to their fam ily history o f  diabetes. Details o f  fam ily history were 
recorded for five generations. The questionnaire contained inform ation on pa tien t’s 
index number, contact num bers, nam e, address, gender, and diabetic status o f  parents, 
grand parents, siblings, children and grandchildren. Their living or non-living status, 
total num ber o f  siblings, children and grand children were recorded. The clinical 
database was scanned for the age o f  diagnosis and date o f birth. The generational m odel 
o f  the questionnaire is shown in figure 2.2. Incom plete questionnaires were 
supplem ented by a postal questionnaire. A separate fam ily history database was
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com piled w ith the inform ation provided. The records were checked to exclude related 
patients. The responses to the questionnaire were requested in the form  o f  “yes/no” or 
“don't know ” . I f  the “don't know ” responses w ould have been considered as “no” this 
w ould result in m isclassification o f the fam ily history results and w ould reduce the 
pow er o f  the study. Also samples obtained from  such a database w ould not reflect the 
true heritability o f  diabetes in Sri Lankan community. Hence, the probands w ith “do not 
know ” responses were considered separately. The created fam ily history database 
provide a useful resource to select subjects for different study designs such as patient 
parent trio studies, sibpair analysis or case control studies. SPSS 13 statistical software 
package was used for data analysis. Descriptive statistics were used to find m eans and 
percentages. Paternal and m aternal groups were com pared for differences by cross 
tabulating to com pute y j  test statistics.
GENERATION 1 ;mgm. MGF PGM PGF
GENERATION 2
Patient jGENERATION 3 Siblings
GENERATION 4 Children
Grand childrenGENERATION 5
Figure 2.2. General form at for data collection for fam ily history database.
Our contact point in this study was patient at generation 3
(M- Mother, M G M  - Maternal Grand mother, M G F - Maternal grand father, F- Father, 
PGF- Paternal grand father, PG M  - Paternal Grand mother)
2.3 Results
2.3.1 Classification of family histories based on parental data provided
Com plete fam ily history data were obtained for one thousand indexed subjects. The 
sample (n=1000) included 502 m ales and 498 fem ales. The m ean (sd) age o f  onset o f  
the diabetes was 47.0(12) years and m ean duration o f  diabetes was 9.2 (07) years. 370 
(37%) subjects (187 male) reported that at least one parent had diabetes. 469 (46.9% ) 
subjects reported no parents w ith diabetes, while 161 (16.1% ) were not aware o f  the 
diabetes status o f  at least one parent. From the total sample, 59.4%  o f  probands had at
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least one affected relative. The probands were classified as maternal (diabetes in the 
mother only), paternal (diabetes in the father only), both, and neither and unknown 
(Table 2.1).
2.3.2 Parental diabetic status
Among the 370 probands with a parental history of diabetes and where both parents’ 
diabetes status was known and only one was affected, diabetes was more common 
among mothers (n=156) than fathers (n=125, p< 0.001). Both parents of 5.4% of 
subjects had diabetes but 3.5% were unaware whether or not the second parent had 
diabetes.
The diabetes status of either the mother or father was unknown in 196 (19.6%) of 
probands. Among the 145 probands who were not aware o f the mother’s diabetes status, 
the mother was not alive in 121 (83.3%) of cases, was living in 14 (9.7%) o f cases, 
while in 10 (6.9%), it could not be determined if the mother was alive or not, owing 
either to illegible records or missing data. In 151 probands who did not know whether 
their fathers had diabetes, the father was dead in 136 (90.1%) of cases, living in 5 
(3.3%) of cases and dead/living status was unclear in 10 (6.6%).
Table 2.1 Diabetes status of parents of 1000 subjects with type 2 diabetes
Mother Father
Yes No Unknown All
Yes 54 (5.4%) 156(15.6%) 20 (2.0%) 230 (23.0%)
Both Maternal* Unknown
No 125 (12.5%) 469 (46.9%) 31(3.1%) 625 (62.5%)
Paternal* Neither Unknown
Unknown 15 (1.5%) 30 (3.0%) 100(10.0%) 145 (14.5%)
Unknown Unknown Unknown
All 194 (19.4%) 655 (65.5%) 151 (15.1%) 1000(100%)
p< 0.001 * parental diabetes status was significantly different in mothers compared to 
fathers
Number (%) Unknown = at least one parent o f uncertain diabetes status
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2.3.3 Diabetes status of Grandparents
A positive history of diabetes in maternal grandparents was more frequent in probands 
with maternal than paternal diabetes (p<0.001) (Table 2.2). In the maternal diabetes 
group, 36/156 (23%) grandmothers and 31/156 (20%) grandfathers had diabetes. In the 
paternal diabetes group, 11/125 (9%) grandmothers and 37/125 (30%) grandfathers had 
diabetes. However, the diabetes status of maternal grandparents was unknown in 
89/156 (57%) of all probands and the diabetes status of paternal grandparents was not 
clear in 77/125 (53.0%) (Table 2.2).
2.3.4 Siblings and children
Among probands in the both-parents diabetic group, the frequency of affected siblings 
was higher than in other groups 33/54 (61%). The frequency of diabetes among the 
siblings were 84/156 (54%) in maternal group and 53/125 (42%) in the paternal group 
(p<0.001). When considering the children, the number affected {7/156 (5%)} was 
higher in the maternal group than in the paternal group, 2/125 (2%) (p<0.001) 
respectively. Among probands who had siblings with type 2 diabetes, 290/333 (88%) of 
those siblings were living. Among those who had children with type 2 diabetes, 43/45 
(96%) of those children were living (Table 2.3). Of the 1000 probands, 330 (33%) had 
one affected sibling, 159 (16%) had two affected siblings, 73 (7%) had three affected 
siblings and 31 (3%) had four affected siblings. Among the probands with a maternal 
history of diabetes, parents were living in 28/156 (18%) of cases, mothers only were 
living in 41/156 (26.3%) of cases and fathers only were living in 11/156 (7.1%) of 
cases. In probands with a paternal history o f diabetes, both parents were alive in 23/125 
(18%) of cases, mothers only were alive in 46/125 (37%) of cases and fathers only in 
5/125 (3%) of cases (table 2.3). Overall, there were 145 probands with both parents 
alive (trios).
2.3.5 Age of onset of diabetes in both parental diabetes groups
The mean (sd) age of onset of diabetes was earlier in the both-parents diabetic 
group 41 (±11.0) year and mean (sd) duration of the condition 11(±6.0) year was longer 
than in no parental diabetes group 47.7(±11.9)] (p<0.05) (Table 2.4).
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Table 2.4 Age of diabetes and age of onset of diabetes of probands grouped by parental diabetes status
2.5 Discussion
One of the aims of this study was to estimate the degree of familial aggregation of type 2 
diabetes in a Sri Lankan population and to investigate the transmission patterns of this 
disorder and their relationship with parents' status of diabetes. Moreover the effect of 
stronger family history on age of onset o f diabetes in the offspring was investigated. A 
family history database which spans several generations of probands family history of 
diabetes was created with information regarding the living status of the relatives in each 
generation.
The results of this present study agree with the concept of familial aggregation of type 2 
diabetes in that 59.4% of those with diabetes had at least one affected first degree relative 
in the family. A familial aggregation for type 2 diabetes has previously been reported by 
researchers in France (66%), England (43%), South India (54%), Japan (43-49%) and 
Tunisia (70%) (Thomas et al. 1994, Alcado & Alcado 1991, Viswanathan et al. 1996, 
Royko et al. 1994, Arfa et al. 2007). Family history studies conducted in the USA have 
observed that people with a family history of diabetes are 2-6 times more likely to develop 
diabetes than those without (Harrison et al. 2003) and in Japan the observed familial 
aggregation in non diabetic population is 15% (Royko et al. 1994). The present study did 
not observe the family history of non diabetic population which is one of the major 
limitations of the study.
The results of the present study show a significant difference in parental transmission 
pattern of type 2 diabetes. The prevalence of diabetes in mothers was 15.6% when 
compared to 12.5% in fathers. Analysis of a parental history of diabetes based on 
questionnaires by Alcolado and Alcolado in the UK found 36% of mothers and 15% of 
fathers were affected with diabetes. Similarly the CODIAB study (33% mothers to 17.1% 
fathers) and a study conducted in Tunisia found (21% of mothers and 3% of fathers) in 
their studies that there was an excess maternal influence for the transmission of the disease. 
Our results are in agreement with these studies. However, they contradict similar studies in 
south India, Korea and Mexican-Americans who observed that there was no excess 
maternal influence (Viswanathan et al. 1996, Kim et al. 2004, Mitchell et al. 1995). 
Viswanathan and co-workers suggested that there may be ethnic variation to this 
phenomenon. The results of the present study however, suggest clearly that there is an
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excess maternal influence on type 2 diabetes in Sri Lanka (15.6% vs. 12.5%). This 
contradicts the suggestion of Viswanathan and co-workers that there is ethnic variation in 
maternal influence (Viswanathan et al. 1996). This excess extends to the grandparents 
(42.9% in maternal to 38.4% in paternal), siblings (49.5% maternal to 40% paternal) and 
children (4.5% maternal to 1.6% paternal) of probands. The study by Viswanathan and co 
workers was clinic-based. Although the current study was not community-based, patients 
were selected from general practices in a defined area, and this should not have incurred 
significant bias.
An excess of maternal transmission was found by Alcolado and Alcolado but their sample 
had a female preponderance (Alcado & Alcado 1991). A study by Mitchell and co-workers 
reported that-excess maternal influence might be attributed to reporting bias, as women in 
some countries use health-care facilities more often than men, and individuals may be more 
likely to know about their mother’s health status than that of their father’s (Mitchell et al. 
1993). A UK study showed that 14% of South Asians and 27% of Europeans were unaware 
of their parental history (Fischbacher et al. 2001). In the present study, 19.6% of subjects 
were unaware of any parental history of diabetes. Of these, fathers were not alive in 90.1% 
and mothers not alive in 83.3% of cases. It is likely that the lack of awareness of diabetes 
status of parents is mainly because they were dead.
Previous studies may have been influenced by an unequal male/female ratio. The South 
Indian study had excess male (668/308) preponderance (Viswanathan et al. 1996). 
According to the Sri Lankan labor force survey conducted by the Department o f Census 
and Statistics, the percentage of total labor force in work is 90.3% and 78.3% for men and 
women, respectively (Sri Lanka Labor Force Survey, Quarterly Report 1999). In the 
present study the clinic from which the patients were recruited was held outside normal 
working hours, and was attended equally by men and women. The present sample consisted 
of 502 males and 498 females. Hence, any effect due to female preponderance and 
women’s use of excess health-care facilities can be excluded in this study. Unlike in 
developed nations, routine screening for gestational diabetes does not take place in Sri 
Lanka. Therefore, mothers are unlikely to be detected as having diabetes more often than 
fathers because of pregnancy screening (Siribaddana et al. 1998).
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According to the current data, more than half of subjects with both parents affected 
developed diabetes before the age of 40 years, and accordingly, mean age at onset was less 
and mean duration of the condition longer, compared with other groups suggesting double 
gene dose effect. Individual risk of developing diabetes increases with the extent of 
diabetes in the previous generation. It has been reported in India that offspring of diabetic 
parents develop diabetes at a younger age (Ramachandran et al. 1988, Vishwanathan et al.
1985). The early onset of type 2 diabetes is characterized by a high prevalence of diabetes 
in both parents and siblings and onset of the disease between 25 and 40 years age (Fajans 
1989). Indeed, early onset of type 2 diabetes mellitus is common among Sri Lankans.
The most serious limitation in this questionnaire-based study is its reliance on the 
information from respondents about their family histories. Diabetes is an asymptomatic 
disease. Undiagnosed diabetes is found in 36% of subjects during community surveys 
(Katulanda et al. 2008). Ideally, therefore, when using questionnaire-based databases to 
perform family studies, glucose tolerance tests should be done to assess the glycaemic 
status of relatives reported to have no diabetes or where diabetic status is not known. 
However, on the basis of the reported data from those with knowledge of maternal and 
paternal status of diabetes, it may be concluded that there is an excess maternal influence 
for the disease in the Sri Lankan community.
Neel (1962) described type 2 diabetes as the major ingredient of a geneticists’ nightmare. 
According to him the major obstacles for the genetic studies of this disorder is the late and 
variable age of onset, that members are middle-aged and have moved from their place of 
birth and the paucity of suitable genetic materials for the study and extensive heterogeneity 
(Editorial, the Lancet 1992). Accordingly non parametric methods for association studies 
family based studies are encouraged to prevent spurious associations due to population 
stratification. In Sri Lanka, as extended families maintain contact suitable genetic material 
for linkage and genetic association studies could be found. This study revealed 145 of the 
1000 probands were trios. It is also clear that the probands with no parental history have 
reported the maximum number of affected siblings and total of 290 living affected siblings 
thus, indicating feasibility of probands and affected siblings for sibpair analyses. Thus it is 
evident from the present study that it is possible to extract suitable pedigrees for genetic
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studies for type 2 diabetes (case control studies, sib pair analysis or transmission 
disequilibrium test analysis).
In conclusion, this study observed that 59.4% of the probands had first degree relatives with 
diabetes, indicating a familial aggregation for type 2 diabetes. An excess maternal 
transmission pattern has also been observed, with 15.6% of diabetics having a positive 
maternal family history compared to 12.5% with positive paternal family history. 
Interestingly, the onset of the disease was early among the probands who had both parents 
with diabetes indicating a double gene dose effect. This part of the study provides useful 
family history information which can be expanded to further study the feasibility of using 
stratified family history data as a method of diagnosing people at high risk of developing 
diabetes.
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Chapter 3
Type 2 diabetes, periodontal status
and
association with metabolic parameters
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3.1 Metabolic abnormalities in type 2 diabetes mellitus
The normal glucose level in the blood is coordinately regulated by tissue uptake by skeletal 
muscle, liver, adipose tissue, kidney and brain and glucose stimulated insulin secretion by 
pancreatic beta cells ( Lowell & Shulman 2005). In type 2 diabetes mellitus a failure in this 
coordination causes insulin resistance or insufficient insulin secretion by the pancreas, 
ultimately leading to high blood glucose levels (Alberti & Zimmet 1998). Deviations from 
normal levels of fats in the blood (dyslipidemia) are consistently associated with type 2 
diabetes mellitus. In both type 1 and type 2 diabetes, hyperglycaemia is often accompanied 
by hyperlipidemia (Kim et al. 1993, Abdel-Aal et al. 2008, Okafor et al. 2008). These 
serum lipid abnormalities are caused by disruption in fatty acid metabolism. The condition 
is characterised by hypertriglyceridemia, with increased very low density lipoprotein 
(VLDL), increased levels of small dense low density lipoprotein particles (LDL), low high 
density lipoprotein (HDL) and increased levels of omega -6 polyunsaturated fatty acids 
(Taskinen 2003, De Mann et al. 1996, Tilvis & Meittinen 1985). Several lines of evidence 
indicate that high triglycerides play a role in insulin resistance and type 2 diabetes 
(Mingrone et al. 1999, Yang et al. 2003a). Recent evidence suggests that a fundamental 
defect is an overproduction of large very low-density lipoprotein (VLDL) particles, which 
initiates a sequence of lipoprotein changes, resulting in higher levels of remnant particles, 
smaller LDL, and lower levels of high-density lipoprotein (HDL) cholesterol. These 
atherogenic lipid abnormalities precede the diagnosis of type 2 diabetes by several years 
(Adiels et al. 2008).
Underlying mechanisms could be activation of hormone sensitive lipase in adipocytes 
which is suppressed under normal conditions by insulin. In insulin resistance states, this 
enzyme is activated and free fatty acids are released into the plasma. As a result there is 
huge influx of free fatty acids to the liver which stimulate synthesis and secretion of VLDL 
(Rivellese 2004). Lipoprotein lipase, the enzyme which catalyses the release of 
triglycerides from lipoproteins is under the influence of insulin (Howard 1999). Thus in the 
insulin resistant state, the prolonged presence of triglyceride rich VLDL particles in the 
circulation promotes the enrichment of HDL with triglycerides. This alteration results in 
faster catabolic rates of the triglyceride rich HDL in comparison with the normal HDL 
under the action of hepatic lipase resulting in low levels of HDL in circulation (Krentz 
2003).
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The elevated levels of lipid also cause lipotoxicity. This lipotoxic effect can also act 
synergistically with glucose to produce even greater deleterious effects known as 
glucolipotoxicity (Such as destruction of pancreatic beta cells) in patients with type 2 
diabetes (Khan et al. 2006).
3.1.2 Periodontitis and diabetes: relationship with hyperlipidemia
Studies performed on patients with systemic infections have documented a relationship 
between infection and hyperlipidemia (Lopes-Virella 1993). Infections induce changes in 
the plasma concentrations of cytokines and hormones leading to a catabolic state 
characterised by altered lipid metabolism (Samara et al. 1996). The main features o f this 
altered metabolism are hypertriglyceridemia and lipid oxidation. There is evidence to 
suggest that even low levels of chronic exposure to Gram negative microorganisms and 
their LPS can manifest a similar response (Lopes-Virela 1993). Consistent with this theory, 
a study conducted to assess the degree of periodontal infection and lipid profiles in diabetic 
subjects has found that elevated levels of LDL cholesterol were significantly associated 
with antibody titers to Porphyromanas gingivalis (Nishimura et al. 2006). Inflammation 
due to infection could induce the prediabetic status characterised by insulin resistance and 
dyslipidemia. Infection induced proinflamatory cytokines (TNF-a and IL-lp) are known to 
exert effects on lipid metabolism (Van der Poll & Saurwein 1993, Moldwer 1994), 
resulting in elevated levels of free fatty acids FFA, LDL/TRG (Feingold et al. 1992, Fried 
& Zechner 1989). People with diabetes are at a higher risk of infection-induced 
hyperglycaemia and hypertriglyceridemia. According to a study by Rufail and coworkers 
prevalence of atherogenic lipoprotein parameters, very low density lipoprotein (VLDL) was 
8.3%, 33.3% and 66.6% in healthy controls, localised aggressive periodontitis and 
generalized aggressive periodontitis patients respectively. This is an indication that 
periodontitis leads to dyslipidemia (Rufail et al. 2007).
3.1.3 Chapter aims and objectives
To determine the impact of type 2 diabetes on lipid parameters 
To determine the impact of periodontal status on lipid parameters 
To determine the effect of diabetes parameters on periodontal health
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3.2 Method
3.2.1 Patient identification
To study the effect of diabetes on periodontal status a cross sectional study was designed. A 
total of 400 patients were identified from the family history database. Letters were sent to 
their last recorded address three weeks prior to the clinics inviting them to participate in a 
special diabetic clinic, followed by telephone calls three days in advance, reminding them 
to attend the clinics. The clinics were held over several days at each of five occasions at 
Endocrinology and Metabolic Disease Trust in Colombo, Sri Lanka between 2000 and 
2006. Periodontal health status was examined by a team of dental professionals from The 
University of Newcastle Upon Tyne (Professor Peter Heasman and Dr. Philip Preshaw) and 
general health status was recorded by an endocrinology team from the University of Sri 
Jayawardanapura (Professor Devaka Fernando, Dr. Namal Weerasuriya, Dr. Noel 
Somasundaram, Dr. Nimantha De Alwis, and Dr. Chandima Idampitiya).
3.2.2 Clinical diagnosis of diabetes and periodontitis
The diabetes status of patients was determined according to WHO diagnostic criteria (Table 
1.1). The fasting plasma glucose level, lipid profile and glycated heamoglobin levels were 
assessed in the clinical laboratory of Durdan’s Hospital in Sri Lanka. Clinical diagnosis of 
periodontitis was assigned according to methods described in sections 4.2.5. and 4.2.6.
3.2.3 Study population
A total of 285 type 2 diabetes patients, 62 biological parents and 73 controls responded to 
the invitation. The present analysis included 285 patients with type 2 diabetes and 72 
(excluding one edentulous control) age matched controls who underwent periodontal 
examination.
3.2.4 Coding data for analysis
Patients were examined for periodontal variables and other relevant data were collected 
according to the method described in chapter 4.2. Statistical analysis was performed using 
SPSS version 16. Categorical variables considered in this study were gender, smoking 
status and genotype status. Continuous variables included age, body mass index (BMI) and 
blood pressure data. Diabetes-related continuous variables included glycated haemoglobin 
(HbAlc), fasting blood glucose (FBG), diabetes duration and lipid parameters including
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cholesterol (TOC), triglycerides (TGL), low density lipoproteins (LDL) and high density 
lipoproteins (HDL). Mean probing depth (Mean PD), Mean Recession (Mean Rec), Mean 
Loss of Attachment (Mean LOA), Maximum Probing Depth (Maximum PD), Maximum 
loss of attachment (Maximum LOA), % bleeding on probing (% BO P), % sites with 
probing depth (PD)( > 4mm, >5mm, >6mm), % sites with LOA (> 2mm, 3mm, 4mm, 5mm 
and 6mm) and number of missing teeth were the recorded periodontal variables.
3.2.5 Control classification
Controls were screened for possible diabetes taking into account both the HbAlc value and 
fasting blood glucose value (FBG). They were considered as having impaired glucose 
metabolism if HbAlc was >6.1% and FBG was > 100 mg/dl. (Saudek et al. 2008). 
Secondly, they were screened for impaired fasting glycaemia or diabetes. WHO criteria 
were used for diagnosis and if the control subject had FBG values greater than 126mg/dl 
they were considered to have possible (though not confirmed) diabetes. If FBG values were 
within the range 1 lOmg/dl -125mg/dl they were catogerised as impaired fasting glycaemia 
(IFG) and if the value was < 1 lOmg/dl they were considered as normoglycaemic. In this 
study, 72 controls who were recruited under the normoglycaemic category 12 exceeded the 
normal threshold values of diabetes diagnosis according to the WHO diagnostic criteria. 
These 12 individuals did not have a confirmed diagnosis of diabetes, but also could not be 
definitively assigned to the non-diabetic control group as they had evidence of IFG. 
Therefore, they were either excluded from some of the analyses, or, where appropriate, they 
were considered as a separate group (IFG, n=12). Therefore, three different groups; 
patients with type 2 diabetes (diabetes), confirmed non-diabetic controls, and a further 
group with IFG (i.e. possible undiagnosed diabetes) were considered.
3.2.6 Statistical Analysis
Statistical analyses were conducted using the statistical software SPSS 16. Frequency 
distributions were determined and descriptive statistics were calculated including means, 
standard deviations, and ranges. All variables were assessed for normality using the 
Kolmogorov-Smimov test, supplemented with histograms. Where there was no evidence to 
reject normality, means and standard deviations of the parametric variables were calculated. 
Where the assumption o f normality was rejected, means and interquartile ranges of these 
non-parametric variables were calculated. Differences in serum mediator levels and subject
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characteristics between the type 2 diabetic subjects and controls, and periodontal status and 
metabolic parameters were assessed using chi- squared tests for discrete variables. 
Differences between groups in continuous measures were evaluated by ANOVA for 
parametric variables. Box plots were constructed and Kruskal Wallis tests were conducted 
for non-parametric variables. Correlations between continuous variables were assessed 
using Pearsons correlations coefficients for parametric data i.e. if both variables were 
normally distributed, or Spearmans correlation coefficients if variables were not normally 
distributed. Scatter diagrams were constructed to illustrate these associations. Statistical 
significance of all tests was assessed at the 5% level.
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3.3 Results
3.3.1 Normality distribution of data
Normality distribution of the variables was tested using Kolmogorov-Smirnov test. In 
general a p value >0.05 for this test indicates that the data have a normal distribution (i.e. 
the distribution is not significantly different from normal). Table 3.1 presents Kolmogorov- 
Smimov p values for all the variables. As can be seen, only low density lipoprotein (LDL) 
and total cholesterol (TOC) levels showed a normal distribution (Figure 3.1). When 
compared to the mean distribution of LDL and TOC between diabetic cases and controls 
(Table 3.2) there were no significant differences between the groups for TOC (p=0.482) but 
LDL values were significantly lower in cases than controls and the IFG group (P<0.001).
Table 3.2. presents mean (standard deviation) and median (interquartile ranges) values and 
respective p values for all categorical, general and diabetes related variables for the three 
groups. When comparing between patients with type 2 diabetes and controls, significant 
differences were observed for systolic blood pressure (Systolic BP) (p=0.005), diastolic 
blood pressure (Diastolic BP) (p=0.006), glycated heamoglobin (HbAlc) (p=0.001), fasting 
blood glucose (FBG) (p=0.001) and triglycerides (TG) (p=0.001). Both systolic BP and 
diastolic BP values were significantly higher in control patients (p=0.007) and IFG group 
(p=0.028) than in patients with type 2 diabetes. The highest mean systolic BP values were 
recorded in the IFG group 142.6 (126.8-151.8 mm/Hg) when compared to diabetic cases
129.6 (120-140 mm/Hg) and controls 136.9 (125.3 - 145.8mm/Hg). A similar trend was 
observed for diastolic BP, with mean values of 81 mm/Hg (73.8-90.0), 85.6 mm/Hg (76.3 - 
93.5) and 88.8 mm/Hg (82.0-95.5) respectively in type 2 diabetes patients, controls and 
patients with IFG. TG and FBG values were significantly higher among patients with 
diabetes than non-diabetic controls (p=0.001). BMI distribution did not differ between the 
three groups. However, age of the IFG group was significantly different from patients with 
type 2 diabetes (p=0.013) and non diabetic controls (p=0.004). There was no significant 
difference in HDL between the diabetic cases and the non-diabetic controls.
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Table 3.1 Normality distribution data
Kolmogorov-Smirnov3 P Kolmogorov-Smirnov3 P
HbAlc (%) 0.000 Mean Probing depth (mm) 0.000
Total Cholesterol (mg/dl) 0.200 Mean Recession (mm) 0.000
Triglycerides (mg/dl) 0.000 Mean Bleeding on Probing (%) 0.000
Low Density Lipoproteins (mg/dl) 0.200 Percentage bleeding on probing (%) 0.000
High Density Lipoperoteins (mg/dl) 0.000 Maximum probing depth (mm) 0.000
Fasting blood glucose (mg/dl) 0.000 Mean Loss of Attachment(mm) 0.000
Maximum loss of attachment (mm) 0.000
Diabetes duration (years) 0.000 % sites with LOA > 1mm 0.000
BMI(kg/m2) 0.003 % sites with LOA > 2mm 0.000
Age (years) 0.000 % sites with LOA > 3mm 0.000
Systolic Blood pressure (mm/Hg) 0.000 % sites with LOA > 4mm 0.000
Diastolic blood pressure (mm/Hg) 0.000 % sites with LOA > 5 mm 0.000
% sites with LOA > 6mm 0.000
a= Lilliefors Significance Correction
Kolmogorov-Smirnov test statistics shows that total cholesterol and low-density lipoprotein 
levels are normally distributed whereas all other variables are not. (Table 3.1, Figure 3.1)
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Figure 3.1 Histograms demonstrating normal distribution of total cholesterol (TOC)
and low density lipoprotein (LDL)
According to Kolmogorov-Smirnov test statistics only TOC and LDL data were normally 
distributed. Figure 3.1 shows the histograms for cholesterol and LDL
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3.3.2 Associations between metabolic parameters
Statistically significant correlations were observed between TOC and LDL (p=0.000), TG 
(p= 0.000), systolic BP (p=0.010), diastolic BP (p=0.013) and HDL (p= 0.000) (Figure 
3.2). In addition age was positively correlated with systolic BP (p=0.000), diastolic BP 
(p=0.000), LDL (p=0.008) and diabetes duration (p=0.000) (Figure 3.3). Apart from 
positive correlations with TOC, TGs correlated significantly with FBG (p=0.039), and FBG 
with HbAlc (Figure 3.4). LDL levels were correlated with HDL cholesterol, systolic BP 
(p=0.003), diastolic BP (p=0.005) and HDL (p=0.015) (Figure 3.5). BMI was positively 
correlated with systolic BP (p=0.011), diastolic BP (p=0.004) and negatively correlated 
with diabetes duration (p=0.003). Positive correlations were also observed between HbAlc 
and FBG (p=0.000), and between diabetes duration and systolic BP (p=0.020) (Table 3.3).
3.3.3 Correlation between periodontal parameters and biochemical parameters
When assessing correlations between periodontal parameters and biochemical parameters, 
significant positive correlations were observed between TG and maximum PD (p=0.02). 
Significant negative correlations were observed between TG and the % number o f sites 
with PD>4mm (p=0.034) (Table 3.4, Figure 3.6). HDL cholesterol had a negative 
significant correlation with mean Rec (p=0.048) and maximum LOA (p=0.004) (figure 
3.7). In addition FBG was positively correlated with all the periodontal parameters except 
with % number of sites with PD>5mm and PD> 6mm. {( maximum PD (p=0.001), mean 
PD (p=0.047), mean Rec (p=0.002), mean % BOP (p=0.000), mean loss of LOA (p=0.01), 
maximum LOA (p=0.003), % BOP (p=0.000) and % sites with PD >4mm (p=0.001)
(Figure 3.8). Diabetes duration was significantly correlated with mean Rec (p=0.002), mean 
LOA (p=0.023) and maximum LOA (p=0.005) (Figure 3.9). No significant correlations 
were identified between HbAlC, TOC, LDL and BMI and periodontal parameters.
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Figure 3.2. Significant correlations of TOC
TOC showed significant correlations with HDL, LDL, systolic BP, diastolic BP and TG.
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Figure 3.3 Significant correlations of age
Age significantly correlated with systolic blood pressure diastolic blood pressure, diabetes 
duration and low density lipoproteins
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Figure 3.4 significant correlations of fasting blood Glucose (FBG)
FBG significantly with H bAlc and triglycerides
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Figure 3.5 Significant correlations of low density lipoproteins (LDL)
LDL was significantly correlated with systolic blood pressure, diastolic blood pressure, 
high density lipoproteins.
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Spearman’s rho values and its significant value for each correlation is given * indicates correlation is significant at 0.01 level.
Mean PD - Mean Probing Depth, Mean Rec- Mean Recession, Mean BOP- Mean Bleeding On Probing, Mean LOA- Mean Loss of Attachment, 
Maximum PD- Maximum Probing Depth, 
Maximum LOA 
- Maximum Loss of Attachment BOP- Bleeding on Probing
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Figure 3.6 Significant correlations of triglycerides with periodontal parameters
Triglycerides were significantly correlated with mean probing depth and 
percentage sites with probing depth > 4mm
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Figure 3.7 Significant correlations of HDL with periodontal param eters
HDL significantly correlated with mean recession and mean loss o f  attachment
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Figure 3.8. Significant correlations of Fasting Blood Glucose (FBG) with periodontal 
parameters
FBG significantly correlated with mean bleeding on probing, mean recession, mean 
probing depth, % sites > 4mm, mean and maximum loss o f  attachment
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Figure 3.9. Significant correlations of diabetes duration with periodontal param eters,
Diabetes duration significantly correlated with mean recession, mean loss o f  attachment 
and maximum loss o f  attachment.
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3.3.4 Impact of periodontal status on the diabetes parameters
The impact o f  periodontal status (i.e. a diagnosis o f  health, gingivitis or chronic 
periodontitis is presented in Table 3.5. Other than for fasting blood glucose (p=0.033) 
(Figure 3.10) there were no significant differences in biochemical param eters o f  diabetes 
care between the three periodontal diagnosis groups. Mann W hitney tests for group 
comparisons revealed that FBG is higher in the periodontal group than healthy group 
(p=0.012). Flowever, the difference was not significant between gingivitis and periodontitis 
(p= 0.847) or between health and gingivitis (p=0.039) (> 0.0167 which would be expected 
for Mann Whitney comparisons).
3 5 0 .0 0 -  p=0.O33 179
3 9 °  204 O
38O
£  250. 00-
0  200. 00-■Oo_o
CO
0 5  1 5 0 .0 0 -
55 72 o
278
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I
Health Gingivitis Periodontitis
Figure 3.10 Box plots demonstrating fasting blood glucose (FBG) according to
periodontal status
Significance difference was between health and periodontal group (p=0.033)
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3.4 Discussion
Patients with diabetes have an altered carbohydrate and lipid metabolism. As a result they 
typically have elevated levels of serum glucose, triglycerides, LDL, total cholesterol and 
normal serum level of HDL decreases. It is evident from the literature that infections have a 
negative impact on glycaemic control and other parameters of diabetes status, and it is 
presumed that this is also true for periodontitis (Lopes-Virella 1993). The present analysis 
aimed to investigate alterations in carbohydrate and lipid metabolism in patients with type 2 
diabetes and non-diabetic controls according to their periodontal status
Similar to previous findings (Kim et al. 1993) HbAlc (7.37% vs. 5.82%), FBG 160.81 vs.
88.4 mg/dl) and TG (152.06 vs. 108.00 mg/dl) were significantly higher in patients with 
diabetes than non-diabetic controls. Furthermore and perhaps not initially anticipated, 
significantly lower systolic BP (129.63 vs. 136.9 mm/Hg), diastolic BP (81.00 vs. 85.60 
mm/Hg) and LDL levels (123 vs. 140 mg/dl) were observed in patients with diabetes 
compared to controls. It has previously been reported that hypertension is present in 23%, 
hypercholesterolemia in 11%, hypertriglyceridaemia in 14% and high density lipoprotein 
cholesterol in 12% in the diabetic population from where the present sample were drawn 
(Weerasuriya et al. 1998). Patients with diabetes remain at high risk for cardiovascular 
events despite appropriate blood pressure management, LDL cholesterol and blood glucose 
control (Huxley et al. 2006). Therefore, the lower blood pressure and LDL levels reported 
by people with diabetes in this study may reflect an increase in the use of lipid and 
hypertension lowering medication and people with diabetes may be under appropriate 
medical care, whereas the controls are not.
According to National Cholesterol Education Program -  Adult treatment Panel III (ATP 
III) of USA the treatment target is < 130mg/dl for serum cholesterol in the absence of 
diabetes or cardiovascular diseases. The target LDL level is reduced to <100mg/dl in 
patients with diabetes or coronary heart disease (CHD) (NCEP Adult Treatment Panel III, 
2001). Based on 2005 American Diabetes Association guidelines, LDL cholesterol goal 
status (<100mg/dl), HDL cholesterol goal status (>45mg/dl), TG (<150mg/dl) and TOC 
(<240mg/dl). (American Diabetes Association 2006). The results of the present study in 
patients with diabetes demonstrate mean values which were higher than the expected goal
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standards status for LDL and triglycerides except for total cholesterol which is 199mg/dl. 
When considering both non diabetic control group and IFG groups, they showed TOC
207.0 (non diabetic group) & 211.0 ( IFG group) and LDL levels 140.5 (non diabetic) & 
140.85 ( IFG group) which were higher than the expected goal standards for a non diabetic 
population. Moreover the IFG group had elevated HbAlc and FBG levels. These data 
shows that the control population of the study is not metabolically healthy despite their 
FBG values.
This study recruited age and sex matched controls randomly from the same population that 
the type 2 diabetes patients were recruited from. These control patients had no previous 
history of diabetes. However, 16.67% of this group (12 patients) showed abnormal FBG 
and HbAlc levels. This is similar to the findings o f a recently conducted study in Sri Lanka 
that identified that the prevalence of IFG was 14.2% in a group of (non-diabetic) people 
aged 30-65 years (Wijewardene et al. 2005) and 13.6% in urban populations of Sri Lankans 
aged > 20 years (Katulanda et al. 2008). The individuals with possible IFG in the present 
study had a mean age of 53.17(48.3-5.5) years. Katulanda and co workers report in their 
study the prevalence of pre-diabetes (IFG and IGT) is 15.5% for the Sri Lankan population 
for the age group of 50-59 which is very similar to the percentage observed in the present 
study (Katulanda et al. 2008).
According to one recently published report, systemically healthy patients with moderate 
periodontitis demonstrated a significantly higher blood glucose levels than patients without 
periodontitis (Losche et al.2000). Although the numbers of subjects are low, 67% of the 
IFG group (i.e. 8 of 12) in the present study were diagnosed with chronic periodontitis. 
When considering serum lipid levels in this cohort of 12 IFG group, levels of LDL, TOC 
and TG , HbAlc, and FBG were higher than those identified in the normoglycaemic 
controls. It is possible that the low number of subjects in the IFG group contributed to the 
lack of statistical significance but studying a large cohort would demonstrate significant 
results. These carbohydrate and lipid abnormalities may be due to infection-induced (i.e. 
periodontitis-induced) abnormalities in metabolism. The IFG group showed the symptoms 
of hypertension and were significantly older (53.17(48.3-5.5) than the type 2 diabetes 
(45.70 (37.-54.5) and control group (45.05 (38-51.8). In addition the mean BMI value of 
the IFG group was 26.79(23.6-31.9) which indicate that they are at moderate risk o f
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morbidity and belong to the category of obese 1 (BMI within the range 25-29.9) for adult 
Asians (WHO technical report series 894 (2000). These results indicate that there is a 
possibility of older obese people to be at an increased risk of developing diabetes and 
associated complications like periodontitis.
The present study observed that people with periodontitis and gingivitis have FBG values 
which are significantly higher compared to people with periodontal health (140.73 mg/dl 
with periodontitis vs. 123.34 mg/dl in periodontal health, 150.27 mg/dl with gingivitis vs. 
123.34 mg/dl in periodontal health). In addition, higher levels o f HbAlc were observed in 
periodontitis (7.04%) and gingivitis (7.11%) than people with periodontal health (6.97%). 
Moreover, this study has observed longer diabetes duration, low HDL values and increased 
levels of triglycerides in gingivitis and periodontitis groups compared to healthy group but 
failed to reach statistical significance. Furthermore, FBG significantly correlated with all 
periodontal parameters except % sites with PD > 4mm and % sites with PD > 5mm. 
Moreover, positive significant correlation of triglyceride levels was observed with 
maximum probing depth indicating possible evidence of an impact of periodontitis on lipid 
metabolism. Other studies have reported similar findings. A study by Hisayama in Japan 
revealed a significant difference in deep pockets with impaired glucose tolerance in a 
subgroup of subjects with normal glucose tolerance ten years previously. This study also 
identified that each additional millimeter in mean pocket depth corresponded to 0.13% 
increase in HbAlc (Satio et al. 2004). Other studies have observed elevated serum total 
cholesterol levels was associated with periodontal damage assessed by the mean depth of 
periodontal pockets (Furukawa et al. 2007). These results suggest the possibility o f an 
infection-induced (i.e. periodontitis induced) metabolic imbalance resulting in 
hyperlipidemia and hyperglycaemia.
The present study also identified significant associations between diabetes duration and 
mean recession, mean loss of attachment and maximum loss of attachment. This may result 
from the long term presence of periodontal disease in patients with diabetes, leading to the 
observed association between these periodontal variables and the duration of diabetes.
In summary it can be concluded that the subjects with diabetes in this population have 
hyperglycaemia and hyperlipidemia. This is to be expected, and is consistent with
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previously reported research. Patients with periodontitis and gingivitis had significantly 
higher FBG values than healthy controls suggesting the possibility of periodontitis- induced 
hyperglycaemia. The severity of periodontitis as measured by Mean PD, Maximum PD, 
Maximum LOA, Mean Rec, mean BOP, %BOP and % sites with PD >4mm were 
significantly correlated with serum FBG values. Moreover, Mean Rec, Mean LOA and 
Maximum LOA correlated with diabetes duration and serum triglyceride levels were 
significantly correlated with Maximum PD and % sites with PD> 4mm, suggesting an 
underlying metabolic imbalance associated with periodontitis. Furthermore, 16.7% of the 
non diabetic population who come under the obese category according to Asian standards 
were at mean age of 53 showing impaired glycaemic control as measured by HbAlc and 
FBG values and 66.7% of this group were diagnosed with periodontitis. Clearly, the 
individuals with IFG may have undiagnosed diabetes and are at a high risk of developing 
diabetes related complications.
Chapter 4
Type 2 diabetes: Periodontal association
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4.1 Periodontitits
Periodontal diseases encompass a range of conditions with variable clinical presentation 
ranging from gingivitis to chronic periodontitis and aggressive periodontitis. Gingivitis is 
highly prevalent, probably affecting (to some degree) the great majority of the population. 
The prevalence of advanced periodontitis is generally estimated to be 10-15% in most 
populations studied. The extent and severity o f periodontitis can be assessed by the number 
o f sites affected and degree of clinical attachment loss. Thresholds for defining severity of 
disease are not well defined, but severe periodontitis would certainly be characterised by 
loss of attachment > 6mm (Preshaw et al. 2007). There is emerging consensus that 
although periodontal diseases are localised to the oral cavity, they may also have systemic 
impact too. In the context of diabetes, periodontal inflammation is associated with an 
elevated systemic inflammatory state which appears to alter glycaemic control.
Furthermore, intervention trials suggest that periodontal therapy, which decreases the intra­
oral bacterial bio-burden and reduces periodontal inflammation, can have a significant 
impact on systemic inflammatory status and is associated with improved glycaemic control 
in many patients with both diabetes and periodontal diseases (Mealey 2008).
4.1.1 Epidemiological data
Chronic periodontitis is considered as a disease o f middle age with a majority of patients 
presenting in their 40s & 50s (Preshaw et al. 2007). In epidemiological terms, mild to 
moderate chronic periodontitis is common, affecting 40-60% of adults in Western 
populations whereas the prevalence of severe periodontitis is approximately 8-15% (Burt 
1996, Fox et al. 1994, Kelly et al. 2000, Oliver et al. 1998). The UK Adult Dental Health 
Survey identified that in adults, dental plaque was visible in 72% and calculus was visible 
in 73% of patients, signifying a poor level of oral hygiene. However, moderate periodontal 
pocketing was observed in only 54% of people. In this population, approximately 43% of 
adults have moderately advanced chronic periodontitis (with attachment loss > 4mm), and 
it was reported that 8% have severe periodontitis (attachment loss >6mm) (Office for 
National statistics 2000, Kelly et al. 2000). These data are, of course, prevalence data, and 
identifying incidence of periodontal disease is extremely difficult. However, according to 
recent statistics in the UK the annual incidence of patients presenting with symptoms of 
periodontal disease in general medical practice is reported as 6 per 10,000 people per year
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(Birmingham Research Unit 2005). The prevalence of gingivitis in the U.S. population was 
estimated as 50% (Albandar et al. 1999). Furthermore, according to the National Health 
and Nutrition Examination survey (NHANES III) data, it has been identified that 
approximate values o f moderate to severe periodontitis is 13% and 5.6% respectively for 
the US population aged 20 years older. Analysis of the data of this survey further revealed 
that 22.5% (23.8 million persons) have gingival recession (one or more tooth surfaces with 
> 3mm). In addition, the presence of calculus and subgingival calculus were reported in 
91.8% and 55.1% of the population, respectively (Albandar et al. 1999).
4.1.2 Periodontal disease severity and type 2 diabetes
In addition to the evidence observed for an increased prevalence of periodontitis in patients 
with type 2 diabetes (See section 1.10 and Table 1.2 for further details) increased severity 
of periodontal disease in patients with diabetes has been reported. A study conducted in 
Native Americans indicated an association o f probing depth (>5mm) to the level of 
glycated haemoglobin (Nelson et al. 1996) thus suggesting more generalised infection may 
have a negative control on blood glucose level (Rees 2000). A recently conducted study in 
Jordan identified a higher prevalence o f periodontitis in patients with diabetes than in 
normoglycaemic people based on clinical measures of PD, LOA and tooth mobility 
(Khader et al. 2008). In a similar study in Hispanic Americans, periodontal status was 
evaluated by measuring PD, LOA, plaque, BOP, visual gingival inflammation and calculus. 
This study reported that type 2 diabetes is associated with significantly more calculus 
formation, tooth loss and increased extent and severity o f periodontal disease. In this 
population, subjects with diabetes demonstrated nearly three times greater LOA and 
PD >6mm, and approximately twice the frequency of moderate to advanced LOA (>3mm) 
than the non-diabetic population. In addition to the increased extent and severity of 
periodontal destruction, the Hispanic Americans with type 2 diabetes had more supra- and 
subgingival calculus, and an increased frequency of tooth loss due to periodontitis. This 
study also found synergistic effects of diabetes and smoking resulting in significantly 
higher frequency of sites with attachment loss > 3mm (Novak et al. 2008).
Another case control study which was designed to study the prevalence of periodontitis 
among patients with diabetes had measured clinical and microbiological periodontal
parameters of periodontal disease among adult Sardinians. Patients with type 2 diabetes had 
significantly fewer remaining teeth, and more PD >4mm, BOP and plaque levels (Campus 
et al. 2005). Al-Otaibi and co-workers also identified that probing depths and clinical 
attachment levels were significantly higher in patients with diabetes than those without 
diabetes in Saudi Arabia (Al-Otaibi et al. 2008). These studies collectively provide 
evidence that measures of periodontal disease such as clinical attachment loss, probing 
depth and bleeding on probing are more advanced in type 2 diabetes.
4.1.3 Periodontitis and level of glycaemic control
Glycaemic control is clearly important when considering the role of diabetes as a risk factor 
for periodontal disease. It is clear from the literature that the severity of periodontal disease 
is greater in diabetic patients with poor metabolic control (Mangan et al. 2000). An 
increased level of glucose is observed in the gingival crevicular fluid of poorly controlled 
patients with diabetes mellitus (Kjellman 1970) which may alter plaque microflora with a 
resultant influence on the development of dental caries and possibly periodontal disease 
(Mealy 1998). It has been shown that the loss of periodontal attachment is most rapid 
during the elevation of blood glucose and the severity of periodontal disease has been found 
to decrease as control of diabetes improves (Ainamo et al. 1990). The monitoring of the 
effectiveness of diabetes control is done by measuring the levels of glycated serum proteins 
especially HbAlc which because of its incorporation into red blood cells gives an 
indication of the serum glucose levels over the proceeding 2 to 3 months (The Diabetes 
Control and Complication Trial Research Group 1993).
Taylor and colleagues have observed that individuals with poorly controlled type 2 diabetes 
compared to those without type 2 diabetes, or with better-controlled type 2 diabetes have a 
significantly greater risk for alveolar bone loss progression, with more severe bone loss 
than in subjects without type 2 diabetes (Taylor et al. 1998). Based onNHANES III data, 
individuals with poorly controlled type 2 diabetes had a significantly higher prevalence of 
severe periodontitis than those without diabetes after controlling for age, education, 
smoking and calculus (Tsai et al. 2002). In another study, the prevalence of severe 
attachment loss increased with decreasing control of diabetes as determined using HbAlc 
(Guzman et al. 2003). It has also been reported that people with impaired glucose tolerance
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also have a higher prevalence of periodontitis in Pima Indians (Shlossman et al. 1987). In 
non diabetic patients, Loesche and co workers found fasting plasma glucose (FPG) levels to 
be on average 15% higher in periodontitis patients compared to controls. (Losche et al.
2000). In contrast, Noack and co-workers did not demonstrate an association between 
increased blood glucose levels and periodontal disease (Noack et al. 2000) and Marugame 
and co-workers found no association between alveolar bone loss and impaired glucose 
tolerance and periodontitis (Marugame et al. 2003).
4.1.4 Periodontal treatment and metabolic control of diabetes
A systemic effect of periodontal disease has been suggested in periodontal treatment studies 
which incorporate systemic antibiotics. Conventional mechanical periodontal therapy 
(subgingival scaling, periodontal surgery and dental extractions) had shown no effect on 
levels of HbAlc levels in subjects with poorly controlled type 1 diabetes (da Cruz et al. 
2008, Seppala & Ainamo 1997, Aldrige et al. 1995, and Smith et al. 1996). Scaling and 
root planing with adjunctive subgingival irrigation with 0.2% chlorohexidine had no effect 
on levels of HbAlc, concentration o f C-peptide, creatinine, C-reactive protein and 
fibrinogen in well controlled type 1 and type 2 diabetic patients (Christgau et al. 1998). 
However, a significant reduction of probing depth and clinical attachment level were 
observed three months after mechanical therapy (ultrasonic bactericidal curettage) (Grossi 
et al. 1997). In contrast, studies incorporating systemic antibiotics with conventional 
mechanical periodontal treatment consistently reported improvement in metabolic control 
following the periodontal therapy. Grossi et al (1997) studied the effect of periodontal 
therapy on glycaemic control in patients with type 2 diabetes. 85 patients were divided into 
four treatment groups and they were followed for a period of one year post treatment period. 
All patients in the 4 groups received scaling and root planing, and then received topical 
irrigation with water, 0.12% chlorohexidine, or 0.05% iodine during therapy. Three of the 
four groups also received 14 days of systemic doxycycline therapy. Significant reductions 
in HbAlc values were observed three months after the treatment in the three groups who 
received doxycycline therapy irrespective of the irrigant used. However, this beneficial 
effect was lost at the subsequent 6-9-and 12 months visit. This study supports the 
hypothesis that anti-inflammatory therapy used for the treatment of periodontal disease can 
potentially improve metabolic control of diabetes (Grossi et al. 1997) In a later study,
Kiran and co-workers found that periodontal treatment in a cohort of patients with type 2
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diabetes resulted in improved glycaemic control three months after treatment. In this study, 
HbAlc scores reduced from 7.3% to 6.5% compared to controls, who demonstrated a (non 
significant) increase in HbAlc from 7% to 7.3% over the same timescale (Kiran et al.
2005).
A study conducted in China also evaluated the effect of non-surgical periodontal therapy 
on glycaemic control in patients with type 2 diabetes. In this study, one group of patients 
was treated with scaling and root planing, and both study groups received systemic 
doxycycline. This study revealed significant reductions in plaque index and bleeding on 
probing scores in the group that underwent mechanical periodontal therapy, and both study 
groups demonstrated reductions in HbAlc values, which was postulated as being possibly 
related to the systemic antibiotic (Yun et al. 2007). A similar study was recently conducted 
in the USA, in which HbAlc scores were evaluated following minimal or enhanced non- 
surgical, non antibiotic treatment in patients with type 2 diabetes. Patients with mildly 
elevated (>7% and <9%) and severely elevated (> 9%) HbAlc scores were randomized to 
one of two non-surgical periodontal therapy protocols. One group received minimal therapy 
(scaling, root planing and oral hygiene instruction) once in six months whereas the other 
group received frequent episodes of scaling, root planing and oral hygiene instructions on 
two occasions six months apart, together with additional 0.12% chlorhexidine rinse twice a 
day. This study observed that clinical loss of attachment (LOA) unchanged in both groups 
but other measures such as probing depth (PD) and gingival index (GI) were improved in 
both groups. Moreover an overall modest improvement in HbAlc was observed in both 
groups with a trend towards the frequent periodontal therapy having a greater impact (3.7% 
reduction) than the minimal therapy with 1.6% reduction (Madden et al. 2008).
A meta-analysis of 10 intervention studies to estimate the effect of periodontal treatment on 
HbAlc identified a weighted mean absolute reduction in HbAlc values of 0.66% in 
patients with type 2 diabetes following periodontal treatment, though this did not achieve 
statistical significance (Janket et al. 2005). A similar reduction level of HbAlc scores 
(0.6%) was observed in the study by Madden and co-workers referred to above (Madden et 
al. 2008). A study that evaluated the impact of mechanical periodontal therapy combined 
with subgingival application of minocycline gel also identified a similar reduction in 
HbAlc levels (0.8% reduction) in 13 Japanese patients with type 2 diabetes (Iwamoto et al.
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2001). Collectively, these results suggest that periodontal treatment has the potential to 
improve glycaemic control in patients with type 2 diabetes.
4.1.5 Glycaemic control and complications
The control of diabetes focuses on controlling blood glucose levels, and there is clear 
evidence that diabetes complications can be prevented by tight glycaemic control. The 
Diabetes Control and Complication Trial (DCCT) conducted in 1993 concluded that, after
6.5 years of follow-up, that strict glycaemic control can delay the onset of complications 
and reductions in the progression of existing complications (DCCT) (DCCT group 1993, 
The diabetes control and complication trial/ Epidemiology of Diabetes Interventions and 
Complications Research Group 2000). Similar results were obtained from the UK 
Prospective Diabetes Study (UKPDS) (UKPDS 1998) in which, after following patients for 
an average of 10 years, it was concluded that tight control of blood sugar is associated with 
reduction in microvascular complications of disease. This study identified a gradational 
effect with a 1% reduction in HbAlc scores accounting for a 35% reduction in diabetes 
complications and a 25% reduction in diabetes related deaths. In both studies outcome 
measures were the onset and progression of diabetic retinopathy, nephropathy and 
neuropathy. However, improved glycaemic control (as measured by reduction of HbAlc) 
achieved with intensive insulin treatment in patients with type 1 diabetes did not result in 
any detectable improvements in periodontal parameters (PD, LOA or BOP) (Sastrowijoto et 
al. 1990).
4.1.6 Periodontitis and diabetes duration
Several studies have suggested that the age at onset of diabetes, and the duration o f diabetes 
may be a more critical factor than the level o f glycaemic control when considering oral and 
systemic complications (Bacic et al. 1998, Taylor et al. 1998, Cerda et al. 1994). Al- 
shamari and co-workers have investigated the association of periodontal disease severity 
with diabetes duration and diabetic complications in patients with type 1 diabetes in Kuwait 
and identified that patients who had diabetes for more than 5 years had more severe 
attachment loss and a higher number of missing teeth than those patients who had diabetes 
for less than 5 years (Alshammari et al. 2006). In another study, the severity of periodontal 
disease as demonstrated by periodontal pocket depth was significantly higher in patients 
with duration of diabetes of more than 5 years (Khader et al. 2008). This parallels findings
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from other studies of complications of diabetes, in that the greater the diabetes duration, 
then the greater the prevalence and severity of the complication (Nathan 1993).
4.1.7 Obesity and periodontitis
Obesity has also been linked to increased periodontal disease (Alabdulkarim et al. 2005). 
Saito and coworkers found that relative risk of periodontitis after adjustment for 
confounders (age, gender, oral-hygiene, smoking) was 3.4 in persons with BMI of 25-29.9 
kg/m2 and 8.6 in those with BMI >30kg/m2 (Saito et al. 2001). Genco and coworkers 
based on data from the third NHANES III survey demonstrated that BMI was positively 
correlated with the severity of periodontal attachment loss (Genco et al. 2005).
4.1.8 Chapter aims and objectives
There is clear, and firmly established evidence to support that there is an association 
between type 2 diabetes and periodontitis in different populations. In Sri Lanka, the 
prevalence o f type 2 diabetes rate is moderately high (14.2%) in adults o f 30-65 years 
(Wijewardena et al. 2005) and 10.3% for Sri Lankans > 20 years of age (Katulanda et al. 
2008). The diagnosis in many cases is incidental and it has been reported that 36% of the 
people with diabetes were previously undiagnosed in this population. The prevalence of 
pre-diabetes was 11.5% (Katulanda et al. 2008). Usually by this time of diagnosis of 
diabetes complications have developed and progressed. The prevalence of diabetes 
complications at the time of diagnosis has been reported previously in this population 
(Weerasuriya et al. 1998). Records of periodontal status in Sri Lankans date back to late 
1970 where the periodontal examinations were conducted in rural tea workers who had no 
access to treatment and periodontal care (Loe et al. 1978, Anerud et al. 1979). However, 
the association of periodontitis with type 2 diabetes has not been evaluated.
Therefore, the aims of this chapter were to
1. evaluate the prevalence and severity of periodontal disease in type 2 diabetes and a 
matched control population of urban Sri Lankans
2. study the relationship between glycaemic control and periodontal disease severity in 
this population
3. investigate the impact of age and duration of diabetes on periodontal status.
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4.2 Method
4.2.1 Ethical Clearance and Informed consent
Ethical clearance for the study was obtained from the Ethics Committee of University of Sri 
Jayewardenepura, the Ethics committee o f the Sri Lanka Medical Association and the 
Newcastle and North Tyne side Health Authority and Joint Ethics Committee. The 
informed consent was obtained from patients and controls after the nature of the procedure, 
purpose of the study, and possible risks and benefits had been fully explained verbally in 
addition to the Patient Information Leaflet provided. They were also notified that they were 
free to discontinue their participation in the study at anytime without any negative effect on 
their usual medical care. Those who agreed to participate, gave written consent by signing 
a consent form.
4.2.2 Inclusion criteria and exclusion criteria
Patients with type 2 diabetes and normoglycaemic controls who underwent periodontal 
examination were included in the study. Patients who were edentulous were excluded from 
the primary dental analysis (n=2). In addition people with other known systemic conditions 
such as rheumatoid arthritis or HIV infections were excluded from the study.
4.2.3 Study population
Age and sex matched subjects in the non diabetic control group was based on a power 
calculation to detect a difference between groups in attachment level of 0.6mm with 90% 
power assuming a significance of 5% and 271 subjects with type 2 diabetes and 50 controls 
were required. Statisticians help was sought in the power calculation and subjects of Sri 
Lankan origin were invited to participate in this study. There were 285 patients with type 2 
diabetes and 72 controls responded. The control group was selected from the same 
population as the patients were recruited from and had no previous records o f diabetes. 
Based on control classification (Sec 3.2.5) controls who exceeded normoglycaemia (n=12) 
were excluded from the present analysis. Therefore, the analysis of impact on diabetes 
status, periodontal status and periodontal variables were based on 345 subjects with 
confirmed type 2 diabetes (n=285) and confirmed non diabetic controls (n=60).
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4.2.4 General health status
All the patients were examined by a medical professional for their systolic blood pressure, 
and diastolic blood pressure. Height and weight measurements of the subjects were 
recorded. Weight in Kilograms (Kg) divided by height in square meters (M2) were used to 
calculate body mass index (BMI) of each subject (Kg/M2). In addition data regarding age, 
date of birth, smoking status and alcohol consumption were recorded. In patients with 
diabetes, age of onset of diabetes, diabetes duration and hypo treatment were recorded.
4.2.5 Measuring probing depth (PD) and loss of attachment (LOA)
The prevalence and severity of destructive periodontal disease was determined by 
measuring the PD and clinical LOA. The manual TPS periodontal probe (Vivadent, Schaan, 
Lichtenstein) was used to record probing depths at 6 sites per tooth on all teeth present 
(excluding 3rd molars). The distance between the free gingival margin (FGM) and the apical 
depth of the probe tip penetration was measured as the PD at each site. The distance 
between the CEJ and the gingival margin was recorded. Gingival recession (GR) was 
recorded by measuring the distance between CEJ and FGM. All measurements taken were 
rounded up to the nearest millimetre and clinical LOA was computed using GR and PD 
values. Measured values were used to calculate periodontal parameters PD ( % sites with 
PD > 4mm, % sites with PD > 5 mm and % sites with PD > 6mm), Mean PD, Maximum 
PD, loss of attachment (LOA) (% sites with LOA >lmm, % sites with LOA > 2mm, % 
sites with LOA > 3mm, % sites with LOA > 4mm, % sites with LOA > 5mm), Mean LOA, 
Maximum LOA, and mean recession which were the continuous variables considered in 
this study. Number of missing teeth from each subject were counted and recorded.
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4.2.6 Diagnosis
Subjects were clinically diagnosed using the diagnostic criteria for periodontal diseases that 
were proposed by the European Workshop of periodontology 2005 and the centre for 
disease control and American academy of periodontology( CDC-AAP) collaboration 2007 
(Tonetti 2005, Page 2007).
Periodontal health : If there is no probing depth (PD) of the true pocket is > 3mm and 
minimal bleeding on probing is <15%.
Gingivitis : In addition to clinical features if the PD < 4mm and demonstrate > 15% BOP 
the subjects were diagnosed for gingivitis
Chronic periodontitis : diagnosis was made when there were > 6 sites with PD of > 5mm
4.2.7 Grouping cases according to HbAlc values
Patients were categorized into good, moderate and poor control of diabetes based on their 
HbAlc value. HbAlc value is considered as a good measure of glycaemic control as they 
reflect the blood glucose levels over the previous three months (Waugh et al. 2007). They 
were considered to be in good control if the HbAlc values were less than or equal 7% 
(HbAlc < 7%). If the values were between >7% -8.5% they were considered as moderate 
control and above 8.5% were catogorised as poor diabetes control (Qaseem et al. 2007).
4.2.8 Statistical analysis
Categorical grouping variables in this study included periodontal status (health, gingivitis, 
periodontitis) and diabetes status (diabetic with good control, diabetic with moderate 
control, diabetic with poor control, non-diabetic). A cohort of subjects (n=12) who, 
according to medical history were initially believed non-diabetic, but who transpired to 
have blood results suggestive of impaired glucose tolerance or possible diabetes, were 
excluded from analyses. Impact of periodontal status on diabetes status (and vice versa) 
was determined using chi-squared statistics. The same statistics were applied to find the 
difference in distribution of periodontal diagnosis according to gender smoking and 
alcoholism. To compare the distribution of continuous variables, independent sample t-test 
statistics were employed for parametric data. Comparisons were made between the groups 
using analysis of variance with post-hoc Bonferroni corrections. When the data were not 
normally distributed comparisons between groups were made using Kruskal-Wallis test
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with post hoc Mann Whitney tests. When employed Mann Whitney test to compare groups 
the critical value p-0.05 was adjusted according to the number of post-hocs performed to 
avoid inflating type 1 error. For some analyses the diabetic patients were collapsed into one 
group, and compared against the non-diabetic patients. In these analyses, comparisons 
between the groups were made using unpaired t tests (parametric data) or Mann Whitney 
tests (non-parametric data). Box plots were plotted for all variables, to indicate median 
values, interquartile ranges, outliers (1.5-3.0 interquartile ranges from the box) and extreme 
values (>3.0 interquartile ranges from the box). Correlations between the variables were 
assessed by Spearman’s correlation coefficient for non parametric data. Scatter diagrams 
were constructed to illustrate these associations. Multiple linear regression analyses were 
employed to identify the ability of key predictor variables to predict outcomes. Significance 
of all the tests was assessed at 5% level.
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4.3 Results
4.3.1 Subject characteristics
A total of 357 subjects recruited represent 285 patients with type 2 diabetes and 72 controls. 
According to HbAlc criteria, 12 (16.6%) of the control subjects were identified as having 
impaired metabolic conditions hence the final periodontal analysis included 285 patients 
and 60 normoglycaemic controls. Females in the study group were 51.5% (184/357). Mean 
(SD) of age was 45.84(±11.99). There were 7.8% current smokers and 12.3% ex-smokers. 
26.1% of the study population were alcohol consumers.
4.3.2 Periodontal status
Table 4.1. shows the proportions of individuals within the diabetes and control groups 
according to periodontal diagnoses (Group 1= health, gingivitis and chronic periodontitis), 
(Group 2 = Health/Gingivitis and Chronic periodontitis). Among patients with diabetes 
38.2% were periodontally healthy compared to 41.7% of the controls. 28.4% of diabetes 
group and 36.7% of the controls had gingivitis. Chronic periodontitis was present in 33.3% 
of the patients with type 2 diabetes and 21.7% of controls. However the difference was not 
statistically significant (p=0.18) A strong trend towards a greater proportion of the people 
with diabetes also having chronic periodontitis compared to non-diabetic controls was 
observed when health and gingivitis patients were considered as a single group (p=0.077)
Table 4.1 Periodontal diagnosis in patients with type 2 diabetes and controls
Periodontal Health 
Group 1
Diabetes /control Total
Diabetes (n=285) Control (n=60) (n=345)
Health 109 (38.2%) 25(41.7%) 134 (38.8%)
Gingivitis 81 (28.4%) 22 (36.7%) 103 (29.9%) p= 0.180
Chronic Periodontitis 95 (33.3%) 13 (21.7%) 108 (32.5%)
Total 285 (100%) 60 (100%) 345 (100%)
Group 2
Health/Gingivitis 190(66.7%) 47(78.3%) 237 (68.7%)
Periodontitis 95(33.3%) 13 (21.7%) 108 (31.3%) p=0.077
Total 285(100%) 60(100%) 345(100%)
P> 0.05 in group 1 and group 2 periodontal diagnosis categories
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4.3.3 Impact of diabetic status on periodontal parameters
Table 4.2 shows the distribution of periodontal parameters between patients with type 2 
diabetes and controls. Subjects with type 2 diabetes generally showed increased disease 
severity compared to controls although all periodontal parameters failed to achieve 
statistical significant difference. Measures for mean recession (mean Rec) (p=0.005) mean 
bleeding on probing BOP (p=0.001), maximum PD (p=0.001), maximum LOA (p= 0.001), 
and % BOP (p=0.015), % sites with PD > 4mm, (p=0.001), > 5mm (p=0.007) and > 6mm 
(p=0.020) were significantly higher in the group with type 2 diabetes than controls (Figure 
4.1).
4.3.4 Periodontal status according to level of glycaemic control
Patients with type 2 diabetes were catagorised into good, moderate and poor control 
diabetes according to HbAlc values. 37.5% of the good control, 38.3% of the moderate 
control and 26.8% of the poorly controlled group were affected with periodontitis (table 
4.3). Table 4.4 presents data of periodontal parameter distribution according to level of 
glycaemic control. When the impact of glycaemic control on periodontal parameters was 
examined, statistically significant effects of diabetes status were identified for maximum 
PD (p=0.025 ) % BOP ( p=0.002), Maximum LOA (p=0.015) % sites with probing depth 
(PD) > 4mm and % sites with PD > 5mm (p=0.05). For % BOP the differences were more 
likely to be between good (18.97%), (p=0.001) and poor (18.78%), ((p=0.002) vs non 
diabetic controls (8.29%). In addition significant differences were observed for maximum 
PD (4.47mm vs. 3,8mm) (p=0.003) and maximum LOA (6.24mm vs. 5.14mm) (p=0.002) in 
subjects with diabetes who have good glycaemic control and non diabetic controls. 
Moreover subjects with moderate glycaemic control displayed significant difference in 
LOA (6.27mm) compared to non diabetic controls (5.14mm) (p=0.011). Considering the % 
sites with PD > 4mm, a significant difference exists between diabetes with good glycaemic 
controls (12.93%) and non diabetic controls (5.08%) (p=0.002). Similarly, % sites with PD 
> 4mm showed a significant difference between poor glycaemic control (6.74%) and non 
diabetic controls (5.07%) (p=0.021). When considering the % sites with PD > 5mm the 
difference was again significant between good glycaemic control (5.45%) and non diabetic 
controls (2.77%) (p=0.007). Collectively these data provide evidence that in people with
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diabetes, the good glycaemic control group have greater disease severity than non diabetic 
controls (Figure 4.2).
Table 4.2. Periodontal parameter according to type 2 diabetes and control
Type 2 diabetes 
(n=285)
Controls
(n=60)
p value
Mean probing depth (mm) 2.13 (1.61-2.39) 2.0(1.51-2.32) 0.552
Mean recession (mm) 0.48 (0.04-0.49) 0.34 (0.02-0.27) 0.005
Mean bleeding on probing 0.17(0.18-0.23) 0.08 (0.01-0.11) 0.001
Mean loss o f attachment (mm) 2.61(2.14-2.87) 2.34(1.71-2.44) 0.214
Maximum probing depth (mm) 4.47 (3.0-5.0) 3.8 (3.0-5.0) 0.001
Maximum loss o f attachment (mm) 6.37 (4.0-8.0) 5.14(3.0-6.0) 0.001
%BOP 16.75(1.80-22.9) 8.3 (0.6-10.7) 0.015
% of sites with PD >4mm 10.47(0.00-9.9) 5.08 (0.0-2.4) 0.001
% of sites with PD >5mm 4.52 (0.00-2.08) 2.77 (0.00-0.60) 0.007
%  o f sites with PD >6mm 0.91(0.00-0.00) 1.04 (2.0-2.0) 0.020
% sites with LOA > 1mm 99.60(100-100 ) 99.73(100-100) 0.873
% sites with LOA > 2mm 72.71 (58.83-91.85) 72.57(60.50-95.60 ) 0.520
% sites with LOA > 3mm 37.54(13.70-58.00) 29.66(7.90-44.20 ) 0.066
% sites with LOA > 4mm 21.53 (2.4-32.50) 15.88(1.60-20.88) 0.109
% sites with LOA > 5mm 18.05(1.73-24.47) 13.15(1.20-11.55) 0.211
% sites with LOA > 6mm 15.46(1.30-20.57 ) 15.06(0 .78-24.75 ) 0.429
M issing teeth 4.83 (1.00-7.00) 5.33 (1.00-7.00) 0.437
Median and inter-quartile ranges are present for all the variables. Overall significance between 
two groups was assessed at 0.05 level (Kruskal-Wallis test for non parametric data)
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Table 4.3. Periodontal health according to level of glycaemic control
Periodontal diagnosis Cases Controls
good glycaemic 
control (n=l 12)
Moderate glycaemic 
control (n=53)
Poor glycaemic 
control (n=41)
(n = 60)
H ealth (n=109) 41(36.6% ) 26 (49.1) 14(34.1%) 25(41.7% )
G ingivitis (n=81) 29(25.9% ) 12(22.6%) 16(39%) 22(36.7% )
Chronic periodontitis 
(n=95)
42(37.5% ) 15(28.3%) 11(26.8%) 13(21.7%)
Total
2  r \ 1
112(100% ) 53(100%) 41(100% ) 60(100% )
x" = 0.172
n= number and percentages in brackets
4.3.5 Correlations between periodontal parameters
Table 4.5 presents data for spearman’s correlation coefficient for periodontal parameters 
All the periodontal parameters (MeanPD, MeanRec, MeanBOP, MeanLOA, Maxumum 
LOA, % BOP, % sites with PD >4mm, >5mm and >6 mm) significantly correlated with 
each other at p<0.01 level. (Figure 4.3 represent some of these correlations).
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% 
sites with LOA 
> 4mm 
24.50(2.25-43.20) 
17.39(3.35-20.50) 
18.69(1.83-23.05) 
15.88(1.60-20.88) 
0.328
% 
sites with LOA 
> 5mm 
20.01 (1.75-29.1) 
33.99(1.30-13.38) 
17.80(1.98-25.00) 
13.15 (1.20-11.55) 
0.374
% 
sites with LOA 
> 6mm 
16.70(2.10-21.18) 
11.43(0.70-9.33) 
14.69(0.70-26.6) 
15.06(0.78-2475) 
0.246
Significance were accessed at 0.05% 
level
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Figure 4.3. Significant correlations between periodontal param eters
Significant correlations were observed between all the periodontal param eters at 5%  
level.
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4.3.6 Impact of gender on periodontal status
Table 4.6 presents the data on periodontal status according to gender. 33.7% of the females 
and 31.2% of the males were affected with chronic periodontitis, and there were no 
statistically significant differences between males and females according to periodontal 
diagnosis.
Table 4.6. Periodontal health according to gender
Periodontal Health
Female
Gender
Male
Total
Health 67(36.4%) 70(40.5%) 137(38.4%)
Gingivitis 55(29.9%) 49(28.3%) 104(29.1%)
Chronic periodontitis 62(33.7%) 54(31.2%) 16(32.5%)
Total 184(100%) 173(100%) 357(100%)
Group 1 x2=0.579
4.3.7 Periodontal status according to age, blood pressure and BMI
The mean (inter-quartile range) age was 42.0 (36.0-47.0) years for people with periodontal 
health, 42.5 (36.0-49.75) for gingivitis and 53.4 (43.3-63.0) for chronic periodontitis. Age 
differed significantly between the three groups (p<0.01) (figure 4.4). Comparison between 
groups revealed that people with periodontitis were significantly older than those with 
periodontal health or gingivitis (p=0.001). Systolic blood pressure showed a trend towards 
being higher in the periodontal group (135.26 mm/Hg), but failed to achieve statistical 
significance however (p=0.079). Diastolic blood pressure and BMI had no effect on 
periodontal status (Table 4.7).
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P=0.001
Health Gingivitis Periodontitis
Figure. 4.4 Box plots that illustrate age distribution according to periodontal status
Age distribution was significantly different between health and periodontitis and gingivitis 
and periodontitis (p<0.001)
4.3.8 Age, BMI and blood pressure distribution according to levels of glycaemic 
control
Statistically significance difference was observed between level o f  glycaemic control and 
systolic BP and diastolic BP. When compared the three glycaemic control groups and non 
diabetic controls, systolic and diastolic blood pressure was higher in non diabetic controls 
compared to diabetes with good control. (p=<0.01) No statistical significance difference 
was observed for age and BMI according to glycaemic levels (Table 4.8, Figure 4.5).
4.3.9 Periodontal health and Alcohol consumption
A total o f  26.1%  o f  the subjects were current alcohol consumers whereas 72.8%  were not.
It was observed that far fewer females in this population consumed alcohol (0.8%) 
compared to males (25.5%). Among those who consume alcohol, 44.1%  were periodontally 
healthy, 24.7%  were affected with gingivitis and 31.2% had chronic periodontitis. O f those 
who never consumed alcohol, 36.5% were periodontally healthy, 30.8%  had gingivitis, and 
32.7% had chronic periodontitis. However, there were no significant differences between 
these groups with regard to periodontal status (p=0.798).
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Table 4.7 Age, blood pressure and BMI distribution according to periodontal health
Periodontal Health Age (years) Systolic BP 
(mm/Hg)
Diastolic BP 
(mm/Hg)
BMI (kg/m2)
Health (n=137)
Gingivitis( n=104)
Chronic periodontitis 
(n=116)
Total (n=357)
Significance
42.01
(36.00-47.00)
42.45
(36.00-49.75)
53.41
(43.25-63.00) 
• 45.84
(37.00-54.00)
0.001
130.98
(120.00-140.00)
130.83
(120.00-135.25)
135.26
(125.00-145.00)
131.96
(120.00-140)
0.079
81.54
(76.00-87.00)
82.29
(74.24-90.00)
84.89
(80.00-90.00)
82.59
(76.00-90.00)
0.172
24.83
(22.46-26.96)
24.70
(22.43-26.81)
24.74
(22.46-26.67
24.76
(22.46-26.78)
0.770
Median and interquatile ranges were present for other variables All variables were tested at 0.05 significant levels 
SP- Systolic blood pressure DP-Diastolic Blood Pressure
Table 4.8. Impact of diabetes control on age, BMI, and blood pressure
Diabetes Non diabetic 
controls
Good glycaemic 
control
Moderate 
glycaemic control
Poor glycaemic 
control
A ge (years)
B M I (kg/m 2)
Systolic BP (m m /H g) 
D iastolic B P(m m /H g)
47.35
(36.00-47.00)
24.49
(21.94-26.36)
127.5
(120.0-130.0)*
80.28
(78.75-84.25)*
45.49
(39.00-49.00)
24.93
(23.14-26.74)
133.06
(120.0-140.0)
81.94
(70.00-88.75)
43.98
(35.50-54.50)
24.50
(23.00-27.26)
133.25
(120.0-147.5)
83.14
(75.75-90.00)
45.05
(38.0-51.75)
24.86
(22.55-27.43)
136.88
(125.3-145.8)*
85.55
(76.25-93.50)*
*p=<0.05
True significance exists between good glycaemic controls with non diabetic controls.
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Figure 4.5 Box plots illustrating age, BMI and blood pressure according to glycaemic 
control in type 2 diabetes compared to controls
Legend :
DGC -  Diabetes with good glycaemic control DMC -  Diabetes with moderate glycaemic control
DPC -  Diabetes with poor glycaemic control NDC -  Non diabetic control group
Systolic blood pressure and diastolic blood pressure were significantly lower in people with DGC than 
NDC (p< 0.05)
4.3.10 Effect of biochemical parameters on periodontal parameters after adjusting 
for confounding factors age, sex, smoking and BMI
Results of multiple linear regression analysis revealed that glycaemic control (HbAlc 
value) is a significant predictor of mean recession (p=0.009) and maximum loss of 
attachment (0.014). HbAlc was not a significant predictor for the remaining periodontal 
parameters (p > 0.05). When considering the TOC, TG, LDL, HDL and their effect on 
periodontal parameters after adjusting for age, sex, BMI and smoking, only FBG was a 
significant predictive indicator o f mean BOP (p=0.034), % BOP (p=0.034) and maximum 
LOA (p< 0.024) (Table 4.11). Significant correlations were observed for diabetes durations 
with mean Rec, mean LOA, and maximum LOA (Figure 3.9)
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4.4 Discussion
This cross sectional study was designed with the primary aim to determine the prevalence 
of periodontitis in patients with diabetes compared to non diabetic controls. This study 
further aimed to investigate the effect of glycaemic control on periodontal health. A number 
of studies reported high incidence of periodontal disease in people with diabetes compared 
to non diabetic controls (Emrich et al. 1991, Taylor et al. 1998). Most of these early studies 
were confined to Pima Indians, a population which has the highest recorded incidence and 
prevalence of diabetes in the world. However, literature published during recent years 
coming from different populations all over the world was consistently in agreement with 
this finding ( Novak et al. 2008, Al-Otaibi 2008, Peck et al. 2006, Cutler et al. 1999). The 
prevalence of type 2 diabetes in Sri Lanka is moderately high, between 10.3%-14.2% 
(Katulanda et al. 2008, Wijewardena et al. 2005). There is evidence of rapidly progressing 
periodontal disease among the age group of 15-45 in Sri Lankan tea workers (Anerud et al. 
1979, Loe et al. 1978, Loe et al. 1986) from previous studies. However, evaluations of 
chronic burden of periodontal disease in diabetes is extremely limited in this population.
4.4.1 Periodontal health in diabetes and controls
In this study 285 people with type 2 diabetes and 60 aged matched controls were examined 
for periodontal health and severity of the disease was determined by level o f attachment 
loss and probing depth. Results of the present study indicate that the prevalence rate of 
chronic periodontitis is 33% among people with diabetes and 22% in the control population. 
When compared the prevalence rates observed in the present study with the results of 
National Health and Nutrition Examination Survey (NHANES) III data in the USA, 
prevalence of periodontitis in people with diabetes is extremely high (33% in Sri Lankan 
patients with diabetes to 17.3% in people with diabetes in the USA). The figures are also 
high for the non-diabetic population, 22% vs. 9% in the Sri Lanka and USA respectively.
In 1994 Perus and co workers have analysed 536 sites of teeth o f256 male Sri Lankan tea
workers. Their study found out of the 536 sites, 87 (16.2%) had pathologically deepened
pockets >6mm (Preus et al. 1995). This group of people were recruited from tea plantations
that represent a minor percentage of the Sri Lankan community who have no access to
proper dental care and treatment. The prevalence of chronic periodontitis observed in the
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present study (22%) from an urban non diabetic population shows comparable results with 
the prevalence of 16% observed by Perus in 1995. These figures are comparatively high 
compared to 9% in the USA (Soskolne & Klinger 2001) and 8-15% in the UK general 
population (Kelly et al. 2000). There is a general agreement that Asians are particularly 
susceptible to periodontitis (Corbert 2006) and the present and previous studies in Sri 
Lanka confirm this statement.
If the relationship between periodontitis and diabetes is a two way relationship then it 
would be expected that the prevalence of diabetes should be higher among people who have 
periodontitis than those who do not. The USA NHANES III survey shows that the 
prevalence of diabetes in patients with periodontitis is 12.5% which is double when 
compared to people with no periodontitis (6.3%) (Soskolne & Klinger 2001). The present 
study lacks data about the incidence of diabetes among patients with periodontitis.
However, 67% (n=8) of the excluded 12 subjects from the control group due to impaired 
metabolic status as determined by higher HbAlc and fasting blood glucose values were 
diagnosed with chronic periodontitis. Similar incidences were reported in other studies. For 
example in a longitudinal study, type 2 diabetes subjects with severe periodontitis at 
baseline has demonstrated significantly worse glycaemic control than diabetic subjects with 
minimal periodontal destruction (Taylor et al. 1996). Loesche and co workers have 
observed that glucose levels are on average 15% higher in periodontitis patients compared . 
to controls in a non diabetic population (Loesche et al. 2000). This may be an indication of 
periodontitis induced metabolic abnormalities. This group of 12 subjects in the present 
study may represent either undiognosed diabetes progressing to complications or 
periodontal status may have led metabolic imbalance as observed with raised FBG or 
HbAlc values. However, the number of subjects in this group is limited (n=12) and cannot 
come to a definite conclusion from these results but this area remains to be further explored.
The observed high prevalence of periodontitis in type 2 diabetes compared with and non­
diabetes controls did not reach a statistical difference in this population. However, 
considering health and gingivitis together in a single group showed a trend (p= 0.077) 
towards people with diabetes to have higher prevalence of chonic periodontitis than non­
diabetic controls. Based on the results of the present study it is evident that there is 1.5 fold 
increase to develop chronic periodontitis in the diabetic group.
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4.4.2 Periodontal disease severity
When considering the severity o f chronic periodontitis the present study adds to the 
evidence that the people with diabetes have more severe destructive periodontal disease 
than non diabetic controls. Severity o f periodontal disease is measured by LOA and PD 
(Glavind & Loe 1967 & Goodson et al. 1984). The results of this study indicate most of 
the periodontal parameters: MeanRec (0.48mm vs 0.34mm), MeanBOP (0.17 vs 0.08), 
maximum PD (4.47 vs 3.8), maximum LOA (6.37mm vs. 5.14mm), % BOP (16.75% vs 
8.3%), % of sites with PD >4mm (10.47 vs 5.08), % of sites with PD> 5mm (4.52% vs 
2.77) and % sites with PD> 6mm (0.91 vs 1.04) were significantly higher in patients with 
type 2 diabetes than non diabetic controls. The measured values for Mean PD and Mean 
LOA were higher in people with diabetes than those without but failed to reach any 
statistical significance. Shlossman et al. observed in Pima Indians, that median attachment 
loss and alveolar bone loss is higher in diabetic subjects for all age groups and for both 
sexes. (Shlossman et al. 1990). Similarly higher attachment loss and probing depth were 
observed in patients with diabetes in some other studies (Novak et al. 2008, Cutler et al. 
1999, Morton et al. 1995, Bridges et al. 1996, Oliver and Trevonen 1993, Emrich et al. 
1991, Lu and Yang 2004 and Mansour et al. 2005). Results observed in the present study 
are therefore consistent with the existing literature indicating increased severity o f the 
disease among patients with diabetes compared to non diabetic controls in the present study 
population.
4.4.3 Diabetes control and periodontal health
Of the total number of people with chronic periodontitis there were 37.5% with good 
glycaemic control, 28.3% with moderate control and 26.8% with poor glycaemic control. 
8.2% of the people with chronic periodontitis did not have HbAlc values. There is a 
general agreement that poorly controlled diabetes is a risk factor for the development of 
periodontitis. A greater prevalence of severe periodontitis is observed in both type 1 and 
type 2 long-term patients with diabetes with poor metabolic control (Mangan et al. 2000). 
Taylor and co-workers also reported that patients with poorer glycaemic control are at 
increased risk of alveolar bone loss and more severe progression of periodontitis compared 
with those without type 2 diabetes (Taylor et al. 1998). The results observed in this study 
follow the opposite trend, more people with good glycaemic control were diagnosed with
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chronic periodontitis than those with moderate or poor glycaemic control. The reasons for 
the observed differences may be due to an imbalance in the number of patients in good 
{(n=l 12 (54%)}, moderate {(n=53 (25.7%)} and poor (n=41(19.9%)} glycaemic control 
groups. Higher number of patients falling into good glycaemic control may have had an 
impact on the negative trend observed with respect to glycaemic control in this study.
Some other authors have stated previously that if there were a large number of poorly 
controlled diabetics in a'study group, then they were more likely to suffer periodontitis than 
the control group. Conversely, if  the study group contained mainly people with diabetes 
with good glycaemic control the difference in periodontal status between the two groups is 
likely to minimal (Oliver and Trevonen 1993). Since the present study group largely 
represents patients with controlled diabetes the prevalence rates observed may not represent 
true data for the diabetic population. This also may be a reason for the results o f the present 
study not agreeing with previously reported data in the literature to support the notion of 
poorly controlled people with diabetes being more likely to be affected with chronic 
periodontitis.
Patients with type 2 diabetes for the present study were selected from a clinic based 
database created for patients in a defined area o f Colombo suburbs in Sri Lanka 
(Weerasuriya et al. 1998). The database was created to assess the complications of newly 
diagnosed patients with type 2 diabetes. At the time of diagnosis neuropathy was present in 
25.1% of subjects, nephropathy in 29%, retinopathy in 15%, coronary vascular disease in 
21%, stroke in 5.6%, and peripheral vascular disease in 4.8%. The present study group was 
managed for at least two years and was under medication. In fact, they were advised to 
attend the diabetic clinic every three months, were on diet control or on medication 
(personal communications) and checked for their FBG, HbAlc and lipid profile regularly 
and received advice from a general practitioner and received newsletters in their native 
language explaining the importance of controlling their blood glucose values since the 
diagnosis. This may have improved their periodontal health in general as their glycaemic 
control improved. Also when patients were randomly selected and invited to participate in a 
research study, there is a likelihood that patients who are concerned about their health will 
attend the clinic more often than those who are not. This is evident from the present study 
that 54% of the study group was under good glycaemic control. It is thus evident that the
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present study group is not a representative sample of good, moderate and poor glycaemic 
control. It under represents people with moderate and poor glycaemic control and results 
obtained in this study cannot be generalized to the status of diabetes in the general 
population.
When periodontal parameters were evaluated according to level of glycaemic control, 
significant differences were observed for maximum probing depth, % BOP Maximum loss 
of attachment, % sites with probing depth (PD) > 4mm and % sites with PD > 5mm 
between diabetes with good control and non-diabetic control. Generally people with good 
glycaemic control express a similar incidence of periodontitis. The results of the present 
study were largely affected by the higher number of subjects representing the good 
glycaemic control group. Poorly controlled diabetes showed significant difference with % 
BOP and % sites with probing depth > 4mm.
Bacic and co-workers have observed that the association between periodontal disease and 
the duration of diabetes is consistent with trends seen in other complications of diabetes and 
that the duration of diabetes may be a more critical factor in developing periodontitis (Bacic 
et al. 1988). The duration of diabetes in the present study population was mean (sd) 7.5 
(±6.28) years.. Significant correlations were observed between diabetes duration with mean 
recession, mean loss of attachment and maximum loss of attachment in this group. Thus 
this may be the critical factor that determines the severity of periodontitis.
4.4.4 Age in relation to periodontal health in type 2 diabetes
One of the aims of the present study was to evaluate the impact of age on periodontal 
status. Subjects with chronic periodontitis were significantly older 53.41(±11.17) than 
subjects with health 42.01 (± 9.58) (p=0.001) and gingivitis 42.45 (±11.23) (p=0.001). 
Regression analysis also revealed that age is a significant predictor of all the periodontal 
parameters when adjusted for gender, smoking and BMI. Ainamo and co workers too 
demonstrated that age, severity of diabetes and oral hygiene of patients contributes to the 
severity and disease progression (Ainamo et al. 1990). The principal finding of a study 
conducted by Emrich and co workers (1991) found that diabetes and age are strong
117
predictors of the development of periodontal disease. Another study regarded age as a 
strong predictor of periodontal disease despite the presence of diabetes (Nelson et al.1990). 
Thus results in this analysis were in agreement with previous studies implicating age may 
be a significant indicator of chronic periodontitis. When assessed for the effect of age 
according to glycaemic control patients with good glycaemic control were slightly older 
than {47.35 (36.00-47.00)} those with moderate {45.49 (39.00-49.00)} and poor glycaemic 
control {43.98 (35.50 -  (54.50)} patients. However, age had no impact on level of 
glycaemic control. Older people with diabetes in this study population shows good 
glycaemic control compared to moderate and poor glycaemic control. The reasons for the 
observed higher prevalence of chronic periodontitis in good glycaemic control group may 
be due to age or diabetes duration.
This study also observed that HbAlc is a significant predictor of mean recession and 
maximum loss of attachment. FBG was identified as a significant predictive indicator of 
mean BOP, % BOP and maximum LOA. Similar results were reported from a study in the 
USA revealing a significant association with baseline level of HbAlc with probing depth > 
3mm (Nelson et al. 1990). Similarly Native Americans with type 2 diabetes and periodontal 
disease demonstrated that the percent o f sites with probing depth > 5mm was significantly 
associated with the level of HbAlc (Papapanou 1996). These results may be an indication 
of peridontitis induced metabolic imbalance that causes hyperglyceamia and subsequent 
elevated levels of HbAlc levels.
In summary the prevalence of periodontitis in patients with diabetes in the Sri Lankan 
population is 33% compared to 22% aged matched controls and these rates are 
comparatively high compared to other populations. The present study adds to the evidence 
that severity of periodontal disease is significantly higher in patients with type 2 diabetes 
compared with controls. Glycaemic control had no impact on periodontal disease in the 
present analysis however age can be considered as a significant predictor of periodontal 
health in this population.
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Chapter 5
Cytokine gene polymorphisms: association with 
periodontitis and type 2 diabetes
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5.1 Introduction
Periodontal disease is a multifactorial complex disease. The occurrence and severity o f the 
disease shows differences between individuals which cannot be explained by their level of 
plaque control. Twin studies suggest that this individual variation could be due to genetic 
predisposition and it has been estimated that genetic factors account for up to 50% of the 
increased susceptibility to periodontitis (Michalowicz et al. 1991). The disease includes a 
broad spectrum of inflammatory and destructive responses to oral microbe infections 
mediated by cytokines that include TNF-a and IL-1. Recent studies provide evidence that 
polymorphisms in cytokine genes may contribute to these genetic factors. Therefore, 
studies have now focused on the polymorphisms in genes encoding proinflammatory 
cytokines as the genetic markers for periodontitis (Komman & di Giovine 1998).
5.1.1 Periodontal Associated Genotype (PAG) and smoking; Impact on periodontal 
pathogenesis
Polymorphisms in the IL-1 gene {IL-1 A and IL1B SNPs) have been extensively studied in
association with periodontal disease. It has been suggested that these polymorphisms
influence the transcription of gene products and thereby the pathophysiology of
periodontitis. Kornman and coworkers reported that a composite genotype of IL1B (+3954)
allele 2 and ILIA (-889) allele 2 (designated as PAG or Periodontal Associated Genotype)
could be a predictor of periodontal disease in non smoking Caucasian patients (Komman et
al. 1997). Additional supporting evidence was provided by some other studies (Papapanou
et al. 2001, McDevitt et al. 2000). They observed that PAG is correlated with severity of
periodontal disease as measured by mean probing depth (Cullinan et al. 2001) and
attachment loss in non smokers (Papapanou et al. 2001, McDevitt et al. 2000). Inconsistent
with these results other studies failed to establish the relationship (Gore et al. 1998, Meisel
et al. 2002). For example Meisel and colleagues observed the PAG to be associated with
periodontitis in smokers. In subsequent studies ILIA (-889) was replaced by ILIA (+4845)
and it was suggested that both positions generate the same genetic information (Komman &
di Giovine 1998). Analysis of the PAG with the latter ILIA  polymorphism by Agrawel and
coworkers found that PAG is a significant risk indicator of periodontal pathogenesis in an
Asian population (Agrawel et al 2006). Contradictory results were observed by Laine and
colleagues. Their findings state PAG was not significantly associated in either smokers
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with chronic periodontitis or non smokers with chronic peiodontitis (Laine et al. 2001). 
However, a meta analysis performed considering data from 13 studies concluded that the 
minor allele of IL1B (+3954) (TT) and minor allele of ILIA (-889) (TT) positive genotype 
has significant association with chronic periodontitis. This analysis has revealed that 
positive genotype is more frequent among cases with periodontitis when compared to 
controls, even though the estimates were marginally insignificant (Nikolopoulos et al. 
2008).
5.5.2 Population differences in PAG status
While the true association between PAG and periodontal status is yet to be elucidated due 
to conflicting results obtained from different studies the percentage distribution of this PAG 
shows variation in different ethnic groups. A frequency percentage of 40.6% has been 
reported from Australia (Cullinan et al. 2000) and a study conducted in people of Northern 
European origin (Sweden) observed 42.9% (Papaponou et al. 2001). A high prevalence rate 
was also observed for the positive PAG in 38.2% of the controls and 44.4% of the patients 
in a Greek population (Sakellari et al. 2003). However, this study failed to demonstrate that 
PAG can act as a differential indicator between chronic periodontitis and controls. A recent 
case control study in European Caucasians reported a high percentage (46.4%) o f PAG 
between periodontally healthy individuals and generalized early onset periodontitis patients 
regardless of smoking status (Hodge et al. 2001). A study on periodontally healthy 
individuals of Hispanic origin has reported a lower rate of 23% for the PAG genotype 
compared to European study (Caffesse et al. 1998). Another study conducted in the Chinese 
population revealed an overall frequency of PAG genotype of 2.3% which is the lowest 
recorded percentages thus far observed (Armitage et al. 2000). Most of these data of 
different populations suggest, these polymorphisms are associated with the severity of adult 
periodontitis and there is a possibility of the difference being race related.
5.1.3 Diabetes, periodontitis and IL-1 genotype
Apart from smoking, diabetes is one of the major risk factors for periodontitis. Diabetes 
patients with periodontitis have significantly higher levels of proinflammatory mediators 
(IL-1 (3, TNF-a, and PGE2) in gingival crevicular fluid compared to non diabetic controls. It 
has been hypothesized that IL-1 participates in the pathogenesis of both periodontitis and
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disturbed glycaemic control as seen in type 1 and 2 diabetes (Kirkovsky et al. 2002) with an 
association of IL-1 p polymorphism with type 1 diabetes reported (Krikovsky et al. 2002).
A population based study conducted in Germany evaluated the association of ILIA  and 
IL1B haplotype in relation to periodontitis in patients with diabetes. It has been observed 
that diabetic subjects with increased levels of HbAlc had more widespread and severe 
periodontal disease than normoglycaemic subjects and diabetic subjects bearing a variant 
IL1B genotype C/T or T/T had an enhanced risk for periodontal disease in comparison with 
their IL-1 wild type counterparts. This study also reports the periodontal parameters; 
bleeding on probing, attachment loss and number of teeth were associated significantly 
with diabetes and the IL-1 genotype (Struch et al. 2008).
5.1.4 TNF- a  and Periodontitis
A significant association between TNFA allele 2 and chronic periodontitis and severity of 
the disease was observed in some studies (Komman et al. 1997, Komman and di Giovine 
1998, Galbraith et al. 1999, Lin et al. 2003). However, the TNFA (-308) SNP was not 
found to be associated with disease severity in some other studies (Galbraith et al. 1998, 
Craandijik et al. 2002, Kinane et al. 1999, Endo et al. 2001, Folwaczny et al. 2004, 
Fassmann 2003). A recently conducted meta analysis of cytokine SNPs in association with 
periodontitis analysed 15 studies that have examined the TNFA (-308) polymorphism. The 
majority were carried out in Caucasian populations and reported no association with 
chronic periodontitis. (Nikolopoulos et al. 2008).
5.1.6 TNFA in association with diabetes and biochemical parameters
Perezl et al. studied the association of aggressive periodontitis and the TNFA (-308) 
polymorphism in Chile. Their study group involved two groups, type 1 diabetes patients 
with aggressive periodontitis and patients with type 1 diabetes only. They concluded that 
allele 2 of (-308) has no significant association with the disease, circulating TNF-a levels 
or production of TNF-a in whole blood in an ex vivo culture system. However, the study 
group with aggressive periodontitis and type 1 diabetes showed higher frequency of TNFA 
allele 2 compared to the other group with type 1 diabetes only suggesting that in people 
with both periodontitis and type 1 diabetes, TNFA allele 2 may have an increased risk of 
developing the disease ( Perezl et al. 2004).
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Fernandes-Real and coworkers reported that TNFA genetic polymorphism was associated 
with insulin resistance. Indeed, TNF-a is believed to suppress insulin signaling via 
interaction with insulin receptor substrate (IRS) (Femaders Real et al. 1997). Shiau et al 
studied the TNFA (-308) polymorphism and type 2 diabetes in Taiwanese population. This 
study failed to find a possible association with respect to TNFA (-308) polymorphism. 
However, they observed the TNFA (-308) allele 2 had significant association with fasting 
blood glucose levels. The biological explanation to this phenomenon could be that TNF-a 
induced insulin resistance would increase plasma glucose concentration in affected 
individuals. A significant association was also observed with TNFA (-238) polymorphism 
with HDL cholesterol. Their study concluded that people who have these two promoter 
polymorphisms together are more susceptible to diabetic complications than others (Shiau 
et al. 2003). Another study conducted in the Netherlands also reported an association of 
TNFA (-308) polymorphism with risk of diabetes (Heijmans et al. 2002).
5.1.7 TNFA (-308) polymorphism in ethnically different populations
The studies of TNFA (-308) promoter polymorphism have failed to achieve consistent 
significant associations with aggressive periodontitis, chronic periodonitis or diabetes. 
Ethnic differences likely play roles in these conflicting results, because the distribution of 
TNFA promoter polymorphism is different among study subjects with different racial 
origins. The (-308) and (-238) polymorphisms were found in comparatively high 
prevalence in Caucasians (Endo et al. 2001). A study conducted in Germany revealed that 
The GA and AA genotypes were present in 33.3% and 2.5% of patients with periodontitis 
whereas in the control group frequencies of the same were 27.5% and 0%. There was no 
significant difference observed between patients and controls with respect to the frequency 
of TNFA (-308) A allele (Folwaczny et al. 2004). It has been observed that the allele 2 
distribution ranges from 9% in Hong Kong Chinese (Lee et al. 2000), 16% in French and 
Scandinavian populations (Hoffstedt et al. 2000, Herrmann 1998), 24% in Australians 
(Dalziel et al. 2002) and 1.78% in Taiwanese population (Shiau et al. 2003). The genotype 
distribution of TNFA (-308) G/A polymorphism was 65.4% (G/G), 32.2% (G/A) and 2.4% 
(A/A) in Netherlands (Heijmans et al. 2002).
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5.1.8 Chapter aims and objectives
1. To estimate the prevalence of the polymorphism of ILIA (+4845), IL1B (+3954) 
and TNFA (-308) genes in the Sri Lankan population
2. To investigate whether or not an association exists between ILIA (+4845), IL1B 
(+3954) and TNFA (-308) cytokine gene polymorphisms and periodontitis in 
patients with type 2 diabetes.
3. To investigate whether the PAG ILIA (+4845) and IL1B (+3954) has any 
association with periodontal status in never smokers.
4. To investigate whether or not ILIA  and IL1B polymorphisms separately or PAG 
has any association with periodontal or biochemical parameters.
5. To investigate whether TNFA (-308) polymorphism has any association with 
diabetes or diabetes related biochemical parameters or periodontal parameters.
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5.2 M aterials and Method
5.2.1 Blood sample collection
Blood samples were collected in parallel to clinical data collection (see sec.3.2.1 for further 
details) from a total of 124 parents, 272 patients and 73 controls. Samples were collected 
either by finger prick blood drop collected in a DNAase free absorbent filter paper or by 
peripheral blood in sodium EDTA containers. Filter papers had been air dried and stored in 
a sealed container at 4°C and blood samples were separated into two aliquots and stored at - 
20°C until further analysis.
5.2.2 Laboratory methods
All techniques relating to IL1B, ILIA  and TNFA genotyping were carried out at the Oral 
Biology Department of the School of Dental Sciences, University of Newcastle upon Tyne, 
UK and Biomedical Research Centre Sheffield Hallam University UK. DNA extraction was 
done at the Faculty of Science, University of Colombo, Sri Lanka.
DNA extraction from whole blood
Two mL of whole blood was used in the extraction process. DNA extraction was carried 
out using QIAamp DNA blood midi column purification kits following manufacturer’s 
instructions (QIAGEN Ltd). Extracted DNA was separated into two aliquots and stored at - 
20°C. One aliquot was transferred to the Biomedical Research Centre, Sheffield Hallam 
University, UK for genotype analysis. The second aliquot was stored separately to establish 
a DNA bank to conduct further genetic studies in relation to type 2 diabetes.
DNA extraction from dried blood spots
One quarter of the dried blood spots was cut into small pieces and boiled in lOOpl of 50mM 
NaOH for 10 minutes at 100°C. 20pl of 1M Tris HC1 was added to neutralize the medium 
and the tubes were briefly microfuged at 4000g. The supernatant was transferred into a 
fresh tube and stored at -4°C.
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Gene frequency analysis in Sri Lankan population
There were 272 patients from whom blood samples were collected. 62 parents from 62 
patients were genotyped for the three SNPs analysed. Thus gene frequency analysis 
included genotyped data from 210 patients, 124 parents and 73 controls (n =407). (There 
were 124 parents. The children of 124 parents (n=62) were excluded from the gene 
frequency analysis of the population since they are dependant variables of their parents and 
are therefore bound to share their alleles). All the subjects were genotyped for ILIA  
(+4845), IL1B (+3954) and TNFA (-308) polymorphisms according to the protocols 
defined in methods section 5.2.4.
5.2.3 Periodontal analysis
After excluding edentulous patients [patients who had no teeth and those who were not 
examined for periodontal health (n=10)] final genotype analysis included 262 patients with 
type 2 diabetes. There were 72 controls after excluding one edentulous subject, thus a total 
of 334 subjects were included in cytokine gene polymorphism analysis in relation to 
periodontitis.
5.2.4 Protocol for genotyping
IL1B (+3954)
This single nucleotide polymorphism (SNP) was described as Taq I restriction fragment 
length polymorphism (RFLP) of IL1B. (Pociot et al. 1992). Sequencing of the region has 
discovered a C/T single base transition at +3954 in exon V that fully explains the RFLP (di 
Giovine et al.2000).
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+3954 -511
telomere
IL-1 A IL-1 B IL-1 RN
Figure 5.1 Position of IL1B  mapped oil 430 Kb region of chromosome 2ql4.
Primers
The specific primers were designed to amplify the region containing the SNP that has a 
control Taq site. Therefore the PCR product will contain constant non polymorphic and one 
polymorphic restriction site for Taq I (di Giovine et al. 2000). The Taq 1 polymorphic site, 
allows identification o f  two alleles o f  the single nucleotide polymorphism corresponding to 
the presence or absence o f  the restriction site. Taq 1 Non polymorphic site will indicate the 
status o f digestion. The IL1B allele 1 was the digested fragment. Therefore, three possible 
genotypes can be expected from a given population (Figure 5.4). DNA samples were PCR 
amplified using oligonucleotide primers (Fig.5.2) which has been described previously in 
the literature (di Giovine et al. 2000).
Prim er 1 : 5 ’ CTC AGG TGT CCT CGA AG A AAT CAA A 3 ’ 
Prim er 2 : 5 ’ GCT TTT TTG CTG TGA GTC CCG 3 ’
Figure 5.2 Primers that amplify the fragment of IL1B containing the (+3954) SNP
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Polymerase Chain Reaction
The sequence o f  the primers designed to flank the region o f  exon 5 o f hum an IL1B (+3954) 
and primers were obtained from Helena Biosciences (Sunderland, UK). PCR reaction 
volume was 50pl. Two pL o f  tem plate DNA obtained from each patient and control were 
amplified in a reaction mixture containing 25pl o f  2 X Biom ix1 M Red (B IO TA Q IM DNA 
polymerase, 125mM Tris-HCl (pH 8.8 at 25°C), 32mM (NH4)2S 0 4 , 3mM M gCF, and 
2mM o f  each dATP, dCTP, dGTP and dTTP) 4pl o f  reverse and forward prim er mix to the 
final concentration o f 0.8pM each and 19pl o f  distilled water. Amplifying conditions 
consisted o f  an initial denaturation at 94°C for 6 minutes, followed by 35 cycles at 94°C for 
1 minute, annealing at 59°C for 1 minute, elongation at 72°C for 1 minute and a final 
extension at 72°C for 5 minutes and cooling to 4°C.
PCR/RFLP genotyping
The PCR product was 194 base pairs in size. Following restriction digestion the resulting 
products o f 12bp + 85bp + 97bp (allele 1- presence o f  restriction site is more common 
allele) and 12bp+182bp (allele 2 absence o f  a restriction site are diagnostic (Figure 5.3). A 
non-polymorphic Taq 1 site gives rise to a 12 base pair fragment, which could not be seen 
on the agarose gel. However, the presence o f the non polymorphic site enables the detection 
o f  the complete digestion when the digested products were run in parallel to undigested 
products.
Q a c T  1 non polymorphic siteTaq 1 polymorphic site
85bp 12bp -►
194bp
Allele 1 - presence o f  a restriction site, common form (C) 
Allele 2 - absence o f a restriction site (T)
Figure 5.3 Graphical representation of the 194bp segment o ilL IB  that shows the 
polymorphic and non polymorphic sites
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Restriction digestion of the PCR products with Tag 1 endonuclease
25 pi of the PCR products were digested with Taq 1 endonuclease enzyme from Thermus 
aquaticus (fermetars). Digest mix, which contained 4pl of lOx buffer and 0.25pl of 
l.Omg/ml BSA and 0.5pl (5U) of Taq 1 and 5.25pL of deionised water. Reagents were 
mixed and incubate at 65°C for three hours.
ILIA (+4845) genotyping
ILIA  gene encodes for interleukin 1 alpha (IL-1 a ) which like IL-lp, is a pro-inflammatory 
cytokine. Sequencing of this gene had revealed a single base variation (G/T) in exon 5 at 
position (+4845), which explains the restriction fragment length polymorphism (Gubler et 
al. 1989).
Primers
The primers were designed to create an Fnu4HI restriction site (di Giovine et al.2000 ) 
(Figure 5.6). These two alleles are in 100% linkage disequilibrium with alleles of ILIA (- 
889). The enzyme Fnu4Hl cuts a constant band of 76bp at the non polymorphic site, 
absence of this band indicates an incomplete digestion. In allele one Fnu4HI cuts a constant 
band of 76bp and two further bands of 29 and 124 bp and in the absence of polymorphic 
site, it gives a single band of 153bp for allele 2 (Figure 5.7).
Polymerase chain reaction
The primers designed to flank the region of exon 5 of human ILIA (+4845) containing the 
Fnu4HI restriction site were obtained from Helena Biosciences (Sunderland, UK). One pL 
of template DNA obtained from each patient and control were amplified in a reaction 
mixture containing 12.5pL of 2 X Biomix™ Red (BIOTAQ™ DNA polymerase, 125mM 
Tris-HCl (pH 8.8 at 25°C), 32mM (NH4)2S04 , 3mM MgCl2, and 2mM of each dATP, 
dCTP, dGTP and dTTP) 2pL of reverse and forward primer mix to the final concentration 
of 0.8pM each and 9.5pL of distilled water. Amplifying conditions consisted with an initial 
denaturation at 95°C for 1 minute, followed by 35 cycles at 94°C for 1 minute, annealing at
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56°C for 1 minute, elongation at 72°C for 2 minutes and a final extension at 72°C for 5 
minutes and cooling to 4°C.
1 2 3  ~"4'.........5
Figure 5.4 Three possible genotypes oilLIB (+3954)
Lane 1 -  Hyper ladder V
Lane 2 -  Positive control (194bp PCR product)
Lane 3 -  Homozygous (TT) -  Allele 2 (Absence of polymorphic sites on both 
chromosomes)
Lane 4 - Heterozygous
Lane 5 -  Homozygous (CC) -Allele 1( Presence of polymorphic site in both 
chromosomes)
Figure 5.4 is a computer generated image of three possible genotypes expected for IL1B 
(+3954) SNP after digesting the PCR products with Taq 1. Three possible genotypes are a 
homozygote for the presence of the restriction site (CC) indicated by two bands o f 97 and 
85 base pairs. A homozygote for the absence of restriction site (TT) has one band of 182 
base pairs. The heterozygotes will have all three bands (12bp fragment cannot be visualised 
in the gel).
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IL-1 B IL-1 R NIL-1 A
+ 4 8 4 5
Figure 5.5 Position of IL IA  mapped on 430 Kb region of chromosome 2ql2.1
P r i m e r  l - 5 ’ - A T G . G T T . T T A . G A A . A T C . A T C . A A G . C C T . A G G . G C A - 3 ’ ( + 4 8 1 4 / + 4 8 4 3 )  
P r i m e r  2 -  5 ’ -  A A T . G A A . A G G . A G G . G G A . G G A . T G A . C A G . A A A . T G T . - 3 ’ ( + 5 0 1 5 / + 5 0 4 4 )
Figure 5.6 Primers that amplify a fragment of IL IA  containing the (+4845) SNP
PCR/RFLP genotyping
The ILIA  PCR product was 229 base pairs in size. Following restriction digestion the 
resulting products o f  a polymorphic site were 76bp + 29bp + 124bp fragments for allele 1 
and 76bp+153bp for non polymorphic site which is allele 2. Three possible genotypes are a 
homozygote for the presence o f  the restriction site indicated by three bands o f 76, 29 and 
124 base pairs. A homozygote for the absence o f  restriction site has two bands o f  153 and 
76 base pairs. The heterozygotes have all three bands (Figure 5.8). 29 base pair band would 
not be visualised in an agarose gel.
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PnuHI polymorphic site FnuHI non polymorphic site
76bp■29bp 124 bp
229bp
Allele 1 - presence o f  a restriction site, common form (G) 
Allele 2 - absence o f a restriction site (T)
Figure 5.7 Graphical representation of 229bp segment of IL IA  with polymorphic and 
non polymorphic sites
Restriction digestion o f the PCR products with Fnu4H l endonuclease
lOpl o f  the PCR products were mixed with digest mix, which contains 3pl o f  lOx 
buffer and 2pl (20U) o f Fnu4Hl endonuclease enzyme and 15pl o f  deionised water. 
Reagents were gently mixed and incubated at 37°C overnight.
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Figure 5.8 Three possible genotypes of IL IA  (+4845)
Lane 1 -  Hyper ladder V 
Lane 2 -  Positive control
Lane 3 -  Homozygous -  Absence o f  polymorphic site on both 
chromosomes 
Lane 4 -  Heterozygous
Lane 5 -  Homozygous -  Presence o f  polymorphic site on both chrom osomes
Figure 5.8 is a computer generated image o f the three possible genotypes expected for ILIA  
(+4845) SNP after digesting the PCR products with FnuH41. Three possible genotypes are 
a homozygote for the presence o f  the restriction site (GG) indicated by a single band o f  124 
base pairs. A homozygote for the absence o f  restriction site (TT) has one band o f  153 base 
pairs. The heterozygotes will have 153 and 124 base pair bands. The PCR product is 229 
base pairs will cut a constant band o f  76 base pairs which can be seen in all three 
genotypes.
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TNFA (-308) genotyping
TNFA gene encodes for tumour necrosis factor 1 alpha (TN F-a) (chromosome 6p21.3). 
Sequencing o f  this gene had revealed that a single base variation (G/A) in the TNFA 
promoter at position (-308), which explains the restriction fragment length polymorphism. 
(Wilson et al, 1992).
-238  -308  1 1
H I0 0 0 Mkb
TNFA TNFB
Class III
Class I
Figure 5.9 Structure of Human MHC complex- chromosome number 6q21, 4 -  5Mb 
region where TNFA gene is located
Primers
Primers were used which create an Ncol restriction site when am plifying allele 1. 
Amplified PCR product will be o f  107bp nucleotides in length, (di Giovine et al.2000) 
(Figure 5.10)
Primer 1 - 5 ’- AG G.CAA.TAG.GTT.TTG.AGG.GCC.AT-3’ (-331/309) 
Primer 2 - 5 ’- TCC.TCC.CTG.CTC.CGA.TTC.CG.-3, (-244/-226)
Figure 5.10 Primers that amplify a fragment containing the TNFA (-308) SNP
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Polymerase chain reaction
The primers designed to flank the promoter region o f  human TNFA (-308) were obtained 
from the Helena Biosciences (Sunderland, UK). One pL o f  template DNA obtained from 
each patient and control were amplified in a reaction mixture containing 12.5pL o f  2 X 
Biomix™  Red (BIOTAQ™  DNA polymerase, 125mM Tris-HCl (pH 8.8 at 25°C), 32mM  
(NH4)2S 0 4 , 3mM M gCl2, and 2mM  o f  each dATP, dCTP, dGTP and dTTP) 2pL  o f  
reverse and forward prim er m ix to the final concentration o f  0.8pM each and 9 .5pL o f 
distilled water. Amplifying conditions consisted an initial denaturation at 95°C for 1 
minute, followed by 35 cycles at 94°C for 1 minute, annealing at 60°C for 1 minute, 
elongation at 72°C for 2 minutes and a final extension at 72°C for 5 minutes and cooling to 
4°C.
PCR/RFLP genotyping
PCR products were 107 base pairs in size. Following restriction digestion the resulting 
products o f a polymorphic site were 87bp + 20bp fragments for allele 1 and 107bp for non 
polymorphic site which is allele 2. Three possible genotypes are a homozygote for the 
presence o f  the restriction site indicated by two bands o f  87 and 20 base pairs. A 
homozygote for the absence o f  restriction site has one band o f 107 base pairs. The 
heterozygotes have all three bands (Figure 5.12). 20 base pair band would not be visualised 
in an agarose gel.
Ncol site
87 bp
107 bp
Allele 1 - presence o f  a restriction site, common fonn (G) 
Allele 2 - absence o f a restriction site (A)
Figure 5.11 Graphical representation of the 107bp segment of TNFA (-308) SNP
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Figure 5.12 Three possible genotypes of TNFA (-308) 
Lane 1 - Hyper ladder maker IV 
Lane 2 - PCR amplified product 
Lane 3 - Homozygous (Allele 2)
Lane 4 - Homozygous (Allele 1)
Lane 5 - Heterozygous
Figure 5.12. represents a computer generated image for the expected three possible 
genotypes for TNFA (-308) SNP after digesting the PCR products with Ncol. Homozygote 
for the presence of the restriction site (GG) will be indicated by a two bands of 87 base 
pairs and 20 base pairs. A homozygote for the absence of restriction site (AA) has one 
band of 107 base pairs. The heterozygotes will have 107 and 87 base pair bands. 20 base 
pair band would not be visualised under UV light.
136
Restriction digestion of the PCR products with Ncol endonuclease 
15 pi o f the PCR products were mixed with digest mix, which contains 2pl of lOx buffer 
Tango and lp l (5U) of Ncol endonuclease enzyme (Fermantas, Life Science) and 18pl of 
distilled water. The total volume of each component was calculated by multiplying the 
number of samples. A control mixture free of enzyme containing 2pl buffer and 18pl of 
distilled water was prepared in each RFLP set up to serve as a control. Reagents were 
mixed gently and spun down and incubated over night at 37°C in the GeneE Thermocycler 
(Techne, Cambridge Ltd, 1994). Digested products were checked on a 4% agarose gel 
electrophoresis at 40mA after one hour.
5.2.5 Control procedures
DNA Extraction control procedure
All the extractions were carried under aseptic conditions. When DNA were extracted from 
dried blood spots, samples were grouped into batches and with every batch of extractions a 
negative control was run in parallel and assayed for amplification. In cases of positive 
results in a negative control, the samples with that batch were discarded and DNA re­
extracted.
PCR Control procedures
A 100 base pair DNA ladder (Bioline UK) was run simultaneously in agarose gels along 
with the PCR products to determined the sizes of the DNA fragments of each 
polymorphism. Every PCR reaction included negative controls to which no template DNA 
was added to ensure that no contamination of the sample had occurred. In the case of 
contamination PCR was repeated. Every PCR reaction included a positive control with 
known human DNA templates. When negative results (absence of bands) for the positive 
control were obtained, PCR was repeated.
5.2.6 DNA visualization and gel electrophoresis
All PCR products were resolved in 3% agarose gel and digested products were 
resolved in 4% agarose gel in TBE buffer. Separated fragments were visualised by UV 
excitation of the Ethidium bromide bound to DNA within the gel. 5pi of 0.5mg/ml of 
ethidium bromide was added to the agarose gel and mixed before setting. Five pi of PCR
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products and total volume of digested products were loaded into the gel and subjected to 
electrophoresis at 70 volts for one hour. The image of the gel was taken.
5.2.7 Statistical Analysis
The number of three different genotypes for each of the polymorphism was 
calculated by direct counting as observed in the gel pictures. Allele frequencies were 
determined from the observed number of genotypes. Data were coded into PAG positive if 
both allele 2 of ILIA  and IL1B were present. The significance of difference between both 
groups (PAG positive and PAG negative) according to periodontal health was determined 
by cross tabulating to determine chi square test statistics. Similar test statistics were applied 
to determine the association TNFA (-308) polymorphisms and periodontal diagnosis. 
Periodontal parameters and biochemical parameters were tested within different groups of 
each genotype using Kruskal Wallis tests for multiple comparisons.
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5.3 Results
5.3.1 SNP/ RFLP pattern generated for IL1B (+3954)
Figure 5.13. represents the genotypes observed for IL1B (+3954) SNP. Bands were 
observed (85bp and 97bp) for homozygotes for allele 1 in lanes 2 to 7. Heterozygotes for 
presence o f  allele 1 (85bp + 97bp) and allele 2 (182bp) were visualized in lane 1.
182bp 194bp 
97 +85bp
L a n e s  3 - 7  -  8 5 b p  +  9 7 b p  ( C C )  L a n e  8  -  1 9 4 b p  ( P C R  p r o d u c t )
L a n e  1 -  1 8 2 b p +  8 5 b p  +  9 7 b p  ( C T )  L a n e  9  -  l O O b p  m a r k e r
Figure 5.13 Gel images generated for IL1B (+3954) RFLP that shows two of the three 
possible genotypes
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5.3.2 SNP/RFLP pattern for IL IA  (+4845) SNP
Figure 5.14 shows all three genotypes expected fox ILIA (+4845) SNP/RFLP. Lane 8 
shows the 229bp PCR product. The digested product generated a 153bp fragment for a 
homozygote for allele 2 as seen in lane 7. Heterozygotes for allele 1 (124bp and allele 2 
(153bp) can be seen in lanes 2, 5 & 6. Homozygote for allele 1 (124bp) can be seen in lane 
1. All lanes from 1-7 shows the constant band o f  76bp which is cut from 229bp PCR 
product.
229bp 
153bp124bp
76bp
L a n e s  1 &  4  -  1 2 4 b p  ( G G )
L a n e s  2 ,  5  &  6  -  1 5 3 b p  +  1 2 4 b p  ( G T )
L a n e  7  - 1 5 3 b p ( T T )
L a n e  8  -  2 2 9 b p  ( P C R  p r o d u c t )
L a n e  9  -  1 O O b p  m a r k e r
Figure 5.14 Gel images for IL IA  (+4845) RFLP demonstrating three possible 
genotypes
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5.3.3 SNP/RFLP pattern TNFA (-308) SNP
Figure 5.15 shows the RFLP pattern for TNFA (-308). Homozygotes for allele 1 digested 
the 107bp PCR product into two fragments o f  87bp and 20bp which can be seen in lanes 2, 
3 and 7. Heterozygotes generated 107bp, 87bp and 20bp fragments as observed in lanes 1, 
5, and 6. Homozygous allele 2 was not digested and gives a 107bp fragment which is seen 
in lane 4.
107bp 
87bp
L a n e s  2 ,  3  &  7  -  8 7 b p  ( G G )
L a n e  l ,  5  6  -  1 0 7 b p  +  8 7 b p  ( G A )
L a n e  4  - 1 0 7 b p ( A A )
L a n e  8  -  1 0 7 b p  ( P C R  p r o d u c t )
L a n e  9  -  1 O O b p  m a r k e r
Figure 5.15 Gel images generated for TNFA (-308) RFLP with three possible 
genotypes
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5.3.4 Population distribution of gene frequencies o ilL IB  (+3954), IL IA  (+4845) and 
TNFA (-308)
A total o f  407 subjects’ genotyped data were included in the present analysis to estimate 
population frequencies. Genotype percentages for IL1B (+3954) CC, CT and TT were 
80.3%, 18.9% and 0.7% respectively. ¥or ILIA (+4845) the distribution o f  GG, GT and TT 
alleles were 55.8%, 36.9% and 7.4% respectively. 82.8% o f  the group possessed GG 
genotype o f  TNFA (-308) SNP whereas GA and AA were 15.2% and 2.0%  only (Figure 
5.16).
ILlB(+3954)
18 .9 % 0 . 70%
M
CC CT T T
ILIA (+4845) 
genotype
5 5 .8 %
3 6 .9 %
7 .4 0 %
JB L
GG GT
TNFA (-3 
genotype
82 .8%
15.2 %
2 .0%L J
GG GA AA
Figure 5.16 Allele distribution of IL1J3 (+3954), IL IA  (+4845), and TNFA (-308)
5.3.5 Test of Hardy Weinberg Equilibrium for genotype distribution in the 
population
Allele (1) and allele (II) frequencies for all the SNPs were calculated m anually 
(Table 5.1) and checked for whether they were in agreement with Hardy W einberg 
Equilibrium. The distribution o f  ILIB  and TNFA genotypes was in agreement with Hardy 
W einberg Equilibrium distribution for this population whereas ILIA  genotype distribution 
slightly deviates from the expected frequency o f  1.
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Table 5.1 Observed gene frequency for the Sri Lankan population
P Q P2 + 2pq + ( f Observedfrequency
IL1B (+3954) 0.90 0.10 0.81 + 0.18 +0.01 1
ILIA (+4845) 0.74 0.26 0.55 + 0.10 +0.07 0.71
TNFA (-308) 0.91 0.09 0.83 +0.164 + 0.0081 1.0
p -frequency observedfor allele 1 
q- Frequency observed for allele 2
5.3.6 IL1B (+3954) genotype and periodontal health
IL1B genotype distribution showed no significant difference according to periodontal health 
(p=0.849). CC (~80%) and CT (~20%) genotype distributions were approximately equal in 
all three groups (health, gingivitis and chronic periodontitis) (Table 5.2).
Table 5.2 IL1B genotype according to periodontal health
IL1B Genotype CC CT TT Total
Health 105 (80.8%) 24(18.5%) 1 (0.8%) 130(100%)
Gingivitis 73 (78.5%) 20(21.5%) 0 (0%) 93 (100%)
Chronic periodontitis 91(81.5%) 20(18.5%) 0(0%) 111(100%)
Pearson y2=0.84
5.3.7 ILIA (+4845) genotype and periodontal health
Distribution of GG genotype among health, gingivitis and chronic periodontitis were 58%, 
50.5% and 55.9% respectively. Similarly GT distribution was 37.7%, 44.1% and 36.9% 
respectively. TT genotype distribution was 7.2% in the chronic periodontal group when 
compared to 3.9% in health and 5.4% in gingivitis group. However there was no significant 
difference of genotype distribution among the three groups (p=0.529) (Table 5.3).
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Table 5.3 ILIA genotype according to periodontal health
ILIA  Genotype GG GT TT Total
Health 76 (58.5%) 49 (37.7%) 5 (3.9%) 130 (100%)
Gingivitis 47 (50.5%) 41(44.1%) 5 (5.4%) 93 (100%)
Chronic periodontitis 62 (55.9%) 41(36.9%) 8(7.2%) 111(100%)
Pearson y?=0.529
5.3.8 PAG status in patients with diabetes and controls
Composite genotype of allele 2 of both IL1B (T) and ILIA (T) is considered as periodontal 
association genotype (PAG) (Komman et al.1997). It has been observed that 12.6% of 
patients with diabetes and 12.5% of controls were PAG positive in this population and there 
was no significant difference in PAG status between the two groups (p=0.983) (Table 5.4).
Table 5.4 PAG status between cases and controls
Patients Controls Total
n % n % n %
PAG positive 33 12.6 09 12.5 42 12.6
PAG negative 229 87.4 63 87.5 292 87.4
Total 262 100 72 100 334 100
Pearson’s Chi squared test for difference in PAG status between cases and controls 
%2 = 0.983
5.3.9 PAG status and periodontal status
Regardless of the diabetes status the PAG status was analysed against periodontal health 
among the total subject population. 38.9% (130/334) of the study group were found to be 
periodontally healthy and among them 13.1% (17/130) were PAG positive. 27.8% (93/334) 
and 32.3% (108/334) had gingivitis and Chronic periodontitis respectively. Among 
gingivitis 16.1% and 9.3% in chronic periodontal group were PAG positive. This analysis
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of PAG status in relation to periodontal status showed no significant association.(Table 
5.5).
Table 5.5. Cross tabulation of PAG status and periodontal diagnosis
Pearson’s Chi squared test for PAG status and periodontal diagnosis 
X2 = 0.456
PAG Positive 
n=32
PAG negative 
n=292
Total
n=334
Health 17(13.1%) 113(86.9%) 130(100%)
Gingivitis 15(16.1%) 78(83.9%) 93(100%)
Chronic Periodontitis 10(9.0%) 101(91.0%) 111(100%)
5.3.10 PAG status in association with never smokers
There were a total of 265 subjects with no history of smoking in the study group, 212 from 
the cases and 53 from the controls. Periodontal status in never smoking group and PAG 
status showed no significant association among cases (p= 0.517), controls (p=0.988) or in 
the entire never smoking group (p = 0.582) (Table 5.6).
Table 5.6. PAG in association with never smoking
Cases Controls
PAG +)ve 
n (%)
PAG(-)ve 
n (%)
Total
n(%)
PAG
(+)ve
n(%)
PAG (-) 
ve n (%)
Total
n (%)
Health 11(13.8) 69 (86.3) 80(100) 2(9.5) 19(90.5) 21(100)
Gingivitis 9(15.8) 48 (84.2) 57(100) 2(10) 18(90) 20(100)
Chronic Periodontitis 6 (8.3) 66 (91.7) 72 (100) 1(8.3) 11(91.7) 12(100
Total 26(12.3) 186(87.7) 212(100) 5(9.4) 48(90.6) 53(100)
Pearson %2 = 0.582)
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5.3.11 PAG status in association with periodontal parameters
When comparing the periodontal parameters with PAG status a significant difference was 
observed between PAG status and mean probing depth (p=0.032). However, the mean 
probing depth was higher in PAG negative group (2.15 (±0.80) than the PAG positive 1.87 
(±0.57) (Table 5.7).
Table 5.7. PAG status in relation to periodontal parameters.
Periodontal parameter PAG (+ve) PAG (-ve) p value
Mean Probing depth (mm) 1.87(1.47-2.15) 2.15(1.64-2.39) 0.039
Mean Recession (mm) 0.40 (0.05 - 0.37 0.48 (0.04-0.51) 0.714
Mean Bleeding on probing 0.12(0.01-0.16) 0.15(0.01-0.21) 0.434
Mean Loss of Attachment (mm) 2.27 (0.58-2.52) 2.63 (1.79-2.82) 0.052
Maximum probing depth (mm) 4.22 (3.00-5.00) 4.37 (3.00-5.00) 0.754
Maximum loss of attachment 
(mm)
5.90 (4.00-7.00) 6.22 (4.00-8.00) 0.826
% BOP 12.24(1.05-16.00) 15.14(1.13 -20.78) 0.448
% sites with PD > 4mm 4.66 (0.00 - 4.75) 10.19(0.00-9.25) 0.513
% sites with PD > 5mm 1.94 (0.00-1.36) 4.52 (0.00- 1.95) 0.448
% sites with PD > 6mm 0.29 (0.00-0.00) 1.00 (0.00-0.00) 0.549
Mean and interquartile ranges are given in brackets
5.3.12 TNFA (-308) genotype in association with type 2 diabetes
Table 5.8 shows the TNFA (-308) allele distribution between patients with diabetes and 
controls. Distribution of Allele 1 (GG) was 83.6% among the cases and 79.2% in controls. 
Heterozygotes (G/A) carriers were 14.1% and 19.4% in cases and controls respectively. 
Homozygotes for allele 1(AA) was rare among the study population and observed 
percentages were 2.3 and 1.4 in cases and controls respectively. However, there was no 
significant difference in the distribution of these alleles between the cases and controls (p = 
0.497).
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Table 5.8. TNFA (-308) genotype distribution among cases and controls
TNFA genotype Case or control Total
Case n (%) Control n (%) n(% )
GG 219(83.6) 57(79.2) 276(82.6)
GA 37(14.1) 14(19.4) 51(15.3)
AA 6(2.3) 1(1.4) 7(2.1)
Total 262(100) 72(100) 334(100)
Number (%) o f Probands with genotype 
=0.497
5.3.13 TNFA (-308) genotype in association with periodontitis
Table 5.9 represents the data for TNFA genotype distribution according to periodontal 
health. Among those who were diagnosed as health, 80% possess the GG genotype. There 
were 18.5% with GA and 1.5% with AA genotype. Distribution of the GG genotype in the 
gingivitis group was 81.7% and 86.1% in chronic periodontal group. 15.1% and 3.2% of 
the subjects in gingivitis group had GA and AA genotypes respectively. In chronic 
periodontal group 12% and 2% demonstrated GA and AA genotypes. These genotypes in 
differently diagnosed groups showed no significant difference in distribution (p=0.770).
Table 5.9. TNFA genotype distribution and periodontal health
TNFA Genotype GG GA AA Total
Health 104 (80.0%) 24 (18.5%) 2(1.5%) 130(100%)
Gingivitis 76 (81.7%) 14(15.1%) 3 (3.2%) 93 (100%)
Chronic periodontitis 96 (86.5%) 13(11.7%) 2(1.80%) 111(100%)
Pearson’s Chi-Square =0.770
Numbers and percentages given in parenthesis
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5.3.14 TNFA allele distribution and periodontal parameters
Significant correlations were observed between TNFA (-308) genotype with mean recession 
mean loss of attachment and maximum loss of attachment. This genotype had no impact on 
other periodontal parameters (Table 5.10).
Table 5.10 Significant correlations of TNFA genotypes with periodontal parameters
Correlation P
Mean recession (mm) (Mean Rec) -0.119* 0.031
Mean loss of attachment (mm) (Mean LOA) -0.113* 0.040
Maximum loss of attachment (mm) MAximum -0.117* 0.033
LOA)
Correlations were significant at 0.05 level. Correlations were significant for mean Rec, Mean LOA 
and Maximum LOA
5.3.15 TNFA (-308) and blood chemical parameters
Table 5.11 presents the relationship between TNFA (-308) genotype and biochemical 
parameters. When tested the TNFA (-308) genotype in association with blood chemical 
parameters the only statistical significant difference was found with HDL levels. The 
values, median (SD) for GG, GA and AA were 48.46mg/dl (6.56), 46.67 mg/dl (5.81) and 
30.40mg/dl (19.45) respectively. Post hoc Bonferroni test has identified that the difference 
was with AA genotype (p = 001). Usually level below 40mg/dl is considered as a risk of 
developing coronary artery diseasaes and <35mg/dl belongs to a high risk group (National 
Cholesterol Education Program 2007). Multiple linear regression analysis for association 
of TNFA (-308) genotype and blood chemistry parameters after adjusting for age, sex, 
diabetes status, and BMI resulted in no significant association with HbAlc (p=0.496), total 
cholesterol (TOC) (p= 0.177), triglycerides (TGL) (p= 0.980), low density lipoproteins 
(LDL) (p=0.340), and fasting blood glucose (FBG) (p=0.649). However, there is an effect 
of TNFA genotype status on HDL (p=0.001) after adjusting for age, sex, diabetes status and 
BMI again proving a statistically significant association between the two. Spearman’s rho 
Correlation coefficient (r) indicates a correlation was a negative correlation, (Figure 5.17).
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Table 5.11 Effect o f TNFA (-308) genotypes in biochemical parameters and BMI
Biochemical parameter
p  value
Biochemical parameter
p  value
Systolic Blood pressure
0.599 Low Density Lipoproteins 0.726
Diastolic blood pressure 0.793 High Density Lipoperoteins 0.001
HbAlc 0.841 Fasting blood glucose 0.597
Total Cholesterol (TOC) 0.333 Diabetes duration 0.486
Triglycerides 0.880 BMI 0.511
p is significant at 0.05 level
10000“
40  0 0 -
w *
TNFA (SOS) g e n o t y p e
Figure 5.17. Significant correlations o f  TNFA (-308) genotype with HDL 
TNFA (-308) genotype AA shows significantly different low level o f  High Density 
Lipoproteins (HDL) (p<0.001)
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5.4 Discussion
A genetic polymorphism in the interleukin 1 gene has been implicated as a factor in 
determining the severity of adult periodontitis. The proinflammatory cytokines such as IL-1 
(IL -la  and IL-lp) and TNF-a have a key role in the initiation and perpetuation of the 
innate response in the periodontium. These cytokines levels appear to be higher in sites o f 
infection and contribute to tissue destruction and alveolar bone resorption in a susceptible 
individual and the presence of polymorphisms make them ideal candidate genes for 
association studies. At the outset it should be emphasized however, that genetic 
predisposition represents only one of several dimensions of patient based risk factors for 
disease progression.
The primary aims of this part of the study was to analyze the role of cytokine gene 
polymorphisms {ILIA (+4845), IL1B (+3954) and TNFA (-308) in association with chronic 
periodontitis in type 2 diabetes. In addition further investigations were carried out to 
determine the association of composite PAG, i.e. the occurrence of allele 2 of both ILIA 
(+4845) & IL1B (+3954) SNPs with periodontitis. Moreover, TNFA (-308) polymorphism 
in association with diabetes or diabetes related biochemical parameters or periodontitis and 
related parameters was investigated.
5.4.1 Gene frequency analysis
Population frequencies analysis of IL1B (+3954) for Sri Lankan population revealed gene
frequencies for allele 1 and allele 2 were 0.9 and 0.1 respectively. Similarly the frequencies
for ILIA (+4845) were 0.74 and 0.26 respectively. Frequencies previously reported for
IL1B (+3954) in North British Caucasian populations are 0.82 and 0.18 for allele 1 and
allele 2 (di Giovine et al. 2000) and for ILIA (+4845) are 0.71 and 0.29 for allele 1 and
allele 2 respectively (Gubler et al. 1989). Thus, the present study observed gene frequencies
that are similar to North British Caucasian populations for ILIA  and IL1B polymorphism.
When the gene frequencies of TNFA (-308) polymorphisms were analysed , frequencies of
0.91 and 0.09 were observed for allele 1 and allele 2 respectively. Frequencies for the same
alleles reported in North British Caucasians were 0.77 and 0.23 respectively (Wilson et
al.1992). The population studied in the present analysis of Sri Lankan population shows
considerable difference in allele distribution for TNFA (-308) polymorphism. Some other
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studies have reported similar frequencies to the present study. They were lfom two other 
Asian populations, Japan and Taiwan. In a Japanese population observed frequencies were 
0.99 for allele 1 and 0.01 for allele 2 (Endo et al. 2001). In Taiwanese patients a frequency 
of 0.94 for allele 1 and 0.05 for allele 2 was observed (Shiau et al. 2003). Thus it is evident 
that Japanese, Taiwanese and Sri Lankan populations have similar gene frequencies for 
TNFA (-308) promoter polymorphism compared to that observed in North British 
Caucasians. This is an indication that some c)4okine gene frequencies are distributed 
differently in certain populations and may be contributing differently to the pathogenesis of 
a disease.
5.4.2 IL1B (+3954), ILIA (+4845) and PAG: Impact on periodontal disease
This study next investigated the effect of composite genotype PAG and its distribution 
between patients with type 2 diabetes and controls. The results of this case control study 
does not support an association between IL1B (+3954), ILIA (+4845) SNPs in association 
with chronic periodontitis in the Sri Lankan population. Also the PAG was equally 
distributed among patients with type 2 diabetes (12.6%) and controls (12.5%). PAG status 
showed no significant association with chronic periodontitis.
Komman and colleagues were the first to report an association between IL1 gene cluster 
polymorphism as a risk indicator for chronic periodontitis. Since then contradictory results 
have been published. A significant association between allele 2 of IL1B (+3954) and 
advanced periodontitis has been reported (Galbraith et al. 1999). Parkhill and colleagues 
observed an association with allele I of IL1B (+3954) genotype with aggressive 
periodontitis (Parkhill et al. 2000). When considering allele 2 of ILIA (-889) and IL1B 
(+3954) polymorphism as PAG, associations were observed in some studies (Gore et al. 
1998, Laine et al. 2001) however, not in others (Hodge et al. 2001, Tai et al. 2002). Since 
ILIA (-889) and ILIA (+4845) are believed to generate similar results in genotyping and 
analysis o f ILIA (+4845) is comparatively easy, in subsequent studies the position of ILIA  
(-889) was replaced with ILIA (+4845). Komman et al. studied the variants (-889) and 
(+3954) and discovered that the PAG status was correlated with severity of periodontitis, 
patients had an approximately seven times greater chance of having severe periodontitis 
than those who were PAG negative in non-smokers (Komman et al. 1997) and Agrawel and
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co-workers found significant associations with PAG (ILIA (+4845) and IL1B (+3954)) 
positions in association with periodontitis in India (Agrawel et al. 2006). In contrast, some 
studies have reported contradictory results (Gore et al. 1998, Cutler et al. 2000, De Sanctis 
& Zucchelli 2000). However, considering all the publication data analysed together there is 
evidence that PAG in ILIA (-889) and IL1B (+3954) combination is a risk factor for 
periodontitis (Nikolopoulos et al. 2008). Up to date there were seven studies conducted in 
Asian populations in relation to the IL-1 gene cluster. (Four studies were conducted in 
China (Duan et al. 2002, Huang & Zhang 2004, Zhong et al. 2002, Tian et al. 2006), one in 
Thailand (Anusaksathein et al. 2003), one in Japan (Soga et al. 2003) and one in India 
(Agrawel 2006)). The results of these seven studies were pooled together and analysed to 
find out whether there is a significant detectable relationship with the IL-1 gene cluster with 
periodontitis (Nikolopoulos et al. 2008). Based on this analysis it was concluded allele 2 of 
IL1B (+3954) is a significant predictor of chronic periodontitis with double the hazard in 
populations of Asian origin. The sample sizes of these studies varied from 30 -182. The 
present study conducted with a sample size of 334 subjects however contradicts the meta 
analysis findings failing to observe a significant association between chronic periodontitis 
and PAG. The present sample however consists o f272 patients with diabetes, 12 IFG 
subjects and 60 controls. Assessed cytokine genotype is not the only contributory factor 
that determines the severity of periodontitis in such a group. Diabetes is also a risk factor 
for periodontitis and we have not accessed the microbiological factors (Plaque 
microorganisms) which are primary determinants of initiation of periodontitis. Previous 
studies that have reported significant difference in genotype distribution in patients with 
chronic periodontitis and controls. The failure of the present study to demonstrate such an 
association may be due to the true effects of genotype (expression is not induced mainly by 
the genotype but other factors) being overshadowed by the effects of diabetes and microbial 
associated factors that influence the severity of periodontitis.
PAG status may be an indicator for periodontal disease severity as measured by 
probing depth measurement. According to results observed in some studies PAG was 
correlated with severity of periodontitis as measured by attachment loss (McDevitt et al. 
2000, Papapanou et al. 2001). A, significant difference was observed between PAG status 
and mean probing depth (mean PD) in the present study. However, the PAG negative group 
shows higher mean PD (2.15 (1.64-2.39)} than PAG positive {1.87 (1.47-2.15)}.
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Smoking is another major environmental risk factor associated with increased incidence 
and severity of periodontitis (Page and Beck 1997).This study was not designed to assess 
the impact on smoking but recorded the smoking status of the participants in order to 
exclude them and study the effect of PAG on non smokers. Observations suggest a negative 
impact on periodontal health of tobacco smoking. This study group represents only 7.8% 
smokers and 12.3% of ex-smokers. Among 79.8% of never smokers only 11.7% were 
demonstrated PAG positive status and only 2.5% of them had chronic periodonititis. 
Komman and co-workers have found the association of PAG and aggressive periodontitis 
in non smokers. Those non smokers who were genotype positive had the same risk of 
disease as smokers who were either genotype positive or genotype negative. In addition 
PAG positive never smokers showed a significantly elevated chance of an increase in % 
bleeding on probing (BOP) (Lang et al. 2000). McGuire and coworkers found that PAG 
was significantly associated with extent of tooth loss after 14 years in 42 patients with 
chronic periodontitis and had an additive effect with smoking (McGuire et al. 1999). This 
provides evidence for interaction between smoking and genotype in conferring 
susceptibility to aggressive periodontitis. A study conducted by Parkhill and co-workers 
demonstrated that allele 1 carriers of IL1B (+3954) are significantly elevated in aggressive 
periodontitis in smokers. But no significant differences were found between IL1B (+3954) 
genotype or allele frequency in aggressive periodontitis non smokers and non smoking 
controls (Parkhill et al. 2000). In contrast to the original Komman study, in a cross 
sectional study of 154 chronic periodontitis patients PAG was associated with increased 
severity of disease in smokers but not in non smokers (Meisel et al. 2002). The present 
study observed difference in smoking status between males and females. This study group 
includes 51.5% females. Stratification according to smoking would be applicable only to 
males in the study group since all the females were non smokers except for one ex smoker. 
The negative impact on smoking status is apparently due to low number of smokers in the 
present analysis.
5.4.3 Population difference of PAG status and carriage rates
Although contradictory results were obtained for PAG in association with pathogenesis of 
periodontal disease a noteworthy finding of this study is the low percentage of PAG 
positive genotype in Sri Lanka. This study revealed it was only 12.6%. Komman et
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al.demonstrated 29.1% occurrence of PAG status in the North European subjects and 
36.3% prevalence in non smoking periodontal patients (Komman et al, 1997). A 40.6% rate 
has been found in Australians of essentially European heritage (Cullinan et al. 2000). In 
Sweden the 42.9% occurrence of the positive composite genotype is comparable to 
Australians but found to be significantly higher than North European subjects (Papapanou 
et al.2001). Another study reported a higher (41%) occurrence rate of the positive 
composite genotype of (ILIA (+4845) & IL1B (+3954) in cases and only 28% in controls, 
although the difference was not statistically significant (McDevitt et al. 2000). The 
composite genotype was found to occur at rates 35% in a sample of periodontally healthy 
subjects comprising both Caucasians and African Americans (Goodson et al. 2000). 35.3% 
of IL-1 genotype positive was observed in Switzerland (Caucasians of central European 
ancestry) (Lang et al. 2000). In Hispanics the percentage declines to 26% (Caffesse et al. 
2002). The prevalence of the composite genotype in Chinese heritage was 2.3% (Armitage 
et al. 2000). This shows variation of PAG distribution in different populations. The present 
study observed only 12.6% of PAG prevalence in Sri Lankans (Figure 5.18). This clearly 
shows that genotypes are distributed differently according to the population studied.
Disease prevalence rates also vary from population to population. For example the 
prevalence rate of diabetes in Sri Lanka is 14.2% and the prevalence of diabetes in the UK 
is 5.1%. Indeed, the exposure to environment factors also vary from population to 
populations thus, variations observed in genetic and environment factors which are the 
main contributors of a common complex disease would indicate that the pathogenesis 
mediates differently. Therefore population studies are a timely requirement for targeting 
genes relevant to different population, ethnic groups and to individuals.
When considering the carriage rate for IL1B (+3954), allele 1 was 80.5% whereas for allele 
2 it was 19.5% for present population. Carrier percentages of 55.4% and 44.6% were found 
for allele 1 and allele 2 of ILIA (+4845). When considering the carriage rates o f the alleles 
in different populations for ILIB (+3954) allele 2, previous studies showed 44.1% 
(Komman 1997) 40.6% (Gore et al. 1998) and 33.7% (Galbraith et al. 1999) in the USA, in 
Sweden 49% (Papapanou et al. 2001) With regard to ILIA  reported rates in the literature on 
the carriage of allele 2 o f ILIA (-889) locus were 50.5% in the USA (Komman et al. 1997) 
and 56.4% for ILIA (+4845) locus in Sweden (Papapanou et al. 2001). A recent study of
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subjects o f  Chinese heritage (Armitage et al.2000) revealed allele 2 carriage rates o f  3.3%  
(1L1B +3954) and 17% (ILIA +4845). It becomes increasingly clear however, that such 
rates should be expected to vary greatly between ethnically and/or racially distinct 
populations. Thus the results o f  this study indicates the observed carrier rates for IL1B 
allele 2 is comparatively low when compared some studies but relatively higher compared 
to Chinese population.
Population differences of PAG status
Figure 5.18 Variations seen in PAG status in different populations.
5.4.4 TNFA (-308) gene variant and periodontal disease.
This study observed no impact o f  this gene variation on periodontal status. However, 
negative co-relations were observed for periodontal parameters mean recession, mean loss 
o f  attachment and maximum loss o f  attachment. A relatively large num ber o f  studies have 
published the association between periodontal disease and polymorphism at position (-308) 
in the promoter region. However the meta-analysis o f all these data has revealed, overall 
there is lack o f  association between the allele 2 polymorphism and the susceptibility to 
chronic periodontitis (Nikolopoulos et al.2008). However, Fassmann and co-workers found 
a significant difference between the combined genotype (TNFA (-308) & Lym photoxin 
Alpha (LTA) (+252) between the control and the patient groups (Fassmann et al. 2003). No 
association was found between the allele 2 polymorphism o f  TNFA (-308) and ex vivo TNF- 
a  levels in Chilean patients with aggressive periodontitis and aggressive periodontitis in 
patients with type 1 diabetes (Perezl et al. 2004) but their study demonstrated that
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aggressive periodontitis combined with diabetes express higher LPS induced TNF-a 
concentration than healthy individuals. The number of studies conducted in periodontitis 
with type 2 diabetes in relation to TNFA (-308) polymorphism is limited. The present study 
is in accordance with the previous studies conducted in literature has observed no 
association of TNFA polymorphism with periodontal status.
5.4.5 TNFA and diabetes
The analysis of TNF gene polymorphism in relation to diabetes in the present study 
observed that TNFA-(308) genotype distribution is not significantly different in type 2 
diabetes patients compared to controls. When comparing three genotypes for blood 
chemical parameters, diabetes duration and BMI, the results implicated a significant 
difference in HDL cholesterol and the difference was associated with the AA genotype. 
Although the numbers are low for AA genotype these findings are similar to results found 
in a study conducted in a Taiwanese population (Shaiu et al. 2003). Shaiu and coworkers 
were also not able to observe a statistically significant variation in the distribution of three 
different genotypes between type 2 diabetes patients and controls however, high-density 
lipoprotein cholesterol (HDL) distribution was significantly different with TNF-a (238) 
genotypes (Shiau et al. 2003). These findings suggest that individuals with 
heterozygous (G/A) or homozygous (A/A) genotypes tended to have lower HDL and higher 
TOC/HDL levels. Additionally individuals with homologous TNFA (-308) (AA) genotype 
tended to have higher fasting blood glucose levels. These results imply that these two 
polymorphisms might be associated with HDL and glucose metabolism. TNFA (-308) 
genotype AA shows longer duration of diabetes (9.5 years) compared to GA (8.5 years) and 
GG (7.41 years). TNF-a is known to play a key role in mediating metabolic imbalance 
through insulin resistance. Insulin resistance eventually increases lipolysis and thereby lipid 
metabolism. Therefore results of this study confirm the conclusion reached by Taiwanese 
study, by concluding that TNFA (-308) cytokine polymorphisms may be associated with 
glucose metabolism. The observed allele 2 frequency (A) is very low in these two 
populations (1.5% in Taiwanese and 0.8% In Sri Lankans).
Discrepancies exists concerning the role of TNFA (-308) in type 2 diabetes pathogenesis.
An association has been reported in some (Fernandes-Real et al. 1997) but not in others
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(Walston et al. 1999, Koch et al. 2000, Rasmussen et al. 2000, Endo et al. 2001). A 
different scenario is reported by a cohort of elderly patients with diabetes in the 
Netherlands, the -308G/A polymorphism in the promoter of the gene encoding TNF-a 
strongly contributed to the risk of diabetes in subjects aged 85 years and over (Heijmans et 
al. 2002). Homozygosity of A allele conferred a more than four fold increased risk of 
diabetes. This is in agreement with the extensive evidence for a direct role of TNF-a in the 
etiology of insulin resistance and type 2 diabetes (Uysal et al. 1997, Hotamisligil et al. 
1994).
The distribution of these two alleles of TNFA is different among study subjects with 
different racial origins. The frequencies of TNFA (-308) allele 2 ranges from 9% in Hong 
Kong Chinese (Lee et al. 2000), 16% in French Scandinavian populations (Hoffstedt et al. 
2000 & Herrmann et al. 1998), 11.9 % -18%  in German (Koch et al 2000, Brand et al. 
2001), to 24% in Australians (Dalziel et al. 2002), 16% in Chileans ( Perezl et al. 2004) and 
ranges from 1.25% in Taiwanese (Shue et al. 2001), 3.5% in UK Caucasian (Grove et al. 
1997), 5.65% in US Caucasian (Walston et al. 1999) and 39.5% in the Spanish (Fernandes- 
Real et al. 1997). Therefore ethnic variation for allele distribution are suggested. In this 
study we have observed an allele frequency of 0.8%. When compared with available allele 
distribution data a low distribution o f allele 2 was observed among Japanese, Taiwanese 
and Sri Lankan populations, further strengthening the fact that ethnic variation may exist 
and contribute differently to the pathogenesis of a disease.
Summary
In summary this study does not support an association between periodontal diagnosis and 
ILIA (+4845), and IL1B (+3954) SNP polymorphisms. PAG percentage (12.6%) was 
relatively low when compared to PAG percentages of European populations but similar to 
the trend in other Asian populations. PAG positive status positively correlated with mean 
attachment loss. Thus PAG could be considered as a risk indicator for severity of 
periodontitis but may not act as a predictor. TNFA (-308) genotype showed no association 
with periodontal status and negatively correlated with some periodontal parameters. 
However, significant negative correlation of HDL with TNFA (-308) allele 2 implies this 
gene may have a role in diabetes pathogenesis.
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6.1 Introduction
The world is experiencing a pandemic of type 2 diabetes and its complications due to 
hyperglycaemia that is causing significant morbidity and mortality. Sri Lanka is a 
developing country in which the prevalence of type 2 diabetes has been observed at the 
very high rate of 10.3% in people > 20 years of age (Katulanda et al. 2008) and 14% in 
people above 35 years o f age (Wijewardena et al. 2005). The projected diabetes prevalence 
in Sri Lanka for the year 2030 is 13.9%, anticipating large numbers of people developing 
the disease in the near future (Katulanda et al. 2008). Insulin resistance is also very 
common. Impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG) also 
constitute a major public health problem. This pre-diabetic state is now recognized as a 
stage in the transition from normality to diabetes. Thus individuals with IGT are at high 
risk of progressing to diabetes, with 70% of affected individuals expected to develop the 
disease (Diabetes atlas 2003). In Sri Lanka, 36% of the people with diabetes were 
previously undiagnosed and 11.5% had pre-diabetes in the form of IFG or IGT (Katulanda 
et al. 2008). The challenge for the medical community lies in testing the right people in a 
timely fashion in order to identify high risk individuals because early treatment o f insulin 
resistance before the condition progresses to diabetes may have beneficial metabolic effects 
thus reducing the development of complications.
Previous studies have identified the burden of diabetes complications in the diabetic 
population at the time of diagnosis in Sri Lanka (Weerasuriya et al. 1998). In this study, 
periodontal disease was not recognized as a complication and data regarding the prevalence 
of the periodontal disease in patients with diabetes were lacking in this community. With 
the anticipated increasing number of patients with diabetes, the resulting burden of 
complications, morbidity and premature mortality is a major growing public health problem 
with huge economic impact in Sri Lanka.
Type 2 diabetes and periodontitis are both considered to be common complex diseases in 
which genetic and environmental factors play a role in the pathogenesis. These two diseases 
are systemically related as evidenced by observational and longitudinal studies. Therefore, 
people with diabetes are more prone to develop periodontal disease than those without and 
once periodontal disease is established in people with diabetes, it is probable that their
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underlying metabolic control is adversely impacted when compared to people with diabetes 
but not periodontitis. Chronic periodontal disease is an inflammatory disease initiated by 
bacterial plaque accumulation in the periodontium and inter-individual variation in cytokine 
secretion and tissue destruction has been observed in different individuals after controlling 
for the confounding factors of plaque, age, smoking and diabetes.
Within this context the principal aims of the present study were to determine the genetic 
contribution to type 2 diabetes based on family history in order to identify people who are 
at high risk of developing diabetes and to investigate the prevalence of periodontal disease 
in patients with type 2 diabetes. It has been observed that poorly controlled diabetes leads 
to increased prevalence of periodontitis in patients with diabetes; therefore the study 
investigated the effect o f level of glycaemic control on periodontal status. Identifying 
genetic risk factors for disease is also likely to become as important as an early diagnostic 
tool to identify people at risk for periodontitis. According to the periodontal literature, 
higher levels of cytokines have been observed in the periodontium of patients with 
destructive periodontitis. Furthermore, the genetic variants of cytokine genes IL-1 (IL1B 
(+3954) and ILIA (+4845) have been implicated as possible genetic markers for 
periodontitis. However, variable and contradictory results from different studies limit the 
conclusions that may be drawn with regard to this potential risk factor. Therefore, this 
study aimed to investigate the genetic variants of cytokine genes IL-1 (IL1B (+3954) and 
ILIA (+4845)) in association with periodontal disease. TNF-a which is mainly secreted by 
adipocytes is found in high levels in the plasma of patients with diabetes. This adipokine is 
known to inhibit insulin action by interacting with insulin receptor substrate 1 (IRS-1) thus 
leading to insulin resistance. Serum TNF -a  levels have also been reported to be higher in 
patients with periodontitis. This may have a potential role in contributing to poorer 
metabolic control in patients with periodontitis. Therefore, this study also aimed to 
investigate any relationship between TNFA (-308) polymorphism and periodontitis.
6.2 Implications of family history study and future directions
The relevance of genetic studies in diabetes is to achieve early diagnosis of people at risk of 
developing disease, and to minimise suffering and disability due to complications (Diabetes 
atlas 2003). In fact, family history data provide useful insights to identify people with a
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probable risk of developing disease compared to those people with no history of diabetes. 
The present analysis of family histories in one thousand patients indicates that the disease 
has a familial aggregation in 59.4% of the diabetic population studied in Sri Lanka. A 
stronger family history of diabetes associated with an earlier age of diagnosis of diabetes 
has also been observed in India (Vishwanathan et al. 1995). The results of the present study 
are therefore in agreement with those results observed in India, that the age of onset of 
diabetes is earlier if both parents o f the patient have diabetes.
A recently conducted study in the USA concluded that family history of diabetes has a 
graded association with prevalence of diabetes. They also identified that this association is 
detectable within strata of several well established risk factors for diabetes such as age and 
BMI. The basis of categorisation of family history was high, moderate and average in the 
US study. When a person has at least two first degree relatives or one first degree and at 
least two second degree relatives with diabetes from the same lineage, they are considered 
to have a higher risk of developing diabetes. If a person has just one first degree and one 
second degree relative with diabetes or only one first degree relative with diabetes or at 
least two second degree relatives with diabetes from the same lineage, this is considered to 
be moderate risk. If there is no family history of diabetes or at most, one second degree 
relative with diabetes, then these individuals are considered to have just an average risk of 
developing diabetes. Reliable estimates of the prevalence of familial risk of diabetes in the 
US population suggest that about 1 in every 3 adults has a moderate risk and about 1 in 
every 13 adults has a high risk of developing diabetes (Valdez et al. 2007).
This US study provides evidence for the feasibility of incorporating family history data as a 
risk factor for development of diabetes. It has also indicated that compared to people 
without a family history of diabetes, those that do have a family history of diabetes are two 
to six times more likely to have type 2 diabetes ( Harrison et al. 2003). Family history 
evaluation in another study in the USA also suggested that it may provide a useful 
screening tool for the detection and prevention of diabetes (Hariri et al. 2006). The present 
study lacks family history data for people who do not have diabetes in Sri Lankan 
population. Therefore, future studies should be directed at obtaining family histories in 
diabetes from a group of people who do not themselves have diabetes in order to establish
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and confirm the strength of using family history data as a predictor in relation to identify 
risk of developing diabetes.
Several genetic variants related to the risk for diabetes have been reported, but their use to 
estimate diabetes risk in populations is limited and has not been considered to be 
economical. A family history is relatively easy to obtain and conveniently conveys 
information on genes and environment shared by close relatives (Valdez et al. 2007). The 
results of the US study show that stratified familial risk combined with other readily 
available indicators of diabetes risk could be a great tool to identify segments of the 
populations at high risk for the disease (Valdez, et al. 2007). A universally agreed upon 
definition of what constitutes a positive family history o f diabetes that is also simple to 
collect would be necessary to establish and compare familial risk across Sri Lanka. Thus, 
incorporating family histories into screening programmes would be a cost effective method 
of identifying people at high risk of diabetes that could be used in a developing country like 
Sri Lanka. This area remains to be explored in the future.
The present study also established a DNA bank of samples from patients with type 2 
diabetes together with controls. Presently, DNA from 100 trios and 285 patients and 60 
controls are available. It is expected to expand this DNA bank in order to conduct genome 
wide association studies to identify genetic determinants of diabetes in relation to this 
population.
6.3 Implications of periodontal study and future directions
The major risk factors for periodontal disease are smoking (Tomar & Asma 2000) and 
diabetes (Nelson et al. 1990, Jansson et al. 2006). Over recent decades, in countries such as 
the USA, the proportion of individuals who smoke has reduced and it has been suggested 
that this has led to a reduction in the incidence of periodontitis of about 31% between 1955 
and 2000 (Hujoel et al. 2003). However, the projected prevalence of diabetes is increasing 
and we know that people with diabetes are more susceptible to develop periodontitis. 
Therefore, although decreases in the incidence of periodontitis may be attributable to 
reduced smoking until now, it is possible that the future will see an increase in the numbers
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of patients with periodontitis as a result of the increasing proportion of the population with 
diabetes.
Regarding an impact of periodontal treatment on glycaemic control, when mechanical 
periodontal therapy has been combined with systemic antibiotics, improvements in 
glycaemic control have been reported (Grossi et al. 1997, Kiran et al. 2005, Yun et al. 
2007). Data from experimental and observational studies suggest that the chronic 
inflammatory burden conferred by advanced periodontitis may contribute to a heightened 
inflammatory state, potentially contributing to poorer glycaemic control and the potential 
for increased development of complications via altered metabolic pathways. An association 
between inflammatory periodontal disease and diabetic nephropathy as well as kidney 
dysfunction has been reported (Naugle et al. 1998). Moreover, periodontal disease increases 
insulin resistance. Hyperinsulinemia, hyperglycaemia and dyslipidemia are all independent 
risk factors for arthrosclerosis (Bierman 1992). Undiagnosed, untreated diabetic patients 
with periodontitits are therefore potentially at increased risk of development of significant 
complications, and management of this high risk group should be a health care priority 
when treating people with diabetes. In other words, periodontal assessment and treatment 
would be of likely benefit as a routine management strategy in patients with diabetes.
A comparatively high prevalence rate of periodontitis was observed in both type 2 diabetes 
and control populations (33% and 21% respectively) in this study in Sri Lanka compared to 
prevalence data reported in the UK and USA (Kelly et al. 2000, Albandar et al. 1999). In 
addition, periodontal parameters such as mean recession, percent bleeding on probing, 
maximum probing depth, maximum loss of attachment, number of sites with probing depth 
>4mm and > 5mm were all significantly higher in people with diabetes when compared to 
controls. HbAlc values recorded in this study indicate that 54% of the patients had good 
glycaemic control. Moreover blood pressure scores and LDL values were significantly 
lower in the people with diabetes than the control group. This is likely because of effective 
medical management of the known diabetes patients, who were receiving medication for 
hypertension, together with cholesterol lowering drugs and their blood glucose level is 
controlled. Therefore this group of patients with managed diabetes may not represent a 
normal diabetic population in Sri Lanka. Therefore, contradictory results observed in this
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study compared to previous studies which reported significant associations between 
periodontitis and diabetes could have arisen because of the effective medical management 
of the diabetes patients in this study. However, when evaluating periodontal disease 
severity as measured by periodontal scores, it is clear that periodontitis is a serious health 
problem among the diabetic population in Sri Lanka. This statement extends to the control 
population as well. According to the results, roughly 1 in every 3 patients with type 2 
diabetes are affected with periodontitis and 1 in every 5 of the people in the general 
population are affected with the condition. When considering the group of people with IFG, 
66.7% of these were diagnosed with periodontitis.
It appears from the data that patients with diabetes may be more prone to develop 
periodontitis due to altered immune-inflammatory responses and susceptibility to infection. 
Once periodontal disease is established, the chronic nature of this infection may aggravate 
glycaemic control and contribute to worsening of diabetic status leading to increased risk of 
microvascular and macrovascular complications. Evidence observed for this relationship 
was reported in a longitudinal case control study which compared the development of 
diabetes complications over a period of 11 years in people with diabetes who also had 
periodontitis to a health / gingivitis control population. They reported significantly greater 
prevalence of proteinuria and cardiovascular complications in those subjects who had 
periodontitis at baseline (Thorstensson et al. 1996). Similarly, controlled clinical trials in 
which mechanical periodontal therapy was combined with systemic administration of 
antibiotics have reported improved glycaemic control (Positional paper 2000). These 
studies support the concept that periodontal disease and diabetes share common pathogenic 
pathways, and that successful treatment of either condition may have a positive impact on 
the other.
Development of diabetes complications is a long term process that occurs as a consequence 
of elevated hyperglycaemia. Periodontal destruction occurs as a result of inflammatory 
response of the immune system to the subgingival bacterial challenge. Type 2 diabetes is 
likely to modify the inflammatory response to the subgingival biofilm, and the net result of 
this is an increased severity of periodontitis that will require specific strategies for early 
intervention and treatment in this high risk population (Novak et al. 2008). Therefore,
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routine dental examinations and adequate oral hygiene should be emphasized as part of the 
standard care of people with diabetes.
One of the limitations of the present study is that there are unequal numbers of patients in 
each category of glycaemic control, with relatively fewer patients with moderate and poor 
control, compared to good control. This may also contribute to the variance between the 
results identified in this study, and those reported in previously published literature. 
Specifically, poor glycaemic control has usually been reported as a risk factor for 
periodontitis in populations with diabetes (Guzman et al. 2003) whereas such a finding was 
not identified in the present study. The lack of statistically significant findings may be 
related to the relatively smaller number of patients with poor glycaemic control in this 
study. Moreover, periodontal disease in diabetes is likely to be a long term complication 
as a consequence of progression of hyperglycaemia. This cross sectional study thus limits 
the interpretability regarding precise relations between development of periodontitis and 
glycaemic control. Although adjustments were made for confounding factors in the 
analyses, in observational studies such as this, the observed associations may be caused by 
unidentified underlying factors. It has been suggested that to circumvent these problems, 
prospective cohort studies should be designed (Pischon et al. 2006). Cohort studies would 
ideally be conducted by enrolling people without periodontitis or diabetes to assess disease 
progression over many years while monitoring individuals for a wide range of quantitative 
traits and lifestyle and exposure data which enable an evaluation of the joint effect of genes 
and environment. Clearly, in the context of a slowly progressing disease such as 
periodontal disease, the costs of such an approach would be prohibitive, however.
In their review Lamster and Lalla suggested that periodontal disease can be considered a 
microvascular complication of diabetes. They also suggested that conducting studies to 
determine the early development of gingival inflammation and periodontal disease in 
people with diabetes represents a risk for development of other complications (Lamster & 
Lalla 2001). Examining a larger cohort with IFG for periodontitis may provide useful 
information regarding the systemic links between the two diseases and increased risk of 
progression to diabetes in patients with both IFG and periodontitis.
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6.4. Implications of the genetic study and future directions
Research into human molecular genetics is now focused on identifying the genetic factors 
involved in complex diseases. If successful, identification of genetic risk factors could lead 
to early identification of individuals with an increased risk for a particular disease. Early 
diagnosis is always preferable, and is likely to result in much better treatment outcomes 
than late diagnosis. Furthermore, establishing the underlying genetic risk factors removes 
one variable from the study of the environmental/genetic interaction. Identification of 
environmental risk factors thus becomes easier and more precise. If the actual genetic cause 
of the disease can be elucidated by genetic testing, then treatment can be better fitted to the 
actual cause rather than the phenotype. Finally, cloning the genes and characterisation of 
the proteins they code for could provide opportunities for better understanding of disease 
pathogenesis and development of therapeutics (Sudbery 2002).
The IL1B , ILIA  genes were considered as ideal candidate genes for genetic studies in 
relation to periodontitis and TNFA in diabetes since the protein levels of these genes are 
elevated in periodontal tissues and diabetic plasma. Moreover, these genes contain SNPs 
and therefore act as molecular markers and are easy to identify by PCR based genotyping.
In this study IL1B (+3954), ILIA (+4845) and TNFA (-308) polymorphisms were studied 
in relation to periodontitis and diabetes. Population frequency analysis of IL1B (+3954), 
ILIA (+4845) and TNFA (-308) revealed that allele 1 and allele 2 frequencies were 0.9 & 
0.1, 0.74 & 0.26 and 0.91 & 0.09 respectively. The TNFA (-308) polymorphism deviated 
' from the frequencies observed in northern British Caucasians (Wilson et al. 1992) but was 
similar to that observed in Taiwan (Shiau et al. 2003) and Japan (Endo et al. 2001). This is 
an indication that certain gene frequencies are distributed differently in different 
populations and may have a direct interaction with the environment in that particular 
population and susceptibility to disease.
The composite genotype (PAG) demonstrated no significant associations with periodontal
status, either in diabetes patients, controls or non smokers (p>0.05) in the present
population. A noteworthy finding is that PAG shows great variation in people with
European ancestry. Greenstein and Hart questioned the rationale for testing for PAG as a
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predictor of susceptibility to periodontitis (Greenstein & Hart 2002). In the original 
Komman study, PAG status was determined by ILIA (-889) and IL1B (+3954) (Komman 
et al. 1997). In subsequent studies ILIA (+4845) and IL1B (+3954) was considered because 
ILIA (+4845) is in strong linkage disequilibrium with ILIA (-889). In their meta-analysis, 
Nikolopoulos and colleagues stated that when considering ILIA (+4854), only two studies 
yielded marginally insignificant results whereas for ILIA (-889) six studies were included 
the results reached significance (Nikolopoulos et al. 2008). Functional differences in the 
two SNP positions may be the result o f observed differences.
IL -la is produced as a 3 lKDa precursor protein and processed into a 17 KDa mature 
protein for export from the cell. Cleavage of precursor IL -la  involves the intracellular 
enzyme calpain. The polymorphism in the ILIA promoter at position -889 (C>T) is 
reported to affect the generation of IL -la  protein but not mRNA in short term cultures, with 
individuals carrying the rare TT genotype having higher levels than those with the CC 
genotype. The ILIA (+4845) polymorphism involve a substitution of 114th amino acid of 
pre IL-la. Pre IL -la  is processed into mature form by the enzymatic cut between 112 and 
113 amino acids (Dinarello 1996).
Several reports suggested the influence of -889 SNP on the transcriptional activity of ILIA  
gene (Dominici et al.2002). However, recent results on human skin fibroblasts indicate that 
the -889 SNP was not involved in transcriptional activity, possibly because the 
transcriptional regulation of the ILIA  gene might be different among different human cell 
types. Thus, further investigations of transcription of the ILIA  gene with -889 SNP in 
human cells would be needed (Kawaguchi et al. 2007). His results indicate that ILIA (-889) 
has no functional significance in the human fibroblast. However polymorphism analysis of 
ILIA (-889) variant with IL l-a  levels in gingival crevicular fluid of patients with 
periodontitis demonstrated that in the diseased population there was at least a four fold 
increase in the mean level of IL -la  protein in patients who carried one or two copies of the 
allele 2 of the ILIA (-889) gene variant when compared with those who were homozygous 
for allele 1 (Shirodaria et al. 2000). Thus multiple risk factors in which all are not genetic 
may determine concentrations of functional protein levels.
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Since ILIA (+4845) substitutes an amino acid in the ILIA  pre-protein this may have a 
direct functional consequence (Dinarello 1996). Phenotypic expression is a result of protein 
secretion. This could be a reason for the insignificant result observed with ILIA (+4845) 
when compared to ILIA (-889) (Nikolopoulos et al. 2008) similar to those reported in the 
present study. Thus, using PAG as a predictor for periodontitis still remains controversial.
It would be interesting to see how the leucocytes or fibroblasts of the patients who are PAG 
positive and PAG negative would respond to LPS. Determining the IL -la and IL-lp levels 
from such a group will help to elucidate the functional relationship between PAG status and 
clinical phenotype. It should also be remembered that common disorders with 
multifactorial pathogenesis such as periodontal disease are not likely to result from single, 
highly penetrant genetic variants, but are likely to be influenced by subtle phenotypic 
variations caused by common alleles of a number of polymorphic genes relevant to disease 
pathogenesis (Hart & Komman 1997). Therefore, future genetic tests should focus on 
number of polymorphic alleles that are invol ved in coding for proteins that are involved in 
periodontal pathogenesis.
Final conclusions
In conclusion this study was able to determine the genetic component of type 2 diabetes in 
Sri Lanka. When considering periodontal status, it is clear that periodontal disease is highly 
prevalent in Sri Lanka, and the condition is exacerbated in patients with diabetes. This 
should be taken into consideration when treating people with diabetes, to diagnose 
periodontal disease early, to implement treatment early, and to potentially improve quality 
of life. PAG status as a predictor for periodontitis still remains ambiguous and does not 
seems to correlate with severity of disease in this population. Functional studies (perhaps 
involving in vitro studies of PAG positive and PAG negative cell lines) would help to 
overcome the ambiguity. It is likely that testing for multiple polymorphisms of the genes 
that encode proteins that play a role in periodontal pathogenesis will help to identify genetic 
determinants that contribute to disease susceptibility. The constructed DNA bank provides 
valuable resource to study the genetic determinants of type 2 diabetes in this population.
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